Genetic mapping of the rat agu gene by Duran Alonso, Maria Beatriz
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
Genetic mapping of the rat agu gene.
by
Maria Beatriz Duran Alonso.
Thesis submitted to the Faculty of Science, University of Glasgow, 
for the degree of Doctor of Philosophy.
Department of Molecular Genetics.
September 1997.

The research reported in this thesis is my own original work 
except were otherwise stated and has not been submitted for 
any other degree.
Marla Beatriz Duran Alonso, September 1997.
*7o n t y  CfMUtcLffOtfoi, 
t& e m o 4 t tf ie c ia l fien& o*t u t t& e w m lc i.
C o n te n ts .
Contents.
Page No.
List of contents.
List of figures and tables.
Abbreviations.
Acknowledgements.
SUMMARY. 1
CHAPTER 1: General Introduction.
1.0 Introduction. 5
1.1 The AS/AGU sub-strain of rat: A new model of movement
disorder. 8
1.2 Parkinson’s Disease. 10
1.2.1 Parkinson’s disease and the basal ganglia. 11
1.2.2 Cause of Parkinson’s disease. Possible mechanisms of cell
damage. 16
1.2.3 Animal models. 21
1.2.4 Treatment of Parkinson’s disease. 23
1.2.5 Preclinical detection of Parkinson’s disease. 25
1.3 Identification of disease-causing genes. 27
1.3.1 Positional cloning approaches. 28
1.3.1.1 Genetic markers. 29
1.3.1.2 Physical mapping. 3 4
1.4 Aims of the project. 39
C o n te n ts .
CHAPTER 2: Materials and Methods.
2.1 Chemicals and biochemicals. 41
2.2 Oligonucleotides, enzymes, kits and other materials. 41
2.3 Nucleic acid isolation and manipulation. 42
2.3.1 Commonly used buffers. 42
2.3.2 DNA isolation. 43
2.3.2.1 Genomic DNA isolation. 43
2.3.2.2 Plasmid DNA isolation. 44
2.3.2.3 P1 DNA isolation. 45
2.3.3 Oligonucleotide synthesis. 47
2.3.3.1 Design ofprimers for PCR and sequencing reactions. 47
2.3.3.2 Synthesis and deprotection o f oligonucleotides. 47
2.3.4 Quantitation of nucleic acid. 48
2.3.5 PI DNA library. 48
2.3.5.1 The \>Ad\ OsacBII vector. 48
2.3.5.2 Construction o f the rat genomic DNA PI library. 5 0
2.3.5.3 Screening o f the PI library. 51
2.3.6 Polymerase chain reaction (PCR). 52
2.3.7 Labelling of DNA with 32P. 53
2.3.7.1 Labelling o f PCR primers. 5 3
2.3.7.2 Labelling o f oligonucleotides. 5 3
2.3.7.3 Labelling o f a 1 kb DNA ladder marker. 53
2.3.8 Digestion of DNA with restriction enzymes. 5 4
2.3.9 Gel electrophoresis. 54
2.3.9.1 Agarose gel electrophoresis. 54
2.3.9.2 Polyacrylamide gel electrophoresis. 55
2.3.9.3 Molecular weight markers. 56
2.3.10 S outhem blotting. 5 6
2.3.11 Hybridisation of oligonucleotides to filter bound nucleic acid. 57
2.3.11.1 Removal of unincorporated radionucleotide. 57
2.3.11.2 Prehybridisation. 5 7
2.3.11.3 Hybridisation and washing. 5 8
C o n te n ts .
2.3.12 Photography/Autoradiography. 58
2.3.13 QIAEXII-DNA agarose gel extraction and purification in
aqueous solutions. 58
2.3.14 Removal of the 5' phosphate from linearised DNA. 5 9
2.3.15 Shotgun cloning of P 1 DNA fragments. 60
2.3.16 Ligation of DNA fragments. 60
2.3.17 Colony hybridisation. 60
2.3.18 Sequencing. 61
2.3.18.1 Preparation o f DNA templates. 61
2.3.18.2 Sequencing o f DNA templates. 63
2.3.19 Computer-assisted sequence analysis. 65
2.4 Statistics. 65
2.5 E. coli strains. 67
2.6 Plasmid vectors. 67
2.7 Media for propagation of E. coli. 67
2.8 Antibiotics and indicators. 68
2.9 Sterilisation. 69
2.10 E. coli growth conditions. 69
2.11 Preservation of E. coli strains. 70
2.12 PI DNA transfer into DH10B by an Ff episome intermediate. 70
2.13 Introduction of plasmid DNA into E. coli. 72
2.13.1 Preparation of competent cells. 72
2.13.1.1 Electrocompetent cells. 72
2.13.1.2 CaCl2 method. 73
2.13.2 Transformation procedures. 73
2.13.2.1 Electro-transformation. 13
2.13.2.2 Transformation o f CaCl2-competent cells. 74
C o n t e n t s .
CHAPTER 3: Establishment of a rat genetic genome scan.
3.1 Introduction. 76
3.1.1 Development of the rat genetic map. 76
3.1.2 Considerations in the establishment of informative crosses
to the AS/AGU sub-strain. 80
3.2 Results. 81
3.2.1 Initial set of SSLPs: Optimisation of the PCR conditions. 81
3.2.2 Selection of parental strains. 82
3.2.3 Optimisation of further SSLPs. 82
3.2.4 Clarification of an ambiguous result. 85
3.3 Discussion. 89
3.3.1 Factors affecting the reliable interpretation of typing data. 89
3.3.2 Establishment of an efficient large scale typing system. 89
3.3.3 Strain distribution pattern of alleles at 103 microsatellite loci. 91
CHAPTER 4: Localisation of the aeu locus to a single chromosomal region.
4.1 Introduction. 94
4.2 Results. 94
4.2.1 Identification of the chromosome which carries the agu gene. 96
4.2.2 Narrowing the chromosomal region to which the agu gene
maps. 96
4.3 Discussion. 105
CHAPTER 5: Development of new genetic markers.
5.1 Introduction. 110
5.1.1 Development of new SSLP markers. 110
5.1.1.1 Amplification o f rat genomic DNA with 
heterologous mouse SSLP primers. I l l
5.1.1.2 Isolation o f rat PI genomic clones for SSLP
analysis. I l l
C o n te n ts .
5.2 Results. 113
5.2.1 Identification of P1 clones containing DNA sequences
from the region of interest. 113
5.2.2 Sequence confirmation of the PCR product obtained from
a single PI clone. 113
5.2.3 PI DNA isolation from a positive single clone. 113
5.2.4 Transfer of PI clones to DH10B. 121
5.2.5 Observed instability of the P1 (DIMcol) clone. 121
5.2.5.1 Loss o f the DIMcol sequence. Growth on solid
media. 121
5.2.5.2 Transfer o f PI (DIMcol) to DH1 OB cells. 123
5.2.5.3 Stability o f the PI (DIMcol) clone in the DH10B
host strain. 124
5.2.6 Identification of repeat sequences in PI inserts. 126
5.2.6.1 Subcloning o f gel-purifiedfragments. 131
5.2.6.2 Shotgun cloning o f Sau3AI-Pl digests. 137
5.2.7 Establishment of new SSLPs. 139
5.2.7.1 Observed instability in one o f the PI (DIMcol) 
subclones. 140
5.2.8. Evidence of chimaerism in the P1 (DIMcol) clone. 143
5.2.9 Sequencing of the PI insert ends. 143
5.3 Discussion. 145
5.3.1 Comparative mapping. 145
5.3.2 Amplification of rat genomic DNA with heterologous
mouse primers. 146
5.3.3 Rat bacteriophage PI library. 146
5.3.3.1 Screening of the PI library. 147
5.3.4 Comparison of PI DNA extracted from two different host
strains. 147
5.3.5 Identification of new rat S SLPs. 148
5.3.6 The V\(DlMcol) clone. 150
5.3.6.1 Instability of the P1 (DIMcol) clone. 150
5.3.6.2 Characterisation of P1 (DIMcol) as a chimaeric
clone. 151
C o n te n ts .
CHAPTER 6; Precise mapping of the a2u locus.
6.1 Introduction. 154
6.2 Results. 154
6.2.1 Search for strain differences at the newly identified SSLP
loci. 154
6.2.2 Mapping of the new informative SSLPs. 157
6.2.3 Mapping of the R158 micro satellite locus. 161
6.3 Discussion. 165
6.3.1 Mapping of new rat SSLPs. 165
6.3.2 Mapping of closer markers. 167
CHAPTER 7: Reassignment of the microsatellite locus DlMehl8 to rat chromosome 3.
7.1 Introduction. 169
7.2 Results. 171
7.2.1 Strain differences at the DlMghl8 locus. Typing of
[AS/AGU x (AS/AGU x F344) FI] offspring. 171
7.2.2 Cloning of the DlMghl8 PCR product. Sequence 
confirmation. 171
7.2.3 Mapping of the DlMghl8 locus. 173
7.2.3.1 Screening o f somatic cell hybrid clones. 173
7.2.3.2 Linkage analysis. 176
7.3 Discussion. 178
CHAPTER 8: General discussion.
8.0 Introduction. 181
8.1 Precise genetic mapping of the agu mutation. 181
8.1.1 Approaches to the chromosomal localisation of agu. 181
8.1.2 Approaches to the precise mapping of agu. 185
C o n te n ts .
8.2 Future work. 188
8.2.1 Physical mapping of the agu region. 188
8.2.2 Identification of genes in the agu region. 189
8.2.3 Identification of the agu mutation. 191
8.3 Final remarks. 193
8.3.1 The agu gene and the molecular basis of movement disorder. 193
8.3.2 Future development of the rat genetic map. 194
APPENDIX A. 196
APPENDIX B. 205
REFERENCES. 208
List of Figures and Tables.
Chapter 1.
Figure 1-1. Diagram of the brain regions which are affected in Parkinson’s
disease. 13
Figure 1-2. Simplified overview of the basal ganglia-thalamo-cortical
circuitry. 14
Figure 1-3. Antioxidant systems in dopaminergic neurons. 20
Figure 1-4. Diagram showing the steps commonly involved in positional
cloning. 38
Chapter 2.
Figure 2-1. Map of the $Ad\0sac8R vector and cloning region. 49
Chapter 3.
Figure 3-1. Resolution of PCR products on 4% MetaPhor agarose gels. 83-84
Figure 3-2. Resolution of ‘CASAGl’-PCR products on an 8%
polyacrylamide gel. 88
Table 3-1. Strain differences observed at each of a series of 29 SSLP loci. 86
Chapter 4.
Figure 4-1. Diagram showing the possible combinations of phenotype and
the amplification pattern for a given SSLP locus in the backcross 
progeny. 95
Figure 4-2. Typing of [AS/AGU x (AS/AGU x BN) FI] progeny with SSLP
markers. 97
Figure 4-3.
Figure 4-4. 
Figure 4-5.
Table 4-1. 
Table 4-2.
Table 4-3.
Table 4-4.
Table 4-5.
Table 4-6.
Figure 5-1. 
Figure 5-2.
Figure 5-3.
Figure 5-3.
Figure 5-4.
Figure 5-5. 
Figure 5-6.
Typing of backcross animals with SSLP markers which are linked
to the agu gene. 101
Linkage maps for rat chromosome 1. 107
Probable order for DlMgh7 and Kal on rat chromosome 1. 108
Segregation of agu and SSLP alleles in backcross progeny. 98
PCR conditions and SDP of alleles corresponding to nine SSLP 
markers on chromosome 1. 99
Linkage estimates between informative SSLP markers on 
chromosome 1 and the agu locus. 100
Order of loci on rat chromosome 1, based on the typing of 
[AS/AGU x (AS/AGU x BN) FI] offspring. 102
Order of loci on rat chromosome 1, based on the typing of 
[AS/AGU x (AS/AGU x F344) FI] offspring. 102
SSLP-containing loci known to map or putatively mapping to
the region flanked by DlM itl and Kal/DlMgh7 on rat
chromosome 1. 104
Chapter 5.
Design of a CAmm-specific PCR primer set. 114
BLAST searches with the sequences obtained from amplification 
with (a) the CKM forward primer and (b) the CALM3 reverse 
primer. 115
(A) Confirmation of the DIMcol sequence obtained from a
P1 (DIMcol) culture. 116
(B) Sequence alignment of the DlGul02-PCR product obtained
from the P I{Scnnlb) clone and the rat Scnnlb gene. 117
Comparison of the PI DNA obtained following various methods 
of isolation. 119
P 1 (DIMcol) DNA that has lost the DIMcol marker sequence. 120
Effects of IPTG and the host strain on P1 DNA yields. 122
Figure 5-7. Instability of the ¥\{DlMcol) clone. Loss of the DIMcol
sequence. 125
Figure 5-8. Apparent stability of the P1 (DIMcol) clone in the DH1 OB host
through consecutive subcultures. 127
Figure 5-9. Further confirmation of instability in the P1 {DIMcol) clone. 128
Figure 5-10. (A) PI(Scnnlb) DNA. Screen for repeat sequences. 129
Figure 5-10. (B) ¥\{DlMcol) DNA. Screen for repeat sequences. 130
Figure 5-11. Subclones of the PI {Scnnlb) clone. Screen for repeat sequences. 132
Figure 5-12. Subclones of the PI {Scnnlb) clone. Screen for repeat
sequences. 134-135
Figure 5-13. Subclones of the PI {Scnnlb) clone. Screen for repeat sequences. 136
Figure 5-14. Subclones of the PI {Scnnlb) clone. Screen for repeat sequences. 138
Figure 5-15. Evidence of chimaerism in the V\{DlMcol) clone. 144
Table 5-1. Newly established rat SSLPs. 149
Chapter 6.
Figure 6-1. Resolution of the amplification products obtained with the
primer setDlGul6. 156
Figure 6-2. Typing of [AS/AGU x (AS/AGU x F344) FI] offspring with
the primer set DIGu 16. 158
Figure 6-3. Resolution of DIGulS PCR products on a 6% polyacrylamide gel. 159
Figure 6-4. Screening of a panel of mouse x rat somatic cell hybrids with
the primer set (D1 )Gu 13. 160
Figure 6-5. Resolution of amplification products obtained from multiplexed
R191/D 1 Gu 10 PCR reactions. 164
Table 6-1. Allelic differences at newly developed SSLP loci. 155
Table 6-2. Assignment of (Dl)Gul3 and (Dl)Gul8 to rat chromosome 8.
Confirmation of the location of DIMcol on rat chromosome 1. 162-163
Chapter 7.
Figure 7-1. Typing of [AS/AGU x (AS/AGU x F344) FI] progeny with the
primer pair CYS S. 172
Figure 7-2. Strain distribution pattern of DlMghl8 alleles. 172
Figure 7-3. Sequence confirmation of the DlMghl8 PCR product with the
rat Cys S gene. 174
Figure 7-4. Screening of rat x mouse somatic cell hybrid clones with the
primer set CYS S. 175
Figure 7-5. Order of the loci (Dl)Mghl8, D3Mit4 and Scn2a on rat
chromosome 3. 176
Table 7-1. Assignment of the DlMghl8 SSLP locus to rat chromosome 3. 177
Table 7-2. Correlation of the presence or absence of the (Dl)Mghl8 PCR
product with each of the chromosomes 1 and 3 in a panel of 
14 mouse x rat somatic cell hybrid clones. 178
Chapter 8.
Figure 8-1. Composite map of the agu-containing region in rat
chromosome 1. 182
Appendix A.
Figure A-l. Rat genetic linkage map, taken from Yamada et al. (1994). 197-198
Figure A-2. Rat genetic linkage map, taken from Jacob et al (1995). 199-202
Figure A-3. Linkage maps for rat chromosome 1, taken from
Gu etal. (1996). 203
Figure A-4. Linkage maps for rat chromosome 1, taken from
Ding et al. (1996). 204
Abbreviations.
ATP adenosine triphosphate.
BAC bacterial artificial chromosome,
bp base pair.
BSA bovine serum albumin.
°C degrees centigrade.
CEPH Centre Etude Polymorphisme Humain.
Ci curie.
cM centimorgan.
cpm counts per minute.
DGGE denaturing gradient gel electrophoresis.
dH20  distilled water.
dNTP deoxyribonucleotide triphosphate.
DTT dithiothreitol.
EDTA ethylene diamine tetra acetate,
g gramme.
GABA gamma amino butyric acid.
GDRDA genetically directed representational difference analysis.
GPi globus pallidus internal segment.
GPe globus pallidus external segment.
GSH reduced glutathione.
IPTG isopropyl p-D-thiogalactopyranoside.
kb kilo base pairs.
MAO-B monoamine oxidase B.
Mb megabase,
mg milligramme.
pCi microcurie,
pi microlitre,
mmol millimol.
MPP+ N-methyl-4-phenylpyridinium.
MPTP 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
ng nanogramme.
6-OHDA 6-hydroxydopamine.
PAC PI-derived artificial chromosome.
PCR polymerase chain reaction.
PD Parkinson’s disease.
PEG polyethylene glycol.
pmol picomol.
RAPD random amplified polymorphic DNA.
RDA representational difference analysis.
RFLP restriction fragment length polymorphism.
RNase ribonuclease.
SAP shrimp alkaline phosphatase.
SD standard deviation.
SDP strain distribution pattern.
SDS sodium dodecyl sulphate.
SN substantia nigra.
SNc substantia nigra pars compacta.
SNr substantia nigra pars reticulata.
SOD superoxide dismutase.
SSC standard saline citrate.
SSCP single-strand conformation polymorphism.
SSLP simple sequence length polymorphism.
STN subthalamic nucleus.
Taq Thermus aquaticus.
TBE Tris-borate/EDTA buffer.
TE Tris-EDTA.
TEMED N,N,N’ ,N’-tetramethylethylene diamine.
Tris Tris (hydroxymethyl) aminomethane.
U units of enzyme activity.
u v ultraviolet light.
V volts.
VTA ventral tegmental area.
W Watts.
X-gal 5 -bromo-4-chloro-3 -indolyl- p-galactopyranoside.
YAC yeast artificial chromosome.
Abbreviations.
AS Albino Swiss.
AS/AGU Albino Swiss/Anatomy Glasgow University.
ATP adenosine triphosphate.
BAC bacterial artificial chromosome.
BN Brown Norway,
bp base pair.
BSA bovine serum albumin.
°C degrees centigrade.
CEPH Centre Etude Polymorphisme Humain.
Ci curie.
cM centimorgan.
cpm counts per minute.
DGGE denaturing gradient gel electrophoresis.
dH20  distilled water.
dNTP deoxyribonucleotide triphosphate.
DTT dithiothreitol.
EDTA ethylene diamine tetra acetate.
F344 Fischer 344.
g gramme.
GABA gamma amino butyric acid.
GDRDA genetically directed representational difference analysis.
GPi globus pallidus internal segment.
GPe globus pallidus external segment.
GSH reduced glutathione.
IPTG isopropyl P-D-thiogalactopyranoside.
kb kilo base pairs.
MAO-B monoamine oxidase B.
Mb megabase,
mg milligramme.
pCi microcurie,
pi microlitre,
mmol millimol.
MPP+ N-methyl-4-phenylpyridinium.
MPTP 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine
ng nanogramme.
6-OHDA 6-hydroxydopamine.
PAC PI-derived artificial chromosome.
PCR polymerase chain reaction.
PD Parkinson’s disease.
PEG polyethylene glycol.
pmol picomol.
PVG black hooded strain of rat.
RAPD random amplified polymorphic DNA.
RDA representational difference analysis.
RFLP restriction fragment length polymorphism.
RNase ribonuclease.
SAP shrimp alkaline phosphatase.
SD standard deviation.
SDP strain distribution pattern.
SDS sodium dodecyl sulphate.
SN substantia nigra.
SNc substantia nigra pars compacta.
SNr substantia nigra pars reticulata.
SOD superoxide dismutase.
SSC standard saline citrate.
SSCP single-strand conformation polymorphism.
SSLP simple sequence length polymorphism.
STN subthalamic nucleus.
Taq Thermus aquaticus.
TBE Tris-borate/EDTA buffer.
TE Tris-EDTA.
TEMED N,N,N’ ,N’-tetramethylethylene diamine.
Tris Tris (hydroxymethyl) aminomethane.
U units of enzyme activity.
u v ultraviolet light.
V volts.
VTA ventral tegmental area.
W Watts.
X-gal 5-bromo-4-chloro-3-indolyl-(3-galactopyranoside.
YAC yeast artificial chromosome.
Acknowledgements.
I would like to thank my supervisors, Prof. Wayne Davies and Dr. Roger 
Sutcliffe for their advise and comments on the writing of this thesis. I acknowledge 
Prof. Martin J. Brodie, from the Western Infirmary of Glasgow, for his support. Thanks 
also to my assessors, Dr. Thora Glencorse and Dr. John Clutterback.
In the lab, I would like to thank Dr. David Livingstone, Dr. Paul Shiels, and Dr. 
Denise Donald for their advise, and Lynn Loughlin and Irene Houghton, for their 
invaluable assistance. Thanks to Dr. Greg Stewart for taking time to show me how to 
carry out automated sequencing. Many thanks to Mary Gardiner; it has been a real 
pleasure to work next to her. Thanks to Robert Heeley for his encouragement and for so 
many useful tips. A special thanks to Eunice-Georgia Stefanou, who has helped me get 
this thesis printed, spending extra time that she did not have.
Thanks also to the people in the Anatomy department for their help, especially 
to Prof. Tony Payne, Dr. Jackie Campbell and Dr. David Russell, for being so kind and 
helpful, and to Neil Bennett for doing such a great job.
My gratitude to the ladies in the prep-room, the wash-room, and the store, for 
making life so much easier and always brightening the day. Many thanks to Mary Burke 
and to Robert MacNab, for their kindness and for coming to the rescue in more than 
one occassion.
A special thank-you to Jenny Robertson and Pierre Schembri for their frienship. 
Thanks also to my “fellow brothers”, Maurice, Tam, Ed, David and Hong for letting me 
share some very good moments with them.
Most of all, I want to thank all my family for their love and support. Very 
especially, I want to thank my mom, for her love, her understanding, her patience, and 
my brother, my best friend. Thanks to my father, for ‘daring’ me not to give up when 
everything looked black. A special thanks also to Hrvoje, who has given me the love 
and the strength I needed to overcome very painful and difficult moments in the last 
two years.
I thank my grandfather, the best model a person could ever have. I thank him for 
always being there for me, for giving me his strength.
I acknowledge the receipt of a CASE studentship from the BBSRC, held in 
conjunction between the Division of Molecular Genetics and Western Infirmary of 
Glasgow.
S u m m a r y .
SUMMARY.
In 1993, a mutant strain, AS/AGU arose spontaneously in an enclosed colony of 
the Albino Swiss (AS) strain of rat, kept at the Anatomy department in Glasgow 
University. AS/AGU animals exhibit a set of locomotor abnormalities. They display a 
general instability and whole body tremor, are slow at initiating movement, show 
reductions in purposeful action, and perform poorly at locomotor tests such as mid-air 
righting. Moreover, there is evidence that these abnormalities are associated with a 
decrease in the levels of dopamine in the midbrain, and it has been demonstrated that L- 
dopa administration or fetal midbrain transplants reverse the majority of the symptoms, 
resembling the observations made on Parkinson’s disease patients. These features make 
the AS/AGU strain a useful model for movement disorders due in significant part to 
failure of the dopaminergic transmission system.
Crosses of AS/AGU to other laboratory rat strains point to a single recessive 
mutation with essentially complete penetrance (<agu/agu) as the cause of the abnormal 
phenotype. There is no evidence of sex linkage or maternal inheritance. In the absence 
of any evidence of the function of the agu gene product, positional cloning of this locus 
was begun.
The first step was the establishment of a genetic map location for the agu locus. 
A large series of microsatellite markers were analysed and used to identify which of the 
strains PVG, BN, and F344 differed to a greater extent from AS/AGU. Differences at 
43%, 62% and 47% of the loci were recorded, respectively. BN and F344 were therefore 
selected as the reference strains in backcrosses to AS/AGU, in an attempt to maximise 
the number of informative markers which could be used to type the progeny. Linkage 
analysis studies on the backcross offspring identified linkage of one of the markers to 
agu, thus revealing the chromosomal location of this gene. Utilisation of a further set of 
microsatellite loci which had been previously described on the particular chromosome 
led to the establishment of two microsatellite-based linkage maps of the agw-containing 
region, defining a 25-30 cM interval. A more precise localisation of the gene was not 
possible at this point as other microsatellite loci already mapped to this region did not 
show allelic differences in our backcrosses. New markers were consequently developed.
1
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The corresponding region of synteny in mouse was identified, and mouse 
microsatellite primers used to amplify rat genomic DNA. Approximately 30% of these 
primer sets yielded a single amplification product. However, no size difference was 
observed between the products obtained from each of the parental strains in the 
backcrosses and further analyses were not carried out.
New microsatellite markers were isolated from PI clones. Selection of these 
clones was carried out by screening for the presence of PCR products from sequenced 
loci known to map or putatively mapping to the agw-containing region. These latter 
consisted of rat homologues of mouse sequences which had been mapped in the mouse 
region of synteny.
PI clones were grown in the presence of sucrose, in order to select for molecules 
which had not lost the insert. Since the PI plasmid is kept at a single copy, the copy 
number was induced by adding IPTG a few hours prior to harvesting the cells. Several 
methods were used to isolate PI DNA, with purification through a CsCl gradient 
yielding the best results, in terms of quality and quantity of plasmid DNA isolated. In 
addition, the effect of the bacterial host on the plamid DNA was assayed, by comparing 
the yields obtained from the original host, NS3529, and those obtained from DH10B 
cultures. Prior to these experiments, PI DNA was transferred, via y5-transposition, from 
the former to the latter strain. Clearly higher yields and better DNA quality were 
observed with the DH10B strain. Moreover, no alterations were observed when growing 
DH10B cells carrying a recombinant PI which had been previously shown to be 
unstable in the NS3529 host.
A series of new markers were established. Three of these were shown to be 
informative between AS/AGU and F344. Consequently, the agw-region was narrowed 
down to an interval of approximately 11 cM. A fourth marker which was also 
informative between the aforementioned strains was shown to map to a different 
chromosome than expected. The corresponding chromosomal location was identified by 
screening a panel of somatic cell hybrids with the primer set. Two uninformative 
markers had been isolated from the same PI clone. Their chromosomal location was 
therefore analysed. One of them was demonstrated to map on the newly identified 
chromosome. The other could not be mapped, as both the mouse and the rat DNAs
2
S u m m a r y .
yielded PCR products of the same size. Further analyses of the corresponding PI clone 
demonstrated that this was chimaeric. This was the same clone that had been shown to 
be unstable during the growth of NS3529 cultures.
Further refinement of the agu region resulted ultimately from the release of new 
rat genetic maps in 1996, which contributed several new markers to the project. One of 
these microsatellites was shown to be informative in both the BN and the F344 
backcrosses and mapped at less than 0.5 cM from agu. This marker was thus selected as 
the starting point for the physical mapping of this region of the rat genome.
Thus the goal of this work, to obtain a genetic map location for agu, was fully 
achieved, and enabled a rapid entry into the physical mapping and gene identification 
phase of positional cloning of the agu gene.
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C h a p t e r  1. G e n e r a l  i n t r o d u c t i o n .
CHAPTER 1
General Introduction.
C h a p t e r  1. G e n e r a l  i n t r o d u c t i o n .
1.0 Introduction.
Pathological states such as Duchenne muscular distrophy (Hoffman et al., 
1987), hemophilia A (Lawn, R.M., 1985; Antonarakis and Kazazian, 1988) and Wilson 
disease (Bull et al., 1993; Tanzi et al., 1993) result from alterations in a single gene and 
show a simple pattern of inheritance. In contrast, many common disorders such as 
diabetes (Davies et al., 1994a; Hashimoto et al., 1994), hypertension (Sever, 1995) and 
Alzheimer’s disease (Farrer et al., 1991; Rao et al., 1996), involve the interaction of 
genetic and environmental factors. In many of these cases, no clear inheritance pattern 
is observed, as the presence of individual factors may not be sufficient to lead to 
disease. Moreover, different genetic and/or environmental factors may each cause 
apparently the same disease phenotype (e.g. Alzheimer’s disease). These features make 
pathogenesis more difficult to investigate in multifactorial diseases. A genetic 
component can usually be deduced from the incidence of disease in first degree 
relatives to probands, compared with the incidence in the general population. 
Comparisons are also established, whenever this is possible, between the risk in 
monozygotic and in dizygotic co-twins. Similarly, identification of regions of identity 
by descent (IBD) between individuals who are not closely related is facilitated in 
isolated populations, who are highly inbred (Nystuen et al., 1996). Environmental and 
genetic factors can be implicated in observed discontinuities in disease incidence in the 
different populations.
Extensive searches for the genes involved in either monogenic or multigenic 
diseases in man could not be attempted until recently, except in the instances where a 
single locus was responsible for the mutant phenotype and this appeared associated to a 
particular allele at a locus of known position in the genome. Initial studies to identify 
disease-loci were based on available biochemical markers and on genetic markers 
(section 1.3) known as minisatellites (Jeffreys et al., 1985) and restriction fragment 
length polymorphisms (RFLPs) (Botstein et al., 1980). The more recent development of 
highly polymorphic (i.e. different alleles of the particular locus exist in the population), 
PCR-typable markers known as microsatellites (Weber and May, 1989; Litt and Luty,
1989), has allowed the establishment of high-resolution human genetic maps 
(Weissenbach et al., 1992; Gyapay et al., 1994; Murray et al., 1994). In turn, the 
availability of an array of markers distributed all throughout the genome permits 
systematic genome-wide screens for genetic linkage of mutant genes. Yet, analysis of 
the components in the development of disease states in man can be very complex.
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Important complications arise from (i) the genetic heterogeneity in man; (ii) the 
impossibility to control the environmental agents the individuals are exposed to; and (iii) 
incomplete pedigrees, as a result of the long time span that separates each generation. It 
is thus very difficult for studies of inheritance in man to be based on the physical 
examination of more than three generations. Many diseases are not manifest early in life 
(e.g. Parkinson’s disease), further hindering the analyses, as older relatives will be 
deceased by the time the illness becomes symptomatic in an individual. The generally 
small size of the families adds to the problem of getting enough samples to study 
segregation patterns. Considerable effort has gone into eliminating, at least partly, some 
of these impediments. Extensive computer-based statistical tests are now available that 
deal with multifactorial diseases (Weeks and Lathrop, 1995). Human lymphoblastoid cell 
lines have been established at the CEPH (Centre d’Etude du Polymorphisme Humain) 
which can be indefinitely propagated in the laboratory. Therefore, data obtained with 
different genetic markers in different projects can be pooled together, on the basis of 
having used these same reference families (Dausset et al., 1990).
Animal models have been traditionally used to aid the identification of disease 
genes in man. The advantages that these models offer are multiple. Inbred strains are 
most frequently employed, which carry a single allele at the majority of the homologous 
loci; these genotypes greatly facilitate the analysis of inheritance in the progeny obtained 
from crosses between strains. Moreover, segregation in laboratory animals can be 
followed up throughout many generations and on a larger scale than in human families. 
Genetic background and the environmental conditions can be actively controlled, 
facilitating the dissection of the various genetic and environmental components in a 
disease, and the study of their contribution to the observed phenotype. In this way, loci 
can also be identified which do not exert a strong effect on the disease phenotype (i.e. 
modifier genes). A possible involvement of any of the identified factors in specific human 
diseases can then be assessed. Comparative mapping plays a crucial role in these studies 
(Eppig and Nadeau, 1995); human homologues of various genes found to be responsible 
for pathological states in research animals have already been shown to be the cause of 
similar alterations in man. An example of this is the gene
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Pax-3, associated to both the mutant ‘splotch’ phenotype in mouse and the human 
Waardenburg syndrome type 1 (WS1) (Tassabehji et a l, 1992).
Recently, new approaches have been developed which are based on the creation 
of transgenic animals. These genetically engineered animals carry a mutated gene or set 
of genes, thus allowing the study of the effect that modifications of the gene(s) have on 
the living organism. Nevertheless, modelling of the human genetic lesion in research 
animals may not lead to the same pathology. Differences in the phenotypic expression 
of a particular mutation can correlate to differences in the biochemical pathways. A 
clear example is found in the murine models of the Lesch-Nyhan syndrome. In these 
animals, the gene coding for the enzyme hypoxanthine phosphoribosyltransferase 
(HPRT) has been disrupted, in an attempt to mimic the human disorder. However, not 
until a second pathway (adenine phosphoribosyltransferase-dependent) is disrupted, do 
these animals exhibit some aspects of the Lesch-Nyhan disease (Wu et al., 1993). 
Moreover, different alterations in the same gene can result in different phenotypes. An 
example is observed in models of p-thalassaemia. Insertional disruption of the P-major 
gene causes severe thalassaemia in mice, in contrast to the milder form which results 
when this gene is deleted (Shehee et a l, 1993). Furthermore, development of a disease 
phenotype may not only depend on the occurrence of a particular alteration of the 
genotype, but also on the presence of other genomic sequences. In this way, transgenic 
mice which carry the full-length cDNA found in Huntington’s disease patients show no 
behavioural abnormalities, the CAG repeat being remarkably stable. This suggests the 
effect of other genomic sequences on repeat instability in man (Goldberg et al., 1996).
Animal models can be classified into two major groups: (a) induced models 
(Kumar et a l , 1995; Sengstock et a l , 1994), where the pathological symptoms 
exhibited by the animal have been caused by the researcher through surgical 
interventions, controlled diets, treatment with chemicals, and (b) spontaneous models 
(Li et a l, 1991; Muramatsu et a l, 1994; Loscher et a l, 1996), which arise due to 
alterations in the genotype or to intercrossing of standard strains which are selected for 
phenotypes of interest. The former allow the establishment of correlations between 
structure and disease. Important observations can be made during these analyses which 
lead to the development of future ways to improve or cure similar pathologies in man. 
Nevertheless, these models are induced and thus do not necessarily relate to the 
mechanisms involved in pathogenesis in man. Identification of the factors underlying
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the mutant phenotype in spontaneous animal models can provide more reliable clues 
towards the establishment of causative agents in human disease.
In 1993, a mutant sub-strain, AS/AGU (agu/agu), arose spontaneously in an 
enclosed colony of the Albino Swiss (AS) strain of rat, kept at the Anatomy department 
in Glasgow University. These animals exhibit locomotor abnormalities which have been 
correlated to alterations in the basal ganglia, resembling various aspects of Parkinson’s 
disease in man (Clarke and Payne, 1994; Campbell et al., 1996a). Identification of the 
gene responsible for the mutant phenotype in these rats is expected to provide new 
information on mechanisms of degeneration of dopaminergic systems in the midbrain. It 
could also offer a new candidate gene for studies on PD families. A positive correlation 
of allelic variation at this locus and the occurrence of Parkinson’s disease would validate 
the AS/AGU mutant sub-strain as a true model for the disease. Studies on these animals 
could reveal particular biochemical pathways of possible involvement in PD and also aid 
the development of treatments which at least ameliorate some of the symptoms observed 
in the patients. A brief description of the AS/AGU sub-strain of rat is presented below 
(section 1.1). Various aspects of Parkinson’s disease in humans are then discussed 
(section 1.2); laboratory animals of current use in the study of PD are also presented. 
An overview of the mapping tools and techniques presently available to the researcher is 
given in section 1.3.
1.1 The AS/AGU sub-strain of rat: A new model of movement disorder.
The AS/AGU sub-strain of rat exhibits a series of neurochemical and behavioural 
abnormalities which appear to involve the basal ganglia. Locomotor abnormalities of 
AS/AGU rats are first observed at around postnatal day 10, and reliable assessment of 
the phenotype is possible at 4-6 weeks. While impairment can be detected from an early 
age, the disorder is progressive. A major characteristic of the fully developed condition is 
a marked difficulty in initiating movement. The rats show rigidity of the hindlimbs 
resulting in a staggering gait and a tendency to fall over every few steps; a slight whole 
body tremor is detectable (Clarke and Payne, 1994). A battery of non-invasive 
neurological locomotor tests allows the confirmation of the mutant phenotype. These 
tests are concerned with a) movement frequency; b) latency of
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initiation of movement; c) stability when going down a slanted plank; d) capability to 
right itself in mid-air during a 50 cm drop from an upside-down position. AS/AGU 
animals are slow at initiating movement, they fail to show purposeful movement, and 
they perform very poorly in the two latter tests.
The sub-strain is true breeding and crosses between these animals result in 
offspring which are all affected. Conversely, crosses between this sub-strain and others 
(AS, Sprague-Dawley) yield FI animals which are all normal. Backcrosses of the FI 
progeny to the AS/AGU parent give both normal and affected litters in a ratio of 1:1. 
These observations point to a single recessive mutation of full penetrance as the cause of 
the abnormal phenotype. The AS/AGU karyotype appears normal. Reciprocal crosses 
yield equivalent phenotypic ratios, arguing against either sex-linked or maternal 
inheritance (Campbell et al., 1996a).
Analyses of the CNS structures in AS and AS/AGU animals do not reveal any 
gross abnormalities. In contrast to the weaver mouse, which exhibits a severe reduction 
in striatal dopamine levels and has been proposed as a model of Parkinson’s disease 
(section 1.2.3), AS/AGU animals do not present any abnormality in the gross histology 
of the cerebellum. It has been observed that the SN pars compacta (SNc) of AS/AGU 
rats is thinner than normal, correlating to a decrease in the number of tyrosine 
hydroxylase (TH)-immunoreactive (TH-ir) neurons in this area (Clarke and Payne,
1994). Tyrosine hydroxylase is the enzyme that catalyses the synthesis of catecholamines 
and is a marker for dopaminergic cells.
Loss of TH-ir neurons is accompanied by an overall reduction in the levels of 
dopamine in the neostriatum of the AS/AGU animals, compared to AS rats (Payne et al., 
1994; Campbell et al., 1996a). Analyses by micropunch followed by high performance 
liquid chromatography with electrochemical detection (HPLC-ECD) indicate that the 
dorsal and the middle regions of the caudate-putamen are most affected, with reductions 
of around 30-35% and 25% in dopamine levels, respectively. Ventral and anterior 
regions are less affected (Campbell et al., 1996a). This topographic specificity is also 
observed in the weaver mouse (Roffler-Tarlov and Graybiel, 1984), and resembles that 
seen in PD patients (Kish et al., 1988). Assessment of the dopamine levels in animals of 
3, 4, 6, 9, and 12 months of age has demonstrated that significant differences between 
AS and AS/AGU rats are only observed from 6 months onwards (Campbell et al., 
submitted). Interestingly, the reduction observed in dopamine levels in AS/AGU animals 
by post mortem micropunch is much smaller than that recorded when
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dopamine is sampled from the extracellular fluid of the striatum by microdialysis 
(reduction of the order of -80%) (J.M. Campbell, A.P. Payne and T.W. Stone, personal 
communication). This suggests that the agu mutation is associated with a defect in the 
functional release of dopamine in the striatum. In addition to dopamine depletion, 
AS/AGU animals show deficits in the noradrenalin levels, resulting from neuronal loss at 
the locus coeruleus (Scott et al., 1994). Depletion of serotonin levels is also recorded 
(Stewart et al., 1994). Studies of [14C]2-deoxyglucose uptake on 43 separate regions of 
the brain of AS/AGU and AS control animals have indicated a significant reduction of 
20-25% in metabolic activity in the SNc, the subthalamic nucleus and the ventrolateral 
thalamus of AS/AGU rats. Smaller, but not statistically significant reductions in 2- 
deoxyglucose uptake have been observed in other brain areas (A. Lam and J. McCulloch, 
personal communication).
Both acute and chronic administration of L-dopa reverse some of the locomotor 
abnormalities observed in AS/AGU animals and restore dopamine levels in the 
neostriatum to those observed in AS animals. Although the rats do not lose their 
disordered hindlimb gait, they show greatly increased frequency of initiation of 
movement, more extensive periods of movement, and ability to execute a righting reflex 
and walk down an inclined ramp. Essentially the same response is observed in animals 
which have been treated with a high dose of L-dopa for 5 days, and in rats that have 
been given a much lower dose of 25mg/kg/day for 4 weeks (Campbell et al., 1997). 
Reversal of the locomotor dysfunction is also observed following fetal midbrain 
transplants into the striatum. These responses resemble those observed in PD patients 
(section 1.2.4).
1.2 Parkinson’s Disease.
Parkinson’s disease is a motor system disorder, firstly recognised by James 
Parkinson in 1817. It shows a world-wide distribution and its incidence rate increases 
steeply with advancing age. The symptoms usually appear between the ages of 50 and 
70, although approximately 5 to 10% of the patients are under the age of 40.
Parkinson’s disease demonstrates a great deal of clinical heterogeneity (Poewe 
and Wenning, 1996); different patients can show different combinations and severity of 
symptoms. Primary symptoms are a characteristic “pill-rolling” tremor, muscular
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rigidity, a significant impairment in movement initiation (akinesia), a reduction in the 
amplitude and velocity of voluntary movements (bradykinesia), and impaired balance 
and co-ordination. Other symptoms may accompany the former, such as visual deficits, 
speech and handwriting alterations, olfactory dysfunction, difficulty in chewing and 
swallowing, memory loss, skin problems; dementia is also shown by a proportion of the 
patients.
The motor disturbances are known to result mainly from the destruction of a 
very high proportion of dopamine-producing cells, primarily located in an area of the 
ventral midbrain known as the substantia nigra pars compacta (SNc). At least 70% of 
these dopamine-producing cells either die or become impaired in Parkinson’s disease 
sufferers. This is in clear contrast to the loss of approximately 4% of the original set of 
dopamine-producing neurones observed during normal ageing. Loss of dopaminergic 
cells results in greatly decreased levels of dopamine in the striatum, the main receptor 
area for the SNc. This region of the brain controls movement, balance, and walking. In 
addition to the dopamine deficiency in the striatum, the dopamine levels are also 
reduced in other parts of the brain related to the corticolimbic system. A deficiency in 
noradrenaline, another chemical transmitter, has also been observed. Noradrenaline is 
found primarily in the locus coeruleus and the lateral tegmental area, both involved in 
governing the involuntary autonomic nervous system. Likewise, the levels of serotonin 
and gamma amino butyric acid (GABA) can also be lower in PD patients than in non- 
affected individuals. These deficiencies may account for some of the secondary 
symptoms in the disease. A brief description of the neurochemical pathways affected in 
Parkinson’s disease is given in section 1.2.1. Characteristic in Parkinson’s disease is the 
presence of eosinophilic inclusions in the degenerating neurones. These formations, 
known as Lewy bodies (LBs), are also observed in other neurodegenerative processes 
such as Alzheimer’s disease, as well as in the brains of normal aged individuals, and 
could be just markers of neurodegeneration (Langston, 1996).
1.2.1 Parkinson ’s disease and the basal ganglia.
The human basal ganglia [Figure 1-1] include the neostriatum, formed by the 
putamen and the caudate, and the globus pallidus, subdivided into an internal segment 
(GPi) and an external segment (GPe). The substantia nigra (SN), which comprises the 
substantia nigra pars reticulata (SNr) and the substantia nigra pars compacta (SNc),
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and the subthalamic nucleus (STN) are also normally included in the basal ganglia, due 
to their close anatomical and functional association to the neostriatum and the globus 
pallidus. Together, these structures form a forebrain system which receives signals from 
various parts of the brain and integrates the information, directing then the execution of 
appropriate responses (Parent, 1990) by selecting patterns of motor activity. The 
neostriatum is the main ‘receptor’ area. Different pieces of information arrive here 
through separate pathways. The overall division observed in the neostriatal input is 
maintained in its output through the globus pallidus and the SN (Alexander and 
Crutcher, 1990). Moreover, a higher level of compartmentalization has been observed 
within the target nuclei. In this way, for example, the neostriatum appears divided in 
striosomes and matrix; these areas differ in their biochemical constituency and establish 
different connections with other neural structures (Graybiel, 1990).
Controlled motor activities are the result of complex interactions between the 
cortex, the basal ganglia, and other areas of the brain such as the thalamus (Graybiel, 
1990; Parent, 1990; Smith and Bolam, 1990; Alexander and Crutcher, 1990) [Figure 1- 
2]. Information is sent from the cortex to the neostriatum by neurons that use excitatory 
amino acids (EAAs), mainly glutamate, as a transmitter. The neostriatum processes 
incoming sensorimotor information with messages from the SNc which seem to 
respond to signalling from the limbic system. Two striatal output pathways have been 
identified: a ‘direct’ pathway, which involves the GPi and the SNr, and an ‘indirect’ 
pathway, which involves the GPe and the STN. Inhibitory GABA-ergic signals sent 
from the neostriatum to the GPi and to the SNr result in the disinhibition of thalamo­
cortical neurons and thus favours motor activity. Inhibitory GABA/enkephalin signals 
from the neostriatum to the GPe leads to the disinhibition of the STN, which then sends 
excitatory glutamatergic signals to the GPi and to the SNr, therefore reinforcing the 
inhibitory action of these latter on the thalamus. Disinhibition of the thalamo-cortical 
neurons results in excitatory signals to various premotor cortical areas. This is, 
however, an oversimplified description of the interactions involved in the control of 
motor and other related activities. Different subpopulations of neurons can be present 
within the same structure (e.g. in the neostriatum, in the GPe) which are involved in 
opposite responses. Additional complexity results from the existence of other 
connections between the different structures (e.g. the STN also innervates the
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BRAIN STEM
CORTICAL REGION 
CONTROLLING MOTION
STRIATUM 4
CAUDATE l> 
PUTAMEN
SUBSTANTIA NIGRA
FIGURE 1-1. Diagram of the brain regions which are affected in Parkinson’s disease, 
taken from Youdim and Riederer (1997).
The subthalamic nucleus, located below the thalamus, is not shown.
Loss of dopamine-producing neurons, particularly marked in the substantia nigra pars 
compacta (SNc), leads to imbalances in neurochemical transmission, which ultimately 
affect motion.
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Cerebral Cortex
Brainstem 
Spinal cord
Thai
GPi/SNr
FIGURE 1-2. Simplified overview of the basal uanulia-thalamo-cortical circuitry, 
taken from Alexander and Crutcher (1990).
Open symbols indicate excitatory neurons and filled symbols inhibitory neurons. 
Striatal cholinergic intemeurons, thought to receive signals from both the cortex and 
dopaminergic neurons (Carlsson and Carlsson, 1990), are not shown. Intrinsic feedback 
loops and other connections between the nuclei exist which are not presented in this 
diagram. GABA-ergic projections also carry: enkephalin (enk), to the GPe; substance P 
(subst P) and dynorphin, to the GPi; either enkephalin or substance P and/or dynorphin 
to the SNr (Fernandez and Dujovny, 1997).
Other abbreviations not shown in the text: 
glu: glutamate.
DA: dopamine.
PPN: pedunculopontine nucleus.
Thai: thalamus.
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neostriatum), as well as from intrinsic feedback loops within each nucleus; these are not 
shown in Figure 1-2.
Fine regulation of both the innervation of target areas and the response to 
received signals seems to correlate to complex interactions between the various 
neurochemicals in the brain. Disruption of the normal balance between them can lead to 
movement disorders (Calabresi et al., 1996; Chesselet and Delfs, 1996). As mentioned 
above, dopamine depletion is the pathological hallmark of Parkinson’s disease. 
Dopamine is the main carrier of signals between the SNc and the neostriatum and plays a 
major role in neurotransmitter expression in the striatal cells (Graybiel, 1990) and in the 
control of purposeful muscle activity through several mechanisms. The activity of 
dopaminergic neurons regulates glutamatergic signalling from the cortex (Calabresi et 
al., 1996). The mechanism is not clear yet, although an interaction of both glutamatergic 
and dopaminergic messages at cholinergic interneurons in the neostriatum is suspected
I
! (Carlsson and Carlsson, 1990; Fernandez and Dujovny, 1997). Dopaminergic
| transmission also plays a crucial role in the integration of information received from
j  sensorimotor areas and from limbic centres, associated to emotion and motivation.
| Messages sent from the latter to the neostriatum are translated into specific signals from
i
the SNc to the striatal areas involved in motor functions. Dopamine exerts different 
| actions on different subpopulations of striatal neurons. It activates the ‘direct’ pathway,
therefore decreasing the phasic inhibition of thalamo-cortical neurons by the GPi and the 
SNr, and it inhibits the striatal output to the ‘indirect’ pathway, increasing the inhibition 
of the STN by the GPe. Both responses favour motor activity. Dopamine depletion in 
Parkinson’s disease results in a decreased striatal output through the ‘direct’ pathway 
and in increased activity of the STN in the ‘indirect’ pathway. Overactivity of the STN in 
PD does not correlate to an expected inhibition of the GPe and it is thought to result 
from other interactions (Chesselet and Delfs, 1996); these could correspond to signals 
from the cortex or from the SNc, which also innervate this area.
Other dopaminergic areas are also affected in parkinsonian brains, although to a 
lesser extent. This is the case of the ventral tegmental area (VTA), associated to the 
limbic circuitry. Serotonin levels, which are high in the normal basal ganglia, are reduced 
in both the striatum and the globus pallidus in PD patients. A 50-85% loss of!i
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noradrenergic neurons in the locus coeruleus has also been reported, associated to a 40- 
70% decrease in the noradrenaline concentrations in the cortex and limbic receptor 
areas.
The fact that Parkinson’s disease does not become clinically manifest until the 
striatal dopamine levels are decreased to about 20% of the normal levels seems to 
indicate the action of some compensatory mechanism to maintain striatal dopamine 
transmission. Increased dopamine biosynthesis by the remaining neurons, 
hypersensitivity of the dopamine receptors in the striatal neurons, and dopamine 
synthesis in striatal cells which do not normally produce this neurochemical are some of 
the possible explanations for the delayed appearance of PD symptoms (Zigmond et al.,
1990). Decreased levels of dopamine-transporter, involved in the reuptake of dopamine 
from the synapse and thus in the termination of neurotransmission, have been observed 
in the remaining nigral cells in the brain of PD patients (Harrington et al., 1996). 
Although this reduction could represent an attempt to increase synaptic dopamine 
concentrations, Harrington et al. (1996) consider it to be more likely the result of 
decreased activity of these neurons.
1.2.2 Cause o f Parkinson*s disease. Possible mechanisms of cell damage.
Despite its world-wide incidence, the cause of most of the cases of Parkinson’s 
disease is still unknown. Initial studies on monozygotic and dizygotic twins argued 
against an important role of genetic factors in the pathogenesis of PD, as the 
concordance rates observed were very low (Duvoisin et al., 1981). Moreover, most 
cases of PD are sporadic; only a few families present multiple affected individuals. The 
occurrence of several cases of PD in a family does not necessarily imply the 
involvement of genetic factors, since, given the high incidence of this neuropathology, 
this could be merely coincidental. These facts, together with the observation that 1- 
methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), a chemical found in impure drug 
preparations, causes neuronal damage similar to that seen in PD, suggested an 
environmental origin of this disease (Rajput, 1993). In agreement with this hypothesis 
were also the reports on a higher risk of PD in rural settings, where exposure to 
herbicides, pesticides and drinking well water were put forward as risk factors. 
However, no geographic clustering of PD cases is observed. This is one of the reasons 
that have led to what is currently the most accepted hypothesis for the cause of PD,
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which proposes the action of environmental factors that determine the development of 
Parkinson’s disease in genetically susceptible individuals (Poirier et al., 1991; Burn et al., 
1992; Langston, 1996). It seems clear that ageing is also a contributing factor. 
Supportive of a genetic involvement in PD are the results obtained when applying newer 
techniques such as positron-emission tomography (PET) scanning of the brain of patients 
and normal co-twins or other relatives. This method allows one to detect the levels of 
striatal 18F-6-fluorodopa (18F-dopa) uptake and thus the assessment of the ability of the 
striatum to convert exogenous L-dopa to dopamine. A reduction of at least 35% of 
putamen 18F-dopa uptake is observed in PD patients, whilst the caudate is relatively 
spared (Brooks, 1991). Brooks (1991) also reports a subnormal putamen 18F-dopa 
uptake in some of the unaffected twins in monozygotic and dizygotic pairs, as well as in 
some relatives of Parkinson’s disease sufferers. These and other subsequent studies 
(Burn et al., 1992) show that the concordance rates between twins are higher than was 
previously considered. Ambiguous diagnostic criteria and, possibly, the classification of 
subclinically affected co-twins as unaffected in the initial studies, probably account for 
the discrepancy in the results. Given that PD becomes usually manifest in the later stages 
of life, absence of parkinsonian symptomatology in the co-twin of a PD case does not 
exclude the possibility that the former will also become affected later on. Genetic factors 
have already been established in some of the familial cases of PD (Polymeropoulos et al., 
1996; Polymeropoulos et al., 1997). Harris and coworkers (1995) reported that a 
mutation in the ceruloplasmin gene leads to abnormal iron metabolism and, ultimately, to 
basal ganglia degeneration, as seen in PD. Genetic anticipation has been observed in 
some cases of Parkinson’s disease, and the involvement of an unstable trinucleotide 
repeat proposed (Payami et al., 1995). Since both the familial and the sporadic cases of 
Parkinson’s disease appear identical, it seems probable that genetic factors are also 
involved in the latter. The occurrence of PD is considered to result from the action of a 
single major gene, with low penetrance, in interaction with other loci which exert a 
smaller effect, or from the interplay of several loci (multifactorial model) (Lazzarini et 
al., 1994); the genetic factors are thought to interact with environmental agents 
(Johnson, 1991; Bum et al., 1992). Low penetrance could explain the absence of various 
cases in a family, as these are normally too small for a second case to occur. The fact 
that symptoms appear only when the levels of striatal dopamine are greatly reduced 
seems to point at a threshold operating in PD.
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Deficient DNA repair mechanisms, the absence of a dopaminergic specific 
growth factor provided by the normal target striatal cells to the SN neurones, 
excitotoxicity, disturbances of calcium homeostasis, or a viral infection that, like the 
poliomyelitis virus, selectively destroys specific neuronal populations, are some of the 
factors which have been proposed as causative agents of the neurodegeneration observed 
in Parkinson’s disease (Poirier et al., 1991; Koller, 1997). A viral aetiology seems, 
however, improbable, as injections of parkinsonian brain tissue extracts into monkeys 
have failed to induce PD in these animals; nevertheless, this could be explained by 
different responses to viral infections in different primates. There is some evidence 
supporting a role of the immune system in PD. McGeer and colleagues (1988) reported 
activated microglia in the basal ganglia of parkinsonian brains. Furthermore, both the 
serum and the cerebrospinal fluid of a large proportion of PD patients carry an antibody 
that reacts with the dopamine neurons. Production of this antibody seems to follow 
release of an encrypted antigen from degenerating dopamine cells. Therefore, it may 
contribute to disease progression, rather than being the cause of neurodegeneration 
(Carvey etal., 1991).
The close resemblance between PD and MPTP-induced toxicity strongly suggests 
the action of an MPTP-like environmental toxin in Parkinson’s disease. Susceptibility to 
the toxin(s) could be dictated by metabolic errors such as deficient detoxification by 
enzymes like the hepatic cytochrome P-450 system or like those involved in sulphur 
metabolism (Williams et al., 1991; Tanner, 1991; Langston, 1996), as these enzymes 
control the type and the quantity of chemical toxins that enter the brain. Were this the 
case, exposure of the individual to otherwise inoffensive doses of a certain compound 
could lead to PD. The pattern of neuronal loss characteristic of this pathology could 
result from the presence of specific uptake systems for the toxin in these populations of 
cells.
It has also been hypothesised that neuromelanin, a product of the oxidation of 
dopamine, plays a role in toxicity (Poirier et al., 1991; Furtado and Mazurek, 1991). 
This concept is based on the observations that the presence of neuromelanin-bearing cells 
correlates mostly to the areas of cell loss in PD, that this pigment accumulates with age, 
and that aged animals are more susceptible to MPTP-induced parkinsonism than young 
ones. It has been proposed that neuromelanin could be permitting a long-
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term trapping of toxic compounds taken up by the cells. On the other hand, not all the 
areas affected in PD are melanized.
Studies on the mechanism of MPTP-toxicity suggest that abnormalities in the 
mitochondria could lead to the development of Parkinson’s disease. The absence of 
maternal inheritance in PD does not rule out this possibility, since several of the 
mitochondrial proteins are in fact encoded by the nuclear DNA. Furthermore, 
heteroplasmic mitochondrial mutations could lead to a non-Mendelian pattern of 
inheritance, as observed in Leber’s hereditary optic neuropathy (Holt et al., 1989; 
Brown et al., 1992). A significant reduction of the activity of Complex I at the SN and 
the striatum has indeed been demonstrated in several PD patients. Complex I-deficiency 
is not specific to this pathology, and it can be found in other disorders such as 
Huntington’s disease (Parker, 1991). The mitochondrial abnormalities seen in PD could 
thus be a secondary effect rather than the cause of neurodegeneration, although it must 
be kept in mind that the same phenotypic alteration can be the result of different 
biochemical defects.
The hypothesis of a “free radical toxicity” proposes that the neuronal death 
observed in PD results from oxidative damage to the cell by the formation of free 
radicals (Olanow, 1992; Jenner and Olanow, 1996). Contrary to early reports, it is now 
believed that many of the antioxidant defenses appear intact in PD patients [Figure 1-3]. 
Interestingly, an increase in the activity of superoxide dismutase (SOD) is observed. 
The levels of reduced glutathione (GSH), involved in the clearance of H20 2 by the 
enzyme glutathione peroxidase, are lowered in parkinsonian brains (Perry et al., 1982). 
Studies on animal models suggest that, rather than leading to nigral pathology on its 
own, GSH depletion renders the dopaminergic system susceptible to toxins (Owen et 
al., 1996). These alterations in antioxidant mechanisms run parallel to higher than 
normal levels of iron, particularly in the SN and striatal areas (Sofic et al., 1988). Free 
iron is considered a potential catalyst of free radical reactions. The high concentrations 
of iron measured in PD brains do not correlate to increased levels of ferritin, which 
binds iron. This suggests that the excess iron exists in its free form. The high iron levels 
do not correlate either to increased numbers of transferrin receptors on the surviving 
melanized neurons in PD. In contrast, the levels of lactoferrin, which strongly binds 
iron, and lactoferrin receptors, are increased in the SNc of PD patients. This could lead 
to increased intracellular iron levels (Faucheux et al., 1997). An increase in the iron
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FIGURE 1-3. Antioxidant systems in dopaminergic neurons.
Diagram taken from Poirier et al (1991). GSSG: oxidized glutathione. GSH: reduced 
glutathione. SOD: superoxide dismutase. 0 2 * : superoxide radical. • OH: hydroxyl 
radical.
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levels is not specific for PD, and it is observed in other neurodegenerative disorders. It 
could thus be a secondary effect in the disease. Nonetheless, it probably is a 
contributing factor to the pathology. These observations on PD brains could well relate 
to increased oxidative stress, with the accumulation of free radicals (OH', NO', 0 2 ) and 
concomitant damage to cellular structures. There are reports on oxidative damage to 
lipids, DNA, and proteins in the brain of Parkinson’s disease patients, although the 
contribution of drug treatments to this damage has not been clearly evaluated yet.
1.2.3 Animal models.
No suitable genetic animal models have been available to date for the study of 
Parkinson’s disease. The weaver mouse shows a loss of dopamine neurons in the SNc 
and a severe decrease in striatal dopamine levels (Roffler-Tarlov and Graybiel, 1984). 
However, other areas affected in PD patients, such as the locus coeruleus, are normal in 
these animals. Moreover, important cerebellar abnormalities, which are not seen in PD, 
are associated with the weaver phenotype. Weaver mice carry a mutation (wv) in a gene 
encoding a G-protein coupled inward rectifier potassium channel (GIRK2) (Patil et al.,
1995). This mutation results in the replacement of a glycine for a serine in a Gly-Tyr- 
Gly motif in the H5 pore region, leading to loss of selectivity for K+. Mutant wvGIRK2 
channels conduct Na+ as well as K+ (Tong et al., 1996). Moreover, these channels show 
constitutive activation, which could be a secondary consequence of intracellular Na+ 
accumulation (Silverman et al., 1996). The Na+ influx must, in turn, enhance the 
channel activity. In addition, wvGIRK2 channels are also permeable to Ca2+, providing 
another mechanism for cellular degeneration in the weaver mouse (Silverman et al.,
1996). Sequencing of the human homologue of the weaver gene in fifty PD patients 
demonstrated no abnormalities. These results suggest a different etiology for the nigral 
degeneration observed in weaver mice and in PD in man (Bandmann et al., 1996). 
Nevertheless, the failure to establish a correlation between the human homologue of the 
weaver gene and PD in the patients studied could merely reflect that allelic variations at 
this locus are not responsible for a large proportion of the PD cases in the general 
population.
Damage models are normally employed which mimic the parkinsonian 
symptoms. By studying the mechanisms involved in the abnormal phenotype, clues may 
be obtained to the possible pathways leading to PD in man (Langston, 1996). As
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indicated above (section 1.2.2), successful identification of mitochondrial abnormalities 
and deficiencies in detoxifying enzymes has been carried out in human patients following 
initial observations on experimental animals. These models also play a crucial role in the 
development of possible treatments for the parkinsonian symptoms. The benefits of L- 
dopa, selegiline, and other drugs, as well as those of surgical interventions 
(transplantation of fetal tissue, pallidotomy) are some examples (section 1.2.4).
Two damage models of PD are mainly employed, obtained by treatment with 
either MPTP, or with 6-hydroxydopamine (6-OHDA). The mechanism of MPTP- 
induced neurodegeneration has been clearly elucidated (Furtado and Mazurek, 1991). 
Toxicity occurs when MPTP crosses the blood brain barrier before it is converted by 
MAO-B to its active form, N-methyl-4-phenylpyridinium ion (MPP+). MPP+ formation in 
the brain takes place mainly in astrocytes. MPP+ is then released into the extracellular 
fluid and taken up by the dopaminergic cells, into their mitochondria. Here, MPP+ 
inhibits the enzyme system Complex I, first stage of the mitochondrial electron transport 
chain. This can lead to a rapid depletion of ATP levels, gradually decreasing energy 
levels, and generation of free radicals.
MPTP-models closely resemble the clinical and biochemical features of PD in 
man (DeLong, 1990; Furtado and Mazurek, 1991). Although not all the animals develop 
the characteristic resting tremor, they show muscular rigidity, akinesia and bradykinesia. 
Damage to the dopaminergic neurons in the SNc and decreased dopamine levels in both 
the SNc and the striatum are observed. There is also some degree of cell loss in the locus 
coeruleus and the raphe, resembling that in PD patients. Interestingly, this damage is 
associated with eosinophilic intraneuronal inclusion bodies, resembling Lewy bodies. 
Large variations in the vulnerability to MPTP-toxicity are observed between different 
species. A correlation between neuromelanin levels and MPTP toxicity has been put 
forward, in an attempt to explain the greater susceptibility shown by primates and 
humans when compared to rodents. The observation that older animals are more 
sensitive to MPTP toxicity than young ones supports this concept. On the other hand, 
rats show a natural resistance to the toxic action of MPTP. Comparative studies between 
Brown Norway rats and C57BL mice (Zuddas et a l, 1994) suggest that the different 
vulnerability to MPTP observed in these animals may result from differences in the 
intraneuronal distribution of MPP+. Differences in the vesicular storage of MPP+ and its 
release could mediate susceptibility to MPTP toxicity.
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Interestingly, Harrington and coworkers (1996) observed decreased levels of a synaptic 
vesicle amine transporter, VMAT2, in the SNc of PD sufferers. This transporter is 
responsible for the repackaging of dopamine into synaptic vesicles and its expression has 
been associated to resistance to MPP+ in in vitro cell lines (Liu et al., 1994). 
Nevertheless, Harrington et al. (1996) reported that some of the remaining nigral cells in 
PD appeared shrunken and atrophied, despite a considerably strong VMAT2 signal.
Neurotoxicity of the dopamine analogue 6-OHDA requires direct administration 
of the drug into the brain, as it can not cross the blood-brain barrier. This neurotoxin is, 
like MPTP, selectively transported into catecholaminergic neurons via high-affinity 
catecholamine uptake systems. Increased free radical levels and a decreased antioxidant 
capability in the target neurons have been observed following administration of 6- 
OHDA. Changes in membrane fluidity result, possibly due to lipid peroxidation. These 
changes seem to lead to a marked increase in the concentration of cytosolic calcium. This 
may, in turn, cause alterations in cellular processes such as signal transduction (Kumar et 
al., 1995).
Evidence supporting a key role of oxidative stress in the pathology of PD, 
together with the observation of abnormal levels of iron in the SN of parkinsonian 
patients have led to the establishment of another model of PD. Intranigral infusion of 
moderate amounts of an iron citrate solution in rats leads to a dose-dependent SN 
neurodegeneration and a concomitant decrease in the levels of dopamine and its 
metabolites in the striatum. Very importantly, single exposure induces persistent and 
progressive changes, which occur through a number of months following infusion 
(Sengstock et al, 1994), thus resembling the progressive degeneration observed in most 
PD patients. This feature is not found in the MPTP- or the 6-OHDA- models, where the 
changes observed following damage do not progress, and tend instead to recover with 
time, following single dose administration.
1.2.4 Treatment of Parkinson's disease.
A wide array of clinical approaches are being applied in the treatment of 
Parkinson’s disease. These measures diminish or eliminate some of the parkinsonian 
symptoms. The most effective approach followed to date is the administration of L-dopa 
or levodopa, a precursor of dopamine. Administration of dopamine faces the problem 
that dopamine does not cross the blood-brain barrier; in contrast, L-dopa can
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readily enter the brain. Although it does not stop the progression of the disease, L-dopa 
treatment delays this progression. Maximum benefit is achieved when this drug is 
administered early after disease onset; in contrast, life expectancy is not altered in those 
cases when treatment commences later in the disease. L-dopa is used alone or in 
combination with other drugs such as anticholinergics, which help partially restore the 
normal balance between acetylcholine and dopamine in the brain, the antiviral drug 
amantadine, which is thought to enhance the synthesis, release or reuptake of dopamine 
from surviving nigral cells, or dopamine agonists like bromocriptine and pergolide. These 
accompanying drugs can complement the action of L-dopa. This is especially important 
when the response to this compound starts to wear-off, usually during the progression of 
the disease. Moreover, around 20% of PD patients do not respond to L-dopa treatment. 
Important side-effects to this treatment are dyskinesias, or involuntary movements, and 
on-off effects, when the patient intermittently changes from normal to parkinsonian 
(Poewe and Wenning, 1996). These adverse side-effects are most commonly 
encountered following long-term administration of the drug. These alterations are a 
serious problem, as the initial dose of L-dopa must often be gradually increased in order 
to continue providing the same beneficial effects. In some cases, cessation of the 
treatment for a short period of time (‘drug holiday’) re-establishes the adequate response 
to L-dopa once treatment starts again. Co-administration of L-dopa with carbidopa, a 
peripheral dopa decarboxylase blocker, helps decrease some of the adverse side-effects 
and allows a reduction of the amounts of levodopa needed. In some cases, destruction of 
the subthalamic nucleus has been carried out to treat serious adverse effects caused by 
long-term administration of L-dopa.
Studies on animal models have demonstrated the benefits of transplanting fetal 
SN grafts into parkinsonian brains, as well as those of surgical interventions where the 
globus pallidus is lesioned (pallidotomy), with the concomitant suppression of the 
pallidal over-inhibition on the thalamus (Fernandez and Dujovny, 1997). Different 
outcomes have been obtained following transplantation of dopamine neurons in the brain 
of PD patients. Studies on research animals indicate the action of free radical toxicity 
during or following grafting, and demonstrate that manipulation of the tissue to be 
grafted, aimed towards the enhacement of antioxidative properties in these cells, leads to 
a greater survival of the dopamine neurons and to a faster and more extensive functional 
recovery (Nakao et al., 1995).
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Administration of trophic factors, such as brain-derived neurotrophic factor 
(BDNF) and glial cell-line derived neurotrophic factor (GDNF), has led to significant 
improvements in animal models of PD (Lapchak et a l, 1997; Fahn, 1997). Various 
strategies can be applied to deliver these factors to the brain. Viral vectors are being 
currently developed which allow both direct transfer of genetic material into the brain, 
or transformation of cell lines prior to transplantation (Horellou et al., 1997).
Treatment of research animals with the drug known as selegiline or deprenyl 
prior to exposure to MPTP protects these animals from neurodegeneration. This drug 
has beneficial effects on PD patients. Although its mechanisms of action still remain 
controversial, it is currently considered that inhibition of MAO-B by selegiline may 
allow the accumulation of dopamine in the surviving cells in the SN. Together with an 
improvement in the symptomatology, a putative neuroprotective action of selegiline has 
been postulated (Jenner and Olanow, 1996; Tatton and Chalmers-Redman, 1996). This 
latter seems to be independent from the inhibition of MAO-B and exerted, instead, 
through transcriptional effects which lead to increased synthesis of trophic, antioxidant, 
and antiapoptotic factors, such as SOD, GSH, BCL-2. Selegiline appears to prevent 
damage to mitochondria which may be associated to the initiation of apoptosis. Were 
apoptosis involved in the neurodegeneration observed in disorders such as Parkinson’s 
disease, this could well explain the neuroprotective effects of selegiline (Tatton and 
Chalmers-Redman, 1996).
1.2.5 Preclinical detection of Parkinson’s disease.
The possibility of neuroprotective approaches makes early detection of 
Parkinson’s disease crucial. This early diagnosis could facilitate the identification of the 
causative agents in PD. The cure for this pathology will not be available until the 
factors and the mechanisms involved are known. Identification of susceptibility genes 
in this disorder is, undoubtedly, a key element to the establishment of the environmental 
agents which precipitate the occurrence of PD, since these genes will point at specific 
biochemical pathways which can lead to the disease (Johnson, 1991). Moreover, 
knowledge of the susceptibility genes involved in Parkinson’s disease could allow the 
identification of populations at a higher risk of developing this disorder; preventive 
therapy could then be attempted in these groups.
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Therefore, early diagnosis of Parkinson’s disease is of great importance for the 
understanding and efficient treatment of the disorder (Langston and Koller, 1991). In 
general, the alterations in the patients are all subtle at first, and worsen with time. Clear 
symptomatology of Parkinson’s disease normally correlates with advanced stages of 
neurodegeneration. Detection of the early manifestations of the disease is therefore 
crucial to identify potential new cases when the neuronal damage is not extensive yet. 
Moreover, PET studies (Burn et al., 1992) and reports on a premorbid personality of PD 
point towards a possible identification of putative cases even before any subtle 
alterations are shown. Biomarkers are being sought among metabolic enzymes which 
have shown reduced activity levels in some groups of patients, as well as in the levels in 
brain and in the cerebrospinal fluid of the metabolites produced in biochemical pathways 
which may be involved in Parkinson’s disease (Carlsson and Fornstedt, 1991; Ellenberg,
1991). Although still controversial, many authors report the existence of a set of 
personality features which are commonly observed in individuals who later on develop 
parkinsonian symptoms (Paulson and Dadmehr, 1991). Comparison of twin pairs often 
shows personality differences which date back to adolescence or early adulthood, the 
affected twin being in general more serious, introverted and nervous than the unaffected 
co-twin (Duvoisin et al., 1981). A lower incidence of alcoholism and cigarette smoking 
is encountered in PD patients. It has been suggested that the premorbid personality 
observed in Parkinson’s disease patients may reflect innate intrinsic levels of dopamine. 
Studies on mouse have shown differences in midbrain TH activity and in the numbers of 
dopaminergic cells between different inbred strains (Baker et al., 1980; Baker et al., 
1983). Interestingly, these variations seem to lead to differences in drug-induced and 
spontaneous behaviours which are mediated by dopaminergic neurons, such as motor 
activity and exploratory behaviour (Reis et al., 1983).
The possibility of a premorbid personality in PD, together with the observation 
that other disorders which are commonly found in the patients, such as loss of interest in 
activities, olfactory dysfunction, subjective sensory abnormalities, are often present 
before the disease becomes manifest, indicate that alterations in brain function start 
several to many years before PD is diagnosed (Koller et al., 1991). Long latency is 
observed in other neurological disorders (Koller et al., 1991), such as Huntington’s 
disease, where the alteration is present throughout the individual’s life but the disease is
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not manifest until mid-life. A slow progression of the symptoms in PD cases over many 
years supports a slow rate of cell death. In disagreement with this hypothesis is the 
observation by McGeer and colleagues (1988) of an active neuropathological process at 
the time of death in PD patients, where the number of cells undergoing phagocytosis is 
up to six times greater than that seen in normal brains. McGeer and coworkers estimated 
a loss of 12000 to 43000 SNc neurons per year in the diseased brains. Considering a 
normal cell complement of around 450000 neurons in the SNc, these authors predicted a 
complete depletion of cells in the SNc in not many years, were this a long-term process. 
Instead, they argued that the marked neurodegeneration observed in PD is the result of 
an active process commencing late in life, and that suppression of the ongoing process at 
these later stages could still interfere with the progression of the disease. On the other 
hand, the process observed by McGeer and his group could have coincided with the first 
years following disease onset in the individuals, as a fast progression of the symptoms 
has been reported to occur at these early stages; in general, this progression is markedly 
slower in later stages.
1.3 Identification of disease-causing genes.
The isolation of genes which determine susceptibility to or occurrence of disease 
states is of prime importance. Extensive work has been undertaken to date to identify 
disease genes in man. As mentioned earlier, these efforts often encounter serious 
problems which result from the complex inheritance patterns of polygenic traits and the 
impossibility to actively control the genetic background. These obstacles can sometimes 
be overcome through the study of highly inbred populations or, very importantly, by 
carrying out research on suitable animal models.
Two main approaches have been followed to identify disease-associated genes. 
One, ‘Functional Cloning’, requires knowledge of the biochemical defect leading to the 
disease process, and therefore of the function and/or the protein product of the sought- 
for gene. The other is known as ‘Positional Cloning’ since identification of the gene 
relies solely on its position in the genome.
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1.3.1 Positional cloning approaches.
Positional cloning methods rely on finding the region containing the disease- 
causing gene through the establishment of linkage of genetic markers to the gene of 
interest. These analyses are greatly facilitated when a cytogenetic rearrangement, such as 
a deletion, has taken place. In the absence of such event, a genome-wide search is 
required to establish genetic linkage of at least one map element to the target locus. A 
requisite for any marker to be useful in these studies is that it is informative, that is, that 
different allelic forms of the marker exist in the population; these variations are in general 
phenotypically neutral.
Recently, new approaches have been developed which allow the isolation of 
sequences in the vicinity of a disease gene(s) by scanning the whole genome in a single 
pass, instead of sequentially assessing segregation patterns of individual loci in relation to 
the disease phenotype (Brown, 1994). These are methods of choice when a ‘functional 
cloning’ approach is not possible and a dense genetic map of the organism under study is 
not available, as identification of nearby sequences does not depend on genetic markers 
having been established within the region (Jonsson and Weissman, 1995). These 
approaches may yield better results than other available techniques when several loci are 
involved in the phenotype. Representational difference analysis (RDA) (Lisitsyn et al., 
1993; Lisitsyn, 1995) is based on the subtraction of common sequences between two 
DNA samples, and the selective amplification by PCR of restriction fragments that are 
present in one of them (‘tester’) but differ or do not exist in the other (‘driver’). Since a 
high genetic variation is oberved in most populations, this method normally results in the 
identification of differences throughout the genome. In order to find variations between 
the genomes in the region carrying the disease gene, both DNA samples must contain the 
same combination of alleles except in the region of interest (Genetically Directed 
Representational Difference Analysis, GDRDA). This is achieved by employing congenic 
strains of laboratory animals or by making use of transmission genetics. The rationale 
behind the latter is that a pool of DNAs extracted from affected individuals will present 
the same allelic variation which is found in the normal population all throughout the 
genome except in a small region where the disease gene maps. This technique has 
already been shown to give excellent results when searching for sequences which are 
specific to regions carrying recessively acting genes (Lisitsyn et a l, 1994). An important 
disadvantage of this technique is, however, that it can only
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detect changes in the genome which cause gross differences in the size of restriction 
fragments. Therefore, very small mutations outside restriction site sequences can not be 
detected with this method. A second technique is known as genomic mismatch scanning 
(GMS) (Nelson et al., 1993; Brown, 1994). This is based on the ability of mismatch 
repair proteins to recognise single base pair mismatches in heteroduplexes formed 
between allelic sequences derived from each of two genomes. Both genomes are 
digested with a restriction enzyme which yields DNA fragments of a large enough size 
as to ensure the presence of base pair differences between those sequences which were 
not inherited from the same source. The combined action of several enzymes results in 
the tagging of homoduplexes (i.e. both strands derive from the same genome) and of 
heteroduplexes which contain mismatches, so that only mismatch-free hybrid molecules 
survive treatment with the enzyme ExolW. These hybrids are subsequently purified, 
labelled, and used to probe ordered arrays of DNAs which represent the entire genome. 
Regions inherited from the same source are thus identified. Excellent results have been 
obtained by Nelson and colleagues (1993) when applying this technique to yeast. 
Application of this method to man faces the greater complexity and the abundance of 
repetitive elements in this genome. Success of the GMS technique on the human 
genome would permit the detection of sequences inherited in common by the affected 
individuals in one or various pedigrees. A considerable fraction of these sequences 
would then most likely correlate to disease gene(s)-regions.
1.3.1.1 Genetic markers.
Different types of markers can be used when analysing inheritance patterns in 
populations. Variations at biochemical and immunological markers are most commonly 
studied by means of electrophoretic and histochemical staining procedures and 
immunoassays (Adams et al., 1984; Adams and van Zutphen, 1990; Gunther, 1990a). A 
disadvantage which is often encountered by these tests is the difficulty to correctly 
characterise some allelic variants, limiting their usefulness for genetic typing. In some 
cases, the results obtained following an electrophoretic screen can be affected by the 
quality of the tissue. Difficulties can also arise when selecting electrophoretic 
conditions and the support medium, or when attempting to interpretate complicated 
banding patterns (e.g. those observed in gels stained for aldehyde dehydrogenase (AHD) 
activity in vertebrates). Moreover, there are cases where heterozygotes may be difficult
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or impossible to distinguish from either of the parental or the sibling homozygotes. In 
contrast to these, the allelic forms of many morphological and physiological markers 
can be easily determined. This is the case of some colour and behaviour markers, 
where the presence or absence of a given allele in an organism can be established by 
simply attending to some particular phenotypic features exhibited by the individual 
(Hedrich, 1990a; Serikawa et al., 1992).
Identification of allelic forms corresponding to other types of genetic markers 
relies on the direct analysis of the DNA sequence. Variation among individuals can 
result from a) differences at restriction site sequences; b) differences in the number of 
repeat units which constitute a repetitive sequence; or c) other changes in the DNA 
sequence which are mainly found in non-coding regions.
Some differences in the DNA sequence can result in either the creation or the 
disruption of a restriction site. Thus, probes that bind to this region of the genome 
demonstrate a difference in the size of the respective hybridising fragment when the 
genomic DNAs are digested with the particular restriction endonuclease. These markers 
are known as Restriction Fragment Length Polymorphisms (RFLPs) (Botstein et al., 
1980; Gunther, 1990b). RFLP maps have been constructed for man (Donis-Keller et al., 
1987), and other organisms (Nam et al., 1989; Burr and Burr, 1991). A disadvantage of 
RFLPs is that only a few allelic forms are normally observed in each case. In the 
instances where one of these alleles is present in the majority of the individuals, the 
utility of the marker in genetic typing is further reduced. Moreover, digestion with 20- 
30 restriction endonuclesases may be required to detect a difference between two 
genomes; this conveys a considerable workload since RFLP analyses involve blotting 
and hybridisation protocols.
Variable number o f tandem repeats (VNTRs) are, as the name indicates, 
repetitive sequences in the genome which may consist of a different number of repeat 
units in different individuals (Charlesworth et al., 1994). This variation leads to 
differences in the length of these genomic regions. These markers are also known as 
minisatellites (Jeffreys et al., 1985; Pravenec et a l, 1996), and are more informative 
than RFLPs. In the cases where the minisatellite repeat unit is of a considerable size 
(some can be up to 50 bp) and/or the number of repeats is large, analysis of the VNTR 
is carried out as in RFLP assays. Minisatellites spanning smaller DNA regions can be 
studied by using the polymerase chain reaction (PCR). Microsatellites (Litt and Luty,
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1989; Weber and May, 1989; Love et al., 1990) are a second type of tandem repeat 
sequences where the unit size is 1 to 6 nucleotides long. Therefore, allelic forms of 
these markers can be easily typed by amplification with PCR primers which bind to 
unique sequences flanking the repeat. These markers have also been called sequence 
tagged microsatellite sites (STMSs; Serikawa et al., 1992), simple sequence length 
polymorphisms (SSLPs; Jacob et al., 1995), simple sequence repeats (SSR; Jacob et al., 
1991; Goldmuntz et al., 1993), or simple tandem repeats (STRs; Smith, 1995; Edwards 
etal., 1991).
Different approaches can be followed in order to detect other variations in the 
DNA sequence which do not result in divergent restriction patterns between the 
genomes (e.g. deletions, insertions, nucleotide mutations at restriction sites) and which 
do not correlate to changes in the number of repeat units in VNTRs. Very efficient 
methods are based on the amplification of the genomic region under study and the 
analysis of the PCR products obtained. Small changes in the length of the products can 
be detected following electrophoresis on denaturing sequencing gels. More subtle 
changes such as single nucleotide substitutions require highly sensitive methods such as 
denaturing gradient gel electrophoresis (DGGE) and single-strand conformation 
polymorphism (SSCP) analysis. The former is based on the melting characteristics of 
DNA (Fischer and Lerman, 1983; Sheffield et al., 1989; Traystman et al., 1990); SSCP 
analysis (Orita et al., 1989; Levitt, 1991; Russell, 1994) is based on the folded 
conformations that single DNA strands adopt when running through non-denaturing 
polyacrylamide gels. Both features depend on the DNA sequence.
Noncoding sequences in the genome are an excellent source of informative 
markers. Variations in the DNA sequence in these regions are in general phenotypically 
neutral and are thought to occur frequently (approximately once in every few hundred 
base pairs). The transcribed 3' untranslated regions of eukaryotic genes are a very good 
target for the establishment of genetic markers. These sequences often span several 
hundreds of base pairs; SSCP analyses have shown that multiple polymorphisms can be 
identified within a single region (Levitt, 1991). Development of these markers requires 
knowledge of the transcribed 3' untranslated sequence, and this in turn implies the 
availability of the cDNA sequence of the corresponding gene. Therefore, markers 
established within these regions can be used to locate the respective genes on the 
genetic maps. This is not always the case with microsatellite markers, since many of
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these are not transcribed (Moore et al., 1991; Levitt, 1991); assignment of a 
microsatellite to a gene requires then the availability of the genomic sequence.
Microsatellite markers.
This type of polymorphisms are considered to result from unequal meiotic 
exchanges or slippage of the DNA polymerase during replication (Litt and Luty, 1989; 
Levinson and Gutman, 1987; Schloetterer and Tautz, 1992). The presence of 
microsatellites in all the eukaryotes tested to date and their absence in bacteria suggests 
that these sequences possess some function. Micro satellites of the type (CA)n and (TC)n 
(n>14) have only been found in nuclear DNA, which strongly supports the action of one 
or more mechanisms unique to eukaryotic nuclear DNA to retain these repeats during 
evolution (Gross and Garrard, 1986). It has been suggested that microsatellite sequences 
could act as hotspots for recombination (Slightom et al., 1980; Treco et al., 1985). 
Other reports do not support such a role (Stallings et al., 1991); it could happen that 
presence of the repeat sequence is necessary but not sufficient for a recombinational 
hotspot to occur. Naylor and Clark (1990) demonstrated a down-regulatory role for a 
(GT)n repeat upstream of the rat prolactin gene, and Hamada and colleagues (1984) 
showed that a similar repeat could enhance transcription when inserted into plasmids 
carrying the choramphenicol acetyltransferase (CAT) reporter gene. A year later Thomas 
and coworkers (1985) reported the presence of microsatellite regions in nontranscribed 
sequences in rDNA; these repeats appeared to be absent from the transcription unit. The 
group established a model postulating that some repetitive sequences could be involved 
in transcription enhancer activities through conformational and other structural 
influences. It has been hypothesized that these repeats could play a role in packaging and 
condensing DNA into chromosomes in eukaryotes. (GT)n repeats are much more 
frequent in euchromatin than in heterochromatin and might be providing a DNA 
conformation that can be condensed and decondensed during the different phases of the 
cell cycle (Stallings et al., 1991). Trinucleotide repeats coding for polyglutamine or 
polyproline tracts have been identified in protein coding regions (Wharton et al., 1985; 
Lindahl et al., 1990). These microsatellites seem to play a role in the normal function of 
the protein. Evidence is being found that supports that variation in the number of repeats 
at SSLP loci can cause quantitative changes in gene expression and function, and that 
these changes may have an effect on the phenotype (Lindahl et
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al., 1990). Consequently, it has been proposed that micro satellites may be a major 
source of the extensive quantitative genetic variation observed in the populations (Kashi 
eta l., 1997).
Micro satellites have rapidly become the basis in the construction of dense genetic 
maps (Weissenbach et al., 1992; Gyapay et al., 1994; Dietrich et al., 1994; Serikawa et 
al., 1992; Jacob et al., 1995) since they offer important advantages in comparison to 
other markers. Some of these advantages are presented below:
a) SSLPs are abundant and widely spread throughout the eukaryotic genomes. 
The (CA)n motif appears as the most common repeat, with approximately 105 copies in 
the genomes of man, mouse and rat (Beckmann and Weber, 1992; Love et al., 1990; 
Serikawa et al., 1992). In addition, microsatellites have shown very little tendency to 
cluster (Luty et al., 1990), in contrast to some hypervariable minisatellite loci which 
cluster at the proterminal ends of chromosomes (Royle et al., 1988).
b) Great variability has been observed at microsatellite loci. In 1990, Weber 
reported that the number of alleles identified at a given (CA)n-microsatellite locus in man 
correlates to the total length of the repeat. The same trend was observed with tri- and 
tetranucleotide repeats (Edwards etal., 1991). Similar results were obtained with mouse 
(Cornall et al., 1991) and cattle (Moore et al., 1991). Studies by Serikawa and 
colleagues (1992) on several rat strains indicated that di- to tetranucleotide repeats 
which consist of 10 or more repeat units have a high probability of showing allelic 
variants.
c) Numerous studies have shown these markers to be stable through many 
generations (Weber and May, 1989; Love et al., 1990; Serikawa et al., 1992; Pravenec 
et al., 1996), and not subject to frequent mutations as has been reported for certain 
minisatellite polymorphisms (Jeffreys et al., 1987; Jeffreys et al., 1988).
d) Newly developed markers can be made readily available to other labs by 
simply releasing the sequences of the PCR primers.
e) Given the extreme sensitivity of PCR (Saiki et al., 1988), typing of 
micro satellite loci requires much smaller amounts of DNA than those needed to carry out 
blotting and hybridisation procedures.
f) Labelling of the PCR primers allows the multiplexing of different PCR 
reactions. Adequate sequencers and computer software are now available which permit
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automation of the typing process, resulting in great amounts of good quality typing data 
being rapidly obtained and processed (Edwards et al., 1991; Levitt et a l, 1994; Smith, 
1995).
1.3.1.2 Physical mapping.
Identification of the gene of interest requires that the genetic map which has been 
established for that region of the genome be developed into a physical map. This 
translates into the isolation of genomic fragments which cover the region. These 
sequences are normally identified following screening of genomic DNA libraries. 
Initially, screening is carried out with the available genetic markers known to map closest 
to the sought-for gene. End-fragment sequences are then obtained from the positive 
clones and used to screen the library for new genomic sequences, and so forth. Analysis 
of restriction patterns and of the presence or absence of unique sequences identified 
within each of the isolated genomic fragments allows the alignment of overlapping clones 
into larger units or contigs. This process is known as chromosome walking (Feil et al., 
1990a; Albertsen et al., 1994; Nehls et a l, 1995). Some important considerations in the 
establishment of a physical map are discussed below.
Genomic DNA libraries.
Different cloning systems can be used in the construction of DNA libraries 
(Monaco and Larin, 1994):
-Cosmid vectors, based on the cos site-mediated packaging of recombinant 
molecules into bacteriophage lambda particles.
-Yeast artificial chromosomes (YACsj, linear vectors consisting of a telomeric 
sequence at each end, a centromere, an origin of replication, and yeast selectable 
markers to allow propagation in yeast.
-PI vector, based on bacteriophage PI elements.
-Bacterial artificial chromosomes (BACs), based on the F-factor plasmid. 
-Pl-derived artificial chromosomes (PACs), based on both the PI and the F- 
factor systems.
Each cloning system presents an array of advantages and disadvantages. Thus the 
establishment of contigs across specific regions of the genome is frequently
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favoured by the use of more than one type of genomic DNA library. YACs (Burke et 
a l, 1987) offer the greatest advantage in terms of insert length, since these 
chromosomes can carry DNA fragments of several hundred kilobase pairs in size. In 
comparison, cosmids allow for a maximum insert size of 40-45 kb; PI vectors 
(Sternberg, 1990a, 1990b), BACs (Shizuya et al., 1992) and PACs (Ioannou et al.,
1994) can carry DNA fragments of 70-100 kb, up to 300 kb, and 100-300 kb, 
respectively. A greater insert size results in a smaller number of clones needed to cover 
a genomic region. However, the YAC system poses some important problems such as 
low transformation efficiencies when preparing libraries, a high rate of chimaerism and 
instability of the genomic insert (Nehls et al., 1995; Ochman and Buckholtz, 1995; 
Harshman et al., 1995), and difficulties in purifying large amounts of YAC DNA from 
the 15 Mb of yeast chromosomal background. Modifications have been introduced to at 
least partially overcome some of these problems. YAC libraries have been constructed 
in recombination-deficient hosts (Haldi et al., 1994), as chimaerism is considered to 
arise mainly from recombination events in the host cell (Nehls et al., 1995). Also, some 
host strains have been identified which yield higher transformation rates than others 
(Burke et al., 1987).
The main improvement has been, however, the use of other vectors such as PI 
(Sternberg, 1990a; Pierce and Sternberg, 1992) and BACs (Shizuya et al., 1992) in the 
construction of new libraries. These systems, while still enabling the cloning of large 
genomic fragments, present a greater insert stability, mainly due to their maintenance in 
the host as low copy number plasmids; chimaerism does not appear to be a frequent 
phenomenon either (Nehls et al., 1995; Harshman et a l, 1995). It has been observed 
that YAC instability often correlates to the genomic region in particular (Nehls et al,
1995) and that some sequences are frequently underrepresented or even absent in this 
type of libraries. In contrast, some of these fragments have been readily identified in 
equivalent PI libraries (Albertsen et a l, 1994). Also, higher transformation efficiencies 
are achieved (Pierce et al., 1992). Construction of PI libraries involves the preparation 
of different packaging extracts to be used at different stages in the formation of 
infectious particles. These steps are eliminated when using BACs, since efficient 
transformation is then carried out by electroporation (Sheng et al., 1995). However, this 
latter system lacks the positive selection for recombinant clones offered by the PI 
vector vAdlOsacBYl (Pierce and Sternberg, 1992). Also, the DNA yields obtained are
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very low. More recently, the PAC system was developed, which combines the 
advantages from both the PI and the BAC systems (Ioannou et al., 1994).
Detection o f unstable and/or chimaeric clones.
Insert instability and the occurrence of chimaerism are a serious problem when 
carrying out chromosome walking. It is therefore crucial that these events are detected 
as soon as possible. Changes such as deletions can be identified through comparisons of 
the marker content and the restriction pattern obtained from the insert with those 
observed in the genomic region of interest as well as through correlations to other clones 
(cosmid clones, for example) which have already been confirmed and characterised (Feil 
et al., 1990b; Wada et al., 1990). Chimaerism can be assessed by confirming the 
chromosomal location of unique sequences identified in the genomic insert. This can be 
done by screening somatic cell hybrids. These are clones which have retained a different 
set of chromosomes or chromosomal regions from the species under study on a genetic 
background derived from another species. Any sequence can be used to screen a panel of 
these clones as long as the products obtained from both species can be distinguished 
from each other. Correlation of the presence or absence of the product from the species 
of interest with the presence or absence of chromosomes (or chromosomal regions) from 
this species in each hybrid clone allows the mapping of this sequence. A second approach 
allows one to map whole inserts; this method is known as fluorescent in situ 
hybridisation or FISH. It consists on the labelling of the genomic insert (or of the whole 
clone) with a fluorescent dye and in situ hybridisation on metaphase spreads. 
Furthermore, more than one fragment can be labelled and used at a time by employing 
different fluorescent dyes; this allows one to confirm the order of the different clones in 
relation to each other (Albertsen et al., 1994).
Correlation o f the genetic map to the physical map.
Genetic maps are constructed on the basis of the recombination frequencies 
observed between loci. Mathematical functions have been designed which allow more 
accurate calculations, taking into account factors such as the simultaneous occurrence of 
a cross-over in each of two contiguous intervals in the chromosome (Green, 1981).
Genetic distances are normally used to estimate the corresponding physical 
distances. The relation between both parameters varies according to the species (e.g. 1 
cM is considered to be the equivalent to 1 Mb in humans, whereas 2.7 kb is considered
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the equivalent to 1 cM in yeast). However, these are general estimates; there are regions 
in the genome where a small physical interval correlates to a region of relatively high 
meiotic recombination frequency, and vice versa. The former can be seen at the 
telomeric regions of many chromosomes; in contrast, centromeric regions often present 
recombination frequencies which are much lower than those anticipated.
Physical maps are constructed once a genetic map has been established which is 
not larger than a few cM in length (Albertsen et al., 1994; Pawar et al., 1995). Yet, this 
normally represents too great a distance to start searching for individual genes in the 
region, as a 1 cM region can contain several tens of genes. Therefore, further reduction 
of this region is in general attempted by searching for recombination events between 
newly identified informative marker loci and the gene of interest. Identification of 
recombinants leads to a higher resolution of both the genetic and the physical maps. New 
flanking markers are thus defined, with the concomitant elimination of outside sequences 
from any further analysis (Zhou et al., 1995). The observations made by Harshman and 
colleagues (1995) underline the importance of establishing fine genetic maps prior to 
searching for candidate genes in the region. Quite a large number of techniques are 
currently available to carry out these searches. Numerous groups have reported the 
isolation of disease-associated genes, normally following a combination of these methods 
(Rommens et al., 1989; Miki et al., 1994; Wang et al., 1996). These approaches are 
discussed in Chapter 8. An overview of the steps involved in the positional cloning of 
disease genes is shown in Figure 1-4.
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FIGURE 1-4. Diagram showing the steps commonly involved in positional cloning. 
Modified from Bailey et al. (1997) and Monaco (1994).
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1.4 Aims of the project.
The ultimate aim of this project is the positional cloning of the agu gene. This 
will be the basis for subsequent studies on the mechanism of action of the mutation 
carried by AS/AGU animals and on a possible correlation of PD in man to mutations in 
the human homologue of the agu gene or in other genes involved in the same 
biochemical pathway. Likewise, a putative role in neurodegeneration might then be 
assigned to the environmental factors which act within this pathway.
My work was directed towards obtaining a sufficiently exact genetic location of 
the agu gene to allow the initiation of physical mapping approaches. Several steps were 
followed:
1._ Identification of informative markers between AS/AGU and other strains of rat. 
Development and optimisation of an efficient, reliable system to screen the rat 
genome.
2._ Selection of the most informative crosses to the AS/AGU sub-strain.
3._ Genetic scan of the rat genome. Identification of the chromosomal location of the 
agu gene.
4._ Mapping of the agu gene to a genetic interval of 1 cM or less.
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CHAPTER 2
Materials and Methods.
C h a p t e r  2.  M a t e r i a l s  a n d  M e t h o d s .
2.1 Chemicals and biochemicals.
Agarose MP (multipurpose), chloramphenicol, lysozyme and 5-bromo-4-chloro- 
3-indolyl-P-galactopyranoside (X-gal) were obtained from Boehringer Mannheim, 
Lewes, UK. MetaPhor agarose was obtained from FMC Bioproducts, Rockland, USA. 
The DNA molecular weight markers were obtained from BRL, Gibco Ltd., Paisley, UK. 
Lambda phage DNA was obtained from Sigma Chemical Co., Poole, UK.
Kanamycin, ampicillin, streptomycin sulfate, isopropyl P-D-thiogalacto- 
pyranoside (IPTG), polyethylene glycol (PEG), ethidium bromide, blue dextran, phenol 
red, N,N,N’,N’-tetramethylethylene diamine (TEMED), N,N-dimethylformamide, and 
urea were obtained from Sigma Chemical Co., Poole, UK.
Formamide was obtained from Aldrich Chemical Co., Gillingham, UK. Anachem, 
Luton, UK supplied 6%(w/v) sequencing solution (19:1) and 40% (w/v) acrylamide/bis- 
acrylamide stock solution (19:1).
Radiochemicals were bought from DuPont/ NEN Research products, Herts, UK.
All other chemicals were of analytical reagent grade and were mainly obtained 
from either BDH Chemical Ltd., Poole, UK, or from Fisher Scientific, Loughborough,
[
2.2 Oligonucleotides, enzymes, kits and other materials.
I
|
; All the enzymes were obtained from BRL, Gibco Ltd., Paisley, UK, except : Taq
DNA polymerase and T4 polynucleotide kinase, obtained from Promega Ltd., 
Southampton, UK; RNAse , obtained from Sigma Chemical Co., Poole, UK; lysozyme, 
bought from Boehringer Mannheim, Lewes, UK; shrimp alkaline phosphatase (SAP), 
obtained from USB, Amersham International p/c, Little Chalfont, UK.
Oligonucleotides were either synthesized in the department, ordered from BRL, 
Gibco Ltd., Paisley, UK, or bought from Research Genetics Inc. (Huntsville, Alabama, 
USA). Oligonucleotides prepared in the department were synthesized on either an ABI 
391 or an ABI 392 DNA/RNA synthesizers (Applied Bio systems Inc., Hertford, UK). 
Some rat DNAs were obtained from Harlan Olac (Oxon, UK).
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The Puregene DNA Isolation kit was bought from Flowgen Instruments Ltd., 
Lichfield, UK. The panel of somatic cell hybrids was kindly provided by Professor 
Claude Szpirer, Laboratoire de Genetique, Universite Libre de Bruxelles, Belgium.
The PI library was a gift from R. J. MacDonald, Department of Biochemistry, 
University of Texas Southwestern Medical Center, Dallas, Texas.
The pDT Blue cloning system was bought from ams Biotechnology, Witney 
Oxon, UK.
2.3 Nucleic acid isolation and manipulation.
2.3.1 Commonly used buffers.
a) TE buffer.
10 mM Tris HCl, pH 8.0; 1 mM EDTA.
b) TBE bu ffer (5x).
54 g Tris, 27.5 g boric acid, 20 ml 0.5 M EDTA (pH 8.0), made up to 1 litre in 
distilled water. The pH should be c. 8.3.
c) TAE buffer (5Ox).
242 g Tris, 57.1 ml glacial acetic acid, 100 ml 0.5 M EDTA (pH 8.0), made up to 
1 litre in distilled water.
d) Agarose pel loading buffer (6x).
4 g of sucrose dissolved in 6 ml TE; 2.5 mg bromophenol blue and 2.5 mg or less 
of xylene cyanol FF added to this solution. Volume made up to 10 ml with 
distilled water.
e) Formamide/EDTA/XC/BPB gel-loading buffer.
10 ml of formamide, 10 mg of xylene cyanol FF, 10 mg of bromophenol blue and 
200 pi of 0.5 M EDTA (pH 8.0).
These and other standard solutions were all prepared according to Sambrook et 
al. (1989).
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2.3.2 DNA isolation.
2.3.2.1 Genomic DNA isolation.
Most of the genomic DNAs handled during the course of this project were used 
as templates in PCR reactions. Initially, a few DNA samples were obtained from Harlan 
Olac (Oxon, UK). Thenceforth, all the DNAs were prepared in house, the first samples 
being extracted from frozen spleens with the use of liquid nitrogen (Method A). The 
majority of the DNAs were prepared using the Puregene DNA isolation kit from 
Flowgen Instruments Ltd. (Method B). Once in solution, the DNAs were all kept at 4°C.
a) Method A.
The frozen tissue was ground with continuous addition of liquid nitrogen. It was 
then transferred to a precooled 50 ml Falcon tube and the liquid nitrogen let to evaporate 
completely.
9.5 ml of NET buffer (100 mM NaCl, 10 mM Tris-HCl (pH8.0), 25 mM EDTA 
(pH8.0)) was gently added onto one side of the tube, resulting in a highly viscous 
solution. 0.5 ml of 10% SDS and 50 til of 20 mg.ml'1 proteinase K was then added and 
the mixture incubated at 50°C for some time.
The DNA was extracted by adding an equal volume of phenol: chloroform (ratio 
1:1) to the sample, leaving the tube on a roller for 15-20 minutes. The sample was then 
centrifuged at 2000 rpm for 10 minutes, and the upper aqueous phase transferred to a 
new tube by using a pasteur pipette cut at its end to avoid shearing the DNA. The 
phenol/chloroform extraction was repeated. The DNA was finally precipitated with 2 
volumes of absolute ethanol in the presence of 0.3 M sodium acetate, pH 5.2. The DNA 
was extracted by swirling it round the end of a pasteur pipette bent at its tip. After being 
immersed in 70% ethanol, the pipette was left in 1 ml of TE and the DNA gently 
resuspended. 2 fil of RNase (10 mg.ml'1) was added to the sample and this was incubated 
at 37°C for 30 minutes. Another phenol/chloroform extraction step followed. The DNA 
was again precipitated and resuspended in 0.5-1 ml of TE. If required, the tube was left 
at 65°C for 15-30 minutes to help the DNA get into solution.
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bl Method B.
The DNAs were extracted using the Puregene DNA isolation kit, following the 
vendor’s instructions.
10-20 mg of frozen tissue (normally spleen) was homogenized in 600 pi of cell 
lysis solution, with the help of disposable pestles. Lysates were incubated at 65°C for 15- 
60 minutes. Following this step, 2pl of RNase A solution (4 mg.ml'1) was added to each 
lysate; the tubes were inverted several times and then left at 37°C for 15-30 minutes. It 
followed a protein precipitation step where, having let the samples cool to room 
temperature, 200 pi of protein precipitation solution was added to each lysate. The 
mixtures were vortexed vigorously for 20 seconds and then centrifuged at 14000xg for 3 
minutes. A tight pellet was expected; in those instances in which the protein pellet 
appeared as loose, the samples were again vortexed, left on ice for five minutes, and 
centrifuged at 14000xg for 5 minutes. The pellet consisted of the precipitated proteins; 
the supernatant, containing the DNA, was transferred into a clean 1.5 ml eppendorf 
tube, and the DNA precipitated with 600 |ft of isopropanol. The tubes were inverted 
gently until white threads of DNA were clearly visible. The samples were then 
centrifuged at 14000xg for 2 minutes, with the DNA appearing at the side of the tube as 
a small white pellet. The supernatant was discarded and the DNA pellet washed with 200 
pi of 70% ethanol. The tubes were centrifuged again at 14000xg for 2 minutes, the 
ethanol carefully discarded, as the pellets might be loose, and the samples dried for 5-10 
minutes. Finally, 100 til of TE was added to each tube, and the DNA allowed to get into 
solution by leaving the samples either at room temperature overnight or at 65°C for 1 
hour. Most DNAs were resuspended at room temperature but the quality of the samples 
did not differ from that of the DNAs resuspended at 65°C.
2.3.2.2 Plasmid DNA isolation.
3 ml LB-cultures were set up and grown overnight, as explained below. The 
cultures were then spun down in a microcentrifuge at 14000 rpm for one minute. The 
supernatant was removed by aspiration and the bacterial pellet thoroughly resuspended in 
200 pi of GTE buffer (50 mM glucose; 25 mM Tris, pH8.0; 10 mM EDTA, pH8.0). 300 
pi of freshly prepared 0.2 N NaOH/l%SDS was added to the tube; the contents were 
gently mixed by inversion and incubated on ice for five minutes. The solution was 
neutralized by adding 300 \x\ of 3 M potassium acetate, pH4.8; the tube was again
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gently inverted and incubated on ice for five minutes. The cell debris and most of the 
chromosomal DNA was removed by centrifugation at 14000 rpm for 10 minutes and the 
supernantant transferred to a clean tube, to which 2 pi of RNase A (10 mg.ml'1) was 
added. The sample was incubated at 37°C for 30 minutes. Two consecutive extractions 
with 400 pi of chloroform followed. The nucleic acid was precipitated by adding an 
equal volume of 100% isopropanol and immediately centrifuging the tube for 10 minutes 
at room temperature. The DNA pellet was washed with 500 pi of 70% ethanol and air 
dried. The DNA was normally resuspended in 40-50 pi dH20  at 37°C for 30 minutes.
2.3.2.3 PI DNA isolation.
As for small scale plasmid DNA isolations, PI DNA was prepared according to 
protocols based on the alkaline lysis procedure (Birnboim and Doly, 1979). Several 
methods were used:
I._ Birnboim and Doly method.
Applied to 25 ml and 50 ml culture volumes.
The cells were pelleted in a centrifuge at 8000 rpm for 10 minutes and 
resuspended in 25 mM Tris-HCl (pH8.0), 50 mM glucose, 10 mM EDTA; 2 mg.ml'1 of 
lysozyme was also added in most isolations. The resuspended cells were incubated at 
room temperature for 10 minutes. 0.2 N NaOH/1% SDS was added to the sample and 
the mixture was incubated on ice for 10 minutes. Finally, potassium acetate, pH4.8, was 
added and the reaction incubated on ice for an additional 10 minutes. The volumes used 
in each case were: 250 pi of lysis solution, 450 pi of 0.2 N NaOH/l%SDS and 350 pi of 
3 M potassium acetate (pH4.8), for 25 ml culture volumes. When working with culture 
volumes of 50 ml, 2 ml of lysis solution, 4 ml of 0.2 N NaOH/l%SDS and 3 ml of 3 M 
potassium acetate (pH4.8) was used. Following the neutralisation step, the lysate was 
centrifuged at 12000-15000 rpm for 15 minutes and the supernatant transferred into a 
clean tube and extracted with an equal volume of phenol/chloroform. The PI DNA was 
precipitated by adding 2 volumes of 100% ethanol. The DNA pellet was washed with 1- 
5 ml of 70% ethanol, air dried, resuspended in TE and treated with RNase at 37°C for 1 
hour. DNA pellets obtained from 25 ml culture volumes were resuspended in 24-40 pi of 
TE and treated with 0.4 pg of RNase. DNA pellets from 50 ml cultures were 
resuspended in 500 pi of TE and treated with 4 pg of RNase. Following RNase
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treatment, the DNA was re-precipitated with 0.3 M sodium acetate (pH5.2) and 2 
volumes of 100% ethanol. The pellet was washed with 1 ml of 70% ethanol, air dried, 
and resuspended in a final volume of 50-150 pi of TE.
II. DNA purification o f PI DNA using Qiagen-tip 100.
Culture volumes of 500 ml were used when applying this method.
The Qiagen Midi purification protocol was followed with the recommended 
volumes of PI, P2, P3 and QC buffers being doubled. The DNA pellet was resuspended 
in 500 p-1 of TE.
III._Modified Qiagen Midi protocol I.- Phenol/chloroform extraction.
This was a variant of the protocol mentioned above. The supernatant obtained 
after removing the cell debris and most of the chromosomal DNA following 
neutralisation with 3 M potassium acetate (pH4.8), was extracted with an equal volume 
of phenol/chloroform instead of being left to flow through a Qiagen-tip 100. After 
extraction, the DNA was precipitated with an equal volume of 100% isopropanol and 
centrifuged at 15000 rpm for 30 minutes at 4°C. The DNA pellet was washed with 2 ml 
of 70% ethanol, air dried and resuspended in 400 pi of TE.
IV. Modified Qiagen Midi protocol II.- CsCl gradient purification.
Culture volumes of 250 ml were used when applying this method of PI DNA 
purification.
The Qiagen Midi protocol was followed to the point where the cell debris and 
most of the chromosomal DNA had been removed by centrifugation, following the 
neutralisation step. The clear supernatant was then transferred to a clean tube and the 
nucleic acid precipitated with 1 volume of 100% isopropanol. The pellet was washed 
with 70% ethanol, air dried, and gently resuspended in 3.5 ml of TE. The DNA was 
purified through a CsCl gradient, as explained in Kimmerly et al. (1994). The pellet was 
resuspended in 100-200 pi of TE.
In some instances where the PI DNA had been isolated through a typical 
Birnboim and Doly method (I and III), this DNA was further purified through a 
proteinase K  treatment (Southard-Smith et al., 1994). A final concentration of 0.05 
pg.ml'1 RNase was added to the DNA solution, and the sample incubated at 37°C for 30
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minutes. EDTA, SDS, and proteinase K were then added to final concentrations of 5 
mM, 0.1%, and 0.2 mg.ml'1, respectively. This mixture was incubated at 55°C for 1 hour. 
The plasmid DNA was extracted once with phenol and once with chloroform. It was 
then precipitated with 2 volumes of ethanol, in the presence of 0.3 M sodium acetate, pH 
7.0, and finally resuspended in TE.
Wide-bore tips were employed in all the PI DNA manipulations, to avoid 
shearing the DNA. The DNAs were resuspended at 37°C for 10-30 minutes and not by 
pipetting the solution up and down. All the PI DNAs were stably kept at 4°C.
2.3.3 Oligonucleotide synthesis.
2.3.3.1 Design o f primers for PCR and sequencing reactions.
Oligonucleotides which were 17 to 25 nucleotides long and had melting 
temperatures (Tm « {(A+T) x 2°C + (G+C) x 4°C}; Suggs et al., 1981) between 50°C 
and 65°C were selected. Both PCR primers in a set were designed to have similar Tm, 
and not to be complementary at their 3' ends. The programs GeneJockey II and 
MacVector were occasionally used to aid the design of the primer sets.
2.3.3.2 Synthesis and deprotection o f oligonucleotides.
The oligonucleotides prepared in house were synthesized on either an ABI 391 or 
on an ABI 392 DNA/RNA synthesizers.
The beads were extracted from the synthesis columns and then thoroughly 
resuspended in 1 ml of fresh liquid ammonium. The samples were left at room 
temperature for 1 to 2 hours and then centrifuged at 14000 rpm for 15-20 minutes, to 
remove the beads. The supernatants, carrying the DNA, were transferred to clean Nunc 
tubes; 1 ml of liquid ammonium was added. The tubes were left at 50°C for 8-17 hours. 
An aliquot of each sample was transferred to another tube and the DNA precipitated 
with 2 volumes of 100% ethanol, in the presence of 0.3 M sodium acetate, pH 5.2. 
Precipitation was carried out at -70°C for 2 or more hours. The DNA was initially 
resuspended in 100 pil of dH20. These were the concentrated stocks; the DNA 
concentrations were calculated in each case and primer working stocks prepared by 
making the appropriate dilutions. Both the concentrated and the diluted primer stocks 
were kept at -20°C. The remaining ammonium stocks were kept at -70°C.
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2.3.4 Quantitation of nucleic acid.
In general, nucleic acid concentrations were determined spectrophotometrically 
at A=260 nm. In a 1 cm path length an absorbance value of 1.0 corresponds to 50 (ig/ml 
for double stranded DNA and 20 |ig/ml for oligonucleotides.
Spectrophotometric quantitation of plasmid DNA (pGEM-3Zf(+), pBluescript II 
KS+, some PI DNAs) was not accurate, since the presence of contaminating 
chromosomal DNA in the sample would result in higher OD readings. Therefore, 
approximate concentrations were calculated by running an aliquot of the plasmid DNA 
against a X/Hindlll marker, loaded at a known concentration, and comparing the 
intensities of the bands on the gel. Approximate concentrations of PI DNAs were 
calculated by adding the estimated concentrations of each of the bands obtained 
following single or double digestion of the DNA with restriction endonucleases.
2.3.5 PI DNA Library.
A brief summary on the construction and some of the characteristics of PI 
libraries follows. A more detailed description is found in Pierce et al., 1992; Pierce and 
Sternberg, 1992; Southard-Smith and MacDonald, 1993.
2.3.5.1 The \)Ad\QsacB\\ vector.
The PI vector pAdlOsacW. differs from its precursor, pNS582fe/144<ilO 
(ipAd\ 0, described by Sternberg (1990a)) in that the former contains an additional 
cassette (sacBII) that provides a positive selection for cloned inserts [Figure 2-1],
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loxP
sacB Sp6 T7 E. coli promoter
Spel Spel Sfil Sail
BamHI
Notl T
cl repressor 
binding site
FIGURE 2-1. Map of the oAdl^sacHH vector and cloning region (Pierce and Sternberg, 
1992; Pierce et al., 1992; Sternberg, 1992).
The .racBII cassette contains the sacB gene from Bacillus amyloliquifaciens, 
which codes for the protein levansucrase. This enzyme converts sucrose to levan. 
Expression of this gene when sucrose is present in the medium kills the bacterium, since 
accumulation of levan is lethal in E.coli. In the PI vector system, expression of the sacH 
gene is regulated by a synthetic near-consensus E.coli promoter. The cloning site is a 
unique BamHI located between this gene and its promoter. Therefore, those PI clones 
carrying an insert will grow in the presence of sucrose; in contrast, cells where the 
expression of the sacQ gene has not been interrupted, will die.
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Digestion of the plasmid DNA at the unique Seal and BamHl restriction sites 
generates a small (~4.4 kb) arm containing a loxP site, a phage PI packaging site, pac, 
and the sacBII cassette. It also generates a larger arm (~27 kb) which contains the 
remaining elements of the PI plasmid: an 11 kb adenovirus DNA fragment, which has 
disrupted an ampicillin-resistance {amp*) gene in the PI vector; a plasmid replicon which 
stably maintains the plasmid DNA at a copy number of 1 PI molecule per E.coli cell; a 
second loxP site; a kanamycin- resistance (kari) gene; a lytic replicon, regulated by the 
lac operon promoter, which is repressed in cells containing the lacE repressor. Addition 
of the lac inducer isopropyl-P-D-thiogalactopyranoside (EPTG) to the growth medium 
results in the activation of this lytic replicon and allows the copy number to be increased 
10- to 20-fold.
2.3.5.2 Construction o f the rat senomic DNA PI library.
DNA fragments in the approximate size range of 70 to 100 kb were selected 
following partial digestion with Sau3Al of high molecular weight genomic DNA 
extracted from Sprague-Dawley rats. The ends of both PI arms were treated with 
alkaline phosphatase, prior to ligation to the genomic digestion products.
Appropriate ligation events resulted in a foreign DNA fragment sandwiched 
between both arms such that the loxP sites were oriented in the same direction. 
Infectious PI phage particles were generated through a two-stage in vitro packaging 
reaction of these ligation products. In the PI system, packaging is initiated at the pac 
site. Encapsidation terminates in a sequence-independent manner by a “headful” cutting 
reaction. Therefore, the amount of DNA packaged is determined by the size of the PI 
head. This meant that very large DNA inserts resulted in the packaging of only one of 
the loxP sites. Recombinant molecules which carried very small inserts were not 
successfully packaged. Infectious particles were finally obtained by the addition of phage 
tails. These were then used to infect the E.coli strain NS3529, containing the laclq and 
the ere genes on two separate integrated X prophages. The ere gene codes for the PI 
Cre recombinase protein, needed for the cyclization of the P 1 DNA molecules after their 
injection into the host. This process involves recombination at the two loxP sites. Thus, 
only those molecules containing both of these sequences (i.e. mostly carrying 70-95 kb 
inserts) were cyclized. Approximately 105,300 independent clones were obtained. 
Characterisation of the size of the genomic insert was allowed by the
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unique restriction sites Noil and Sfil, located at each side of the BamHI cloning site. 
Digestion with these enzymes resulted in the extraction of the insert fom the PI 
molecule. The average insert size was 75 kb. Therefore, greater than 2.5 genome 
equivalents were represented in this library. Colonies were collected and arrayed in 209 
frozen glycerol pools. These primary pools contained on average 550 clones/pool (in a 
range of 230 to 1200 clones/pool).
2.3.5.3 Screening o f the PI library.
Identification of a single PI clone of interest was achieved in 3 stages:
a) Identification o f a positive primary pool
A small aliquot was removed from each glycerol pool and resuspended in 100 pi 
of dH20. The suspensions were thoroughly vortexed and heated at 100°C for 10 or 20 
minutes to prepare lysates. An aliquot of the lysate (1 pi) was used for PCR 
amplification.
b) Identification o f a positive secondary pool
Once a positive primary pool was identified, an aliquot was taken from this and 
resuspended in 3 ml of LB medium. The cell density was calculated by measuring the 
absorbance at 600 nm in a spectrophotometer. Appropriate dilutions were made and 
plated which allowed to obtain single colonies on the plates. These dilutions were 
prepared considering that an OD600 value of 1 corresponded to a density of 108 cells.ml'1. 
Individual colonies were picked and gridded on new plates. Once these colonies grew on 
the new plates, each row of 10 colonies was taken as a secondary pool. A small volume 
of cells was removed from each of the colonies in a secondary pool and these were 
resuspended in a volume of 100 pi of dH20. Lysates were prepared as before and again 
screened by PCR.
c) Identification o f a single positive PI clone.
A  small fraction was taken from each of the colonies which constituted a positive 
secondary pool. Each of these was resuspended in a separate volume of 100 pi of dH20. 
Individual lysates were then prepared and, again, screened by PCR.
All the lysates were kept at -20°C.
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2.3.6 Polymerase chain reaction (PCR).
In general, 50-100 ng of template DNA and 40-50 ng of each the forward and 
the reverse primers was used in each reaction. Most amplifications were carried out in a 
volume of 10 jliI, in the presence of lx magnesium free-Tag polymerase buffer (50 mM 
KC1, 10 mM Tris-HCl, 0.1% Triton X-100), 1-3 mM MgCl2, and 0.5 mM dNTPs. 1.5 U 
of Taq polymerase was added to each sample, normally following a hot start.
Amplifications were carried out on a GeneAmp 9600 System. The standard 
cycling conditions were one cycle at 99°C for 10 minutes, preceding the addition of Taq 
polymerase to the samples, at 80°C; one cycle at 94°C for 3 minutes; 25-35 cycles at 
94°C for 30 seconds, Tann. (annealing temperature; in the range 50°-65°C) for 30 
seconds, and 72°C for 30 seconds; a final extension cycle followed, at 72°C for 3 
minutes.
In a few of the reactions where mouse primers were being used to amplify 
heterologous rat DNA, formamide was added to a final concentration of 5%.
Multiplexed amplifications with the primers R191 and DIGulO were carried out 
in a final volume of 15 |il. 100 ng of DNA template, 50 ng of each oligonucleotide 
primer, 1 mM MgCl2, lx Taq polymerase buffer, and 0.7 mM dNTPs was added to each 
tube. Reactions were run following a hot start, with the addition of 1.5 U of Taq 
polymerase.
Amplifications with radioactively labelled primers were run on a Perkin Elmer 
Cetus apparatus. A 1:50 ratio of labelled to unlabelled forward primer was used in each 
reaction. A hot start was not used in these amplifications and Taq polymerase was 
directly added with all the other reagents. Reactions were carried out in a final volume of 
10 pi, overlaid with light mineral oil. Most primer sets worked optimally at identical 
conditions in both the GeneAmp 9600 system and the PE Cetus thermal cycler. A cycle 
at 95°C for 4 minutes preceded the amplification cycles, at 94°C for 30 seconds, Tann. 
for 30 seconds, and 72°C for 30 seconds; this cycling was followed by an additional cycle 
at 72°C for 3 minutes.
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2.3.7 Labelling o f DNA with 32P.
T4 polynucleotide kinase (Promega) was used in these reactions. This enzyme 
exhibits a 5' polynucleotide kinase and a 3' phosphatase activity. It catalyzes the transfer 
of the y-phosphate of ATP to a 5' hydroxyl group of DNA or RNA. Two different 
reactions were carried out with this enzyme:
- A forward labelling reaction, where a phosphate group (labelled with y-32P) was 
added to nucleic acids with 5' OH groups (2.3.7.1 and 2.3.7.2).
- An exchange labelling reaction, where the 5' phosphate group from DNA was 
removed, exchanged to ADP, and replaced using [y-32P]ATP as the donor (2.3.7.3).
2.3.7.1 Labelling o f PCR primers.
50 ng of forward primer (6-8 pmoles) was mixed with 1 pi of lOx kinase buffer 
(Promega; 700 mM Tris-HCl, pH 7.6; 100 mM MgCl2, and 50 mM DTT), 1 pi of [y- 
32P]ATP (10 pCi/pl, 4500 Ci/mmol), and 1 pi of enzyme (10 U), in a final volume of 10 
pi. The sample was incubated at 37°C for 1 hour. The reaction was then placed at 70°C 
for 10 minutes and either directly used in PCR amplifications or stored at -20°C for 
future use.
2.3.7.2 Labelling o f oligonucleotides.
(CA)10, (G C )io, (CT)io, and the forward and reverse DIMcol primers were 
labelled with [y-32P] in 30 pi reactions containing approximately 50 ng of the 
oligonucleotide (5-8 pmoles), 3 pi of lOx kinase buffer (Promega), 5 pi of [y-32P]ATP 
(10 pCi/pl, 4500 Ci/mmol) and 2 pi (20 U) of T4 polynucleotide kinase. The enzyme 
was added last and the reaction carried out at 37°C for 1 hour. The sample was then 
heated up at 70°C for 10 minutes, prior to removal of the unincorporated radioactivity 
(2.3.11.1).
2.3.7.3 Labelling o f  a 1 kb DNA ladder marker.
5 pg of 1 kb DNA ladder marker (BRL) was labelled in a 25 pl-reaction, with the 
addition of 5 pi of 5x exchange reaction buffer (BRL; 250 mM Imidazole-HCl, pH 6.4, 
60 mM MgCl2, 5 mM 2-mercaptoethanol, and 350 pM ADP), 3 pi of [y-32P]ATP (10 
pCi/pl, 4500 Ci/mmol), and 1 pi of T4 polynucleotide kinase (10 U). The reaction was 
carried out at 37°C for 30 minutes and then stopped by adding EDTA to a final
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concentration of 5 mM or by heating the sample at 70°C for 10 minutes. An aliquot was 
diluted 1:50 to prepare the working stock.
2.3.8 Digestion of DNA with restriction enzymes.
Restriction digests of most plasmids were carried out in 10-20 pi reactions for 1- 
1 1/2 hours. In some instances, restriction digests of PI DNA were set up in final 
volumes of 30-40 pi and left at 37°C for 2-4 hours. All the digestions were carried out at 
37°C. The BRL React buffers provided with each enzyme were appropriately used at a 
final concentration of lx React buffer; 1 pi (lpl = 10 U) of restriction enzyme was used 
per 10 pi reaction. When DNA was digested with two enzymes these were selected so 
that both yielded 100% activity in the same buffer (e.g. EcoKL and Notl both show 100% 
activity in lx React buffer 3).
2.3.9 Gel electrophoresis.
2.3.9.1 Agarose gel electrophoresis.
Horizon™ 58 and Horizon® 11.14 horizontal gel electrophoresis systems (BRL) 
were most commonly used. Eight to 14 samples could be loaded on the former, and up 
to 28 on the latter. In some instances, when large sets of backcross animals were being 
typed, the Kodak Biomax HR2025 system was used; 40 to 80 samples were run on these 
gels.
When studying strain differences at any new microsatellite locus, 4% MetaPhor 
agarose gels were always used. In the cases where a strain difference was large, any 
further characterisation of this SSLP and/or typing of the corresponding backcross 
progeny was often carried out on standard 4% agarose gels.
Analysis of the products obtained following amplification of PI lysates or 
somatic cell hybrid DNA template was commonly carried out on standard 1-2% agarose 
gels, with the exception of those instances when the PCR product was very small. In 
these latter cases, 4% agarose gels were used.
Most gels were cast and run on lx TBE. A few were prepared and run in lx 
TAE; in these latter, changes in the running buffer were required when running the 
samples for several hours. All the gels contained ethidium bromide at a concentration of
0.1-0.2 pg/ml. Running times of 45 minutes to 4 hours were needed, depending on the
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agarose concentration and the level of resolution required. In general, 95-140 V were 
applied.
Plasmid DNAs and their restriction fragments were always run on 0.8-1% 
agarose gels, cast and run on lx TBE. No ethidium bromide was added to these gels. 
Instead, these were stained after running the samples, in distilled water containing 0.4-
0.6 pg/ml of ethidium bromide. Appropriate resolution of the bands was normally 
achieved in 45-60 minutes, at 85-90V.
2.3.9.2 Polyacrylamide gel electrophoresis.
Denaturing 6%-8% polyacrylamide gels were used to analyse microsatellite 
alleles of similar sizes. In general, 8% gels were employed in those cases where the 
products being analysed were smaller than 150 bp. Products of 200 bp or more were 
normally studied on 6% polyacrylamide gels, prepared by mixing 80 ml of 6% 
sequencing solution (19:1) (acrylamide 6% (w/v), Bis-acrylamide, ratio 19:1; 7 M urea; 
lx TBE buffer, pH 8.3) (Anachem, Luton, UK) with 0.8 ml of 10% ammonium 
persulfate (APS) and 35 pi of N,N,N ’ ,N ’-tetramethylethylene diamine (TEMED). In 
order to prepare 8% polyacrylamide gels, 42 g of urea was dissolved in 20 ml of 5xTBE 
buffer and 10 ml of dH20; the solution was left to cool; 20 ml of 40% (w/v) 
acrylamide/bisacrylamide stock solution (19:1) was added, and the volume made up to 
100 ml with dH20. One ml of 10% APS and 32 pi of TEMED was added and the mix 
immediately poured between two 20.3 cm x 60 cm plates. In all cases, the 10% APS 
solution had been either freshly made or kept at 4°C for no longer than a week.
Gels (0.4 mm in thickness) were run on IBI Base Runners (International 
Biotechnologies Inc.). Prior to loading the samples on the gel, this was pre-run at 60 W 
for 20-40 minutes. Approximately 10 pi of loading buffer was added to each PCR 
sample. Loading buffer was also added to an aliquot of the diluted labelled ladder. The 
samples were heated at 100°C for 10 minutes and immediately placed on ice. 5 pi of 
each sample was loaded on the gel; the remaining volumes were kept at -20°C.
6% and 8% polyacrylamide gels were run on lx TBE, at 60 W for 3 hours and at 
15-20 W for 8-10 hours, respectively. Then the gels were lifted on Whatman 3MM 
paper, covered in Saran wrap, and dried under vacuum at 80°C for 30-45 minutes. The 
gels were placed in cassettes, together with X-ray film, and placed at -70°C for 10 hours 
to 2 days.
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23.9.3 Molecular weight markers.
A 1 kb DNA ladder marker (BRL; 12 bands each containing from 1 to 12 
repeats of a 1018 bp DNA fragment, and 11 additional bands of 75, 134, 154, 201, 220, 
298, 344, 396, 506, 517 and 1636 bp, respectively) was normally used as the size 
standard when running PCR products on agarose gels. In some cases, a 100 bp ladder 
marker (BRL; 15 fragments ranging in length from 100 bp to 1500 bp, at 100 bp- 
increments, and an additional 2072 bp-fragment) was employed. Both ladders were 
diluted in dH20  and loading buffer to yield a final concentration of 100 ng.ml'1. A total 
of 500 ng was loaded per well.
An aliquot of the 1 kb ladder marker was radioactively labelled (2.3.7.3) to be 
run on polyacrylamide gels. Approximately 5 ng of marker was then loaded per well.
XIHindlU fragments (fragment sizes, in kb: 0.56, 2.0, 2.3, 4.4, 6.6, 9.4, 23.1) 
were used as size markers when running plasmid DNA; the 1 kb ladder was also often 
run on these gels. The former was prepared by digesting X phage DNA with the enzyme 
Hindlll, at 37°C for 1 1 / 2 - 2  hours, and then diluting the reaction to a final 
concentration of 25 ng of X DNA per pi. Following digestion with Hindlll and 
subsequent dilution, the sample was incubated at 65°C for 10 minutes and immediately 
put on ice for another 10 minutes. A total of 250 ng of XIHindlll DNA was loaded per 
well.
All the markers, with the exception of the radioactively labelled 1 kb marker, 
were kept at 4°C. The labelled marker was kept at -20°C.
2.3.10 Southern blotting.
Following electrophoresis and resolution of the fragments obtained from the 
digestion of plasmid DNA with restriction endonucleases, the DNA was tranferred to 
nylon membranes (Magna nylon transfer membrane; Micron Separations Inc.).
The gel was left in 0.25 M HC1 for 10 minutes. This solution was discarded and 
the gel washed in distilled water. The gel was kept immersed in denaturing solution (1.5 
M NaCl, 0.5 M NaOH) for 15 minutes. Passed this time, this solution was replaced with 
fresh 1.5 M NaCl, 0.5 M NaOH and the gel soaked for an additional 15 minutes. Gentle 
agitation was kept throughout the washes. The gel was finally removed from the 
denaturing solution and placed on a flat surface (normally a glass plate). A piece of 
membrane cut according to the measures of the gel was briefly immersed in denaturing 
solution and carefully placed on the gel. The DNA was transferred to the nylon 
membrane by capillary action. After blotting for at least 8 hours, the membrane was
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washed in 2x SSC (0.3 M NaCl, 30 mM tri-sodium citrate) to remove any adhering 
agarose, and exposed to UV radiation. Membranes were kept at -20°C in sealed 
polythene bags.
2.3.11 Hybridisation o f oligonucleotides to filter bound nucleic acid.
2.3.11.1 Removal o f unincorporated radionucleotide.
30 jul of blue dextran solution and 10 pi of phenol red solution was added to the 
30 pl-labelling reaction after this was heated up at 70°C for 10 minutes (section 
2.3.7.2). The sample was let to flow through a Sephadex G25 column (NAP™ S 
columns; Pharmacia Biotech.), which had been previously equilibrated in TE buffer. 
Flow was maintained through two 0.5 ml TE-washes. The blue fraction, containing the 
labelled oligonucleotide, was collected. The specific activity of the probe (SA=cpm per 
pg of DNA) was estimated by measuring on a scintillation counter the counts given by 
an aliquot of the collected fraction, and then applying the following calculation:
cpm in 1 pi x total volume of the blue fraction (pi) x 103(ng)
SA = -------------------------------------------------------------
Amount of DNA in the labelling reaction (-50 ng)
In general, specific activities in the 108-109 range were obtained with all the
probes.
2.3.11.2 Prehybridisation.
Filters were placed in cylinders containing a hybridisation solution. This was 
always prepared fresh, and contained:
- 2.5 ml of 20x SSC (3 M NaCl, 0.3 M tri-sodium citrate).
-100 pi of 0.1 M sodium pyrophosphate.
- 1 ml of 50x Denhard’t solution (2.5 g Ficoll (type 400), 2.5 g of polyvinyl­
pyrrolidone, 2.5 g BSA(fraction V; Sigma); volume made up to 250 ml with 
dH20. Filtered and kept at -20°C).
- 0.5 ml of 1 M sodium phosphate buffer, pH 6.8.
- 2 ml of formamide.
-170 pi of 10 mg.ml'1 salm sperm DNA.
Volume made up to 10 ml with dH20.
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Volumes of 3-10 ml were used in the prehybridisation step, depending on the size 
and the number of filters in each cylinder. Prehybridisation was carried out at 42°C for 1- 
2 hours.
2.3.11.3 Hybridisation and washing.
The prehybridisation solution was discarded and the probe was added to a 
volume of fresh hybridisation solution that was approximately half of that used for 
prehybridisation. Enough probe was added in order to obtain about 106 cpm.ml'1. 
Hybridisation was carried out for 10-20 hours at 42°C.
Following hybridisation, the membranes were washed twice in 2x SSC/0.1% 
SDS, at room temperature for 15 minutes. A last wash followed, in lx SSC/0.1%SDS, at 
50°C, for an additional 15 minutes. The filters were then removed and placed in sealed 
polythene bags. These were placed in a cassette, together with X-ray film that was 
exposed at -70°C for 10 to 72 hours.
2.3.12 Photography/Autoradiography.
Gels stained with ethidium bromide were viewed on an UV transilluminator and 
photographed using either a Mitsubishi image and video copy processor or a Polaroid® MP- 
4 Land camera.
Autoradiography was performed in metal cassettes (medical chest X-ray type) using 
Fuji medical X-ray films. Enhancement of the intensity of the autoradiographic images was
obtained by exposing the film at -70°C. The X-ray films were developed using an X- 
OGRAPH Compact X2 automatic processor.
2.3.13 QIAEXII- DNA agarose gel extraction and purification in aqueous solutions.
QIAEX II resin (Qiagen Ltd., Dorking, UK) was used to extract DNA from 
agarose gels, and also to purify and concentrate DNA from aqueous solutions without 
the need for phenol extraction or ethanol precipitation steps. The vendor’s instructions 
were followed. In general, samples were eluted only once, in 20 pi of dH20. Only in 
those cases when large amounts of DNA were being purified were 2 elution steps (i.e. 2x 
20 pi) carried out.
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I._ DNA purification in PI lysates.
In some instances, the confirmation of the presence of a particular locus in PI 
primary pools required purification of the DNA in the lysates. The lysates were then 
prepared in a volume of 30 |nl of dH20, instead of 100 pil, and the DNA extracted with 
QIAEXII resin.
II._ DNA extraction from agarose gels.
DNA fragments obtained from the digestion of PI and other plasmid clones were 
excised from 0.8-1% agarose gels after these had been stained in ethidium bromide for a 
very short time. All the non-nucleic acid impurities present, including the agarose, were 
then removed. The same approach was used when preparing vector DNA for cloning 
experiments. In this case, vector DNA was run on a low percentage agarose gel (0.8- 
1%), following linearisation and dephosphorylation steps. The band corresponding to the 
linearised plasmid was extracted and purified, with the consequent removal of any 
remaining uncut plasmid.
PCR products were extracted from 2% agarose gels except when these products 
were of a considerable small size. In these cases, 4% low melting point agarose gels were 
run, the product band extracted, and the DNA purified as before.
2.3.14 Removal o f the 5' phosphate from  linearised DNA.
In order to avoid self ligation of the vector when carrying out cloning 
experiments, the 5' terminal phosphate groups on linearised plasmid DNA were removed 
prior to any ligation stages. The enzyme shrimp alkaline phosphatase (SAP) was used for 
this purpose. SAP works in most restriction buffers; therefore, an aliquot (1 U) of this 
enzyme was added to 20 \x\ of vector DNA restriction digests. The sample was then left 
at 37°C for 30 minutes. Removal of the enzyme was achieved by running the 
dephosphorylated sample on a low percentage gel and then extracting the band 
corresponding to the linearised vector (section 2.3.13 (II)). Prior to this step, the sample 
was heated at 65°C for 10-15 minutes.
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2.3.15 Shotgun cloning of PI DNA fragments.
Approximately 0.5 to 1 fig of PI DNA was digested with Saul Al enzyme in 10- 
20 pi reactions. A phenol/chloroform extraction followed; the aqueous phase was 
transferred to a clean tube and further extracted with an equal volume of chloroform. 
The DNA was precipitated with 2.5 volumes of 100% ethanol, in the presence of 0.3 M 
sodium acetate, pH 5.2. The DNA was resuspended in 10 pi of dH20  and ligated to 50- 
60 ng of vector DNA.
2.3.16 Ligation of DNA fragments.
The vector was dephosphorylated when it had been cut with only one enzyme. 
When cloning into pGEM-3Zf(+) vector which had been cut with both Kpnl and Hincll, 
no phosphatase treatment was required, since the two ends were non-cohesive. When 
cloning specific band-purified DNA fragments, concentrations of both the insert and the 
cloning vector were estimated prior to ligation by running respective aliquots on a low 
percentage gel, against 250 ng of a X/Hindlll marker. The molar ratio of insert to vector 
was approximately 3:1. This ratio was estimated to be higher in the shotgun cloning 
experiments (section 2.3.15).
All the ligations were performed in 20 pi of lx ligation buffer (50 mM Tris-HCl, 
pH 7.6; 10 mM MgCl2; 1 mM ATP; 1 mM DTT, 5% (w/v) PEG 8000), containing 1.5 U 
of T4 DNA Ligase (BRL). The reactions were incubated for 4 hours at room 
temperature, or overnight at 16°C.
Cloning of the D3Gul PCR product was carried out using the pDT Blue Cloning 
System (ams Biotechnology). The yield of amplification product was considerably low 
(10-15 ng in a 10 pi reaction); 5.5 pi of a fresh PCR reaction was mixed with 2 pi pDT 
vector DNA (100 ng), 1 pi of lOx ligase buffer, 1 pi of 10 mM ATP, and 0.5 pi of T4 
DNA ligase. The reaction was incubated at 16°C overnight.
2.3.17 Colony hybridisation.
Colony lifts were prepared with nylon membranes cut to the appropriate sizes. A 
first set of membranes were placed on the plates and removed after 30 seconds. The
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second set were left on the plates for 1 minute and then removed. Four Petri dishes ((a) 
to (d)) were used as trays containing Whatman 3MM paper soaked in:
(a) 10% SDS,
(b) 0.5 M NaOH; 1.5 M NaCl,
(c) 1.5 M NaCl; 0.5 M Tris, pH 7.4,
(d) 2x SSC, 
respectively.
The filters were sequentially placed on each of these plates, the side of the 
membrane carrying the colonies up. The filters were left on the plates (a), (b), (c), and 
(d), for 3, 5, 5, and 5 minutes, respectively. The DNA was then fixed to the membranes 
by UV-crosslinking. The membranes were washed in O.lx SSC/0.1% SDS at 80°C for 1 
hour, and the cell debris removed by thorough rubbing of the surface of these filters 
whislt still immersed in solution. The membranes were then prehybridised and hybridised 
at 42°C, in the same solution than that used to probe blots of plasmid DNA digests 
(section 2.3.11). A larger volume of hybridisation mix was employed both in the 
prehybridisation and in the hybridisation steps. Approximately 106 to 107 cpm per ml of 
hybridisation solution was used. Washes were also carried out under the same conditions 
than when working with Southern blots. X-ray film was exposed at -70°C for 2-3 days.
2.3.18 Sequencing.
Sequencing was carried out on an ABI 373 sequencer apparatus (Perkin Elmer), 
using the ABI PRISM™ Dye Terminator Cycle Sequencing Ready Reaction Kit. The 
manufacturer’s instructions were followed.
2.3.18.1 Preparation o f DNA templates.
Plasmid clone DNA and PCR products were sequenced. Good results were 
mainly dependent on the purity and the amount of DNA used in each sequencing 
reaction. Different approaches were followed to obtain the required yields of clean DNA.
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I. _P1 DNA.
PI DNA was isolated from the E.coli NS3529 and the DH10B strains, following 
either the CsCl purification protocol (section 2.3.2.3) or another modification of the 
alkaline lysis protocol. This latter is described below.
A single colony of the PI clone was seeded into 15 ml of TB containing 
25pg.ini'1 kanamycin (when working with NS3529; 50 pg.ml1 kanamycin when using 
DH10B). The culture was grown at 37°C overnight. The cells were pelleted at 6000 rpm 
for 5 minutes and then resuspended in 3 ml of dH20. Another centrifugation step 
followed, as before; this time the pellet was thoroughly resuspended in 2 ml of GTE 
(1% glucose/ 50 mM Tris, pH8.0/ 10 mM EDTA) and left on ice for a few minutes. 3 
ml of 1% SDS/ 0.2 N NaOH was added and the tube inverted 3-5 times and left on ice 
for 10 minutes. 3 ml of 3 M sodium acetate (pH 4.8) was then added, the tube gently 
inverted 3-5 times, and left on ice for 20 minutes, th e  sample was centrifuged at 15000 
rpm for 10 minutes to remove the cell debris and most of the chromosomal DNA. The 
supernatant was transferred to a new tube and the DNA precipitated with an equal 
volume of isopropanol. The DNA was recovered as a clear pellet at the side of the tube 
after centrifuging at 15000 rpm for 10 minutes. This pellet was dissolved in 0.4 ml of
0.3 M sodium acetate, pH4.8. An equal volume of phenol/chloroform (ratio 1:1) was 
added and the sample vigorously vortexed and centrifuged at 14000 rpm for 5 minutes. 
The phenol/chloroform extraction was repeated 1 or 2 more times. 1 ml of 100% 
ethanol was finally added to the recovered aqueous phase and the tube centrifuged at 
14000 rpm for 10 minutes. The DNA was washed with 0.4 ml of cold 70% ethanol, air 
dried, and dissolved in 0.4 ml of TE; 5 pi of RNase A was added and the tube incubated 
at 37°C for 2 hours. 4 pi of 1 M MgCl2 and 200 pi of 40% PEG800o was then added and 
the sample vortexed and centrifuged at 14000 rpm for 15 minutes. The pellet was rinsed 
with cold 70% ethanol and air dried; it was then dissolved in 0.4 ml of 0.5 M 
ammonium acetate. One ml of 100% ethanol was added and the sample centrifuged at 
14000 rpm for 10 minutes. The pellet was rinsed twice with 0.4 ml of cold 70% 
ethanol, air dried, and finally dissolved in 55 pi of dH20.
All the isolated PI DNAs were dialysed for 6-14 hours prior to sequencing.
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II._ Other plasmid DNAs.
pGEM-3Zf(+), pBluescript II KS+, and pDT Blue clone DNAs were isolated 
from 3 ml LB cultures, as previously described (section 2.3.2.2). The DNA was 
resuspended in 32 pi of dH20  and re-precipitated by adding 8 pi of 4 M NaCl and 40 pi 
of 13% PEGgooo. The sample was thoroughly mixed, left on ice for 20 minutes, and 
centrifuged at 14000 rpm for 15 minutes, at 4°C. The DNA pellet was washed with 70% 
ethanol, air-dried, and finally resuspended in 20 pi of dH20.
III. _ PCR products.
PCR reactions were carried out under the conditions established as optimal, in a 
volume of 25 pi. Purification of the amplification product was rapidly achieved using 
MicroSpin™ S-400 HR columns (Pharmacia Biotech.); the manufacturer’s instructions 
were followed. In a few instances, the yield of purified product was too low to be used in 
sequencing reactions. In these cases, the PCR reaction was repeated and the product run 
on an agarose gel and purified with QIAEXII resin. In the instances where the yield was 
still too low, two modifications were introduced:
a) The number of cycles in the PCR reaction was increased. The appearance of 
background bands did not pose a problem, since only the specific PCR product was 
extracted from the gel, purified, and sequenced.
b) In the cases when increasing the number of PCR cycles did not result in 
sufficient amounts of product being obtained, a first PCR amplification was carried out 
and the PCR product run on a low melting point agarose gel. A small sample was taken 
from the product band and used as the template in a second amplification reaction. The 
final product was run on an agarose gel and purified with QIAEX II resin.
2.3.18.2 Sequencing o f DNA templates.
Approximately 3 to 5 pg of PI DNA was used as template in each sequencing 
reaction. Aliquots (1 or 2 pi) of the purified plasmid DNAs and the PCR products were 
run on agarose gels to estimate the concentration of these DNAs. Approximately 30- 
100 ng of PCR product was added to each sequencing reaction. The amount of plasmid 
DNA used as template for sequencing normally ranged between 0.3 and 0.5 pg.
All the sequencing reactions were carried out in a volume of 20 pi. Eight 
microlitres of the Terminator Reaction Mix (available with the sequencing kit) and
63
C h a p t e r  2. M a t e r i a l s  a nd  M e t h o d  s .
3.2 pmoles of the appropriate sequencing primer was added to the template. Sequencing 
was carried out on a GeneAmp PCR System 9600. The cycling conditions were 1 cycle 
at 96°C for 1 minute, followed by 25 cycles at 96°C for 10 seconds, 50°C for 5 seconds 
and 60°C for 4 minutes.
When sequencing PCR products, the corresponding PCR primers were used. 
Sequencing of pGEM-3zf(+) and pBluescript IIKS+ clones was carried out with the -21 
Ml 3 Forward and the M13 Reverse primers:
-21 M13 FORWARD PRIMER: 5’- TGTAAAACGACGGCCAGT -3'
M13 REVERSE PRIMER: 5'- CAGGAAACAGCTATGACC -3'
Sequencing of pDT Blue clones was carried out with the -21 Ml 3 Forward 
primer and a T7 primer:
T7 PRIMER: 5’- CTAATACGACTCACTATAGG -3'
PI clone DNAs were sequenced with either the SP6 or the T7 sequencing 
primers described by Kimmerly et a l (1994):
SP6 PRIMER: 5'- GGCCGTCGACATTTAGGTGACAC -3'
T7 PRIMER: 5'- CCGCTAATACGACTCACTATAGGG -3'
Once the cycling had finished, the DNA was precipitated with 2.5 volumes of 
100% ethanol, in the presence of 0.3 M sodium acetate, pH 5.2. Each product was 
finally resuspended in 4 pi of loading buffer (deionized formamide and 25 mM EDTA 
(pH 8.0) containing 50 mg/ml blue dextran, in a ratio of 5:1 formamide to EDTA/Blue 
dextran). The samples were heated at 90°C for 2 minutes before loading.
Sequencing gels (0.4 mm in thickness) were prepared by mixing 50 ml of 6% 
sequencing solution (19:1) (acrylamide 6% (w/v), Bis-acrylamide, ratio 19:1; 7M urea; 
lx TBE buffer, pH8.3) (Anachem, Luton, UK) with 250 pi of 10% APS and 25 pi of 
TEMED. The samples were run at 30 W (2500 V; 40 mA) for 14 hours, in lx TBE. 
Sequencing data were collected and analysed using Model 373 Software (Applied 
Biosystems, Perkin Elmer).
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2.3.19 Computer-assisted sequence analysis.
Search for specific sequences in the database was carried out by using the “GCG 
Sequence Analysis Software Package, Version 7” from the Genetics Computer Group at 
the University of Wisconsin (UWGCG). The programs Stringsearch and Fetch were used 
to identify sequences which corresponded to specific character patterns in the database 
and to copy those sequences or data files into appropriate directories, respectively.
Primer design was aided by the MacVector™ 4.1.4 and the GeneJockevII 
Sequence Processor (Biosoft, Cambridge, UK) programs. The latter was used to analyse 
the sequences obtained following sequencing in the ABI 373 system. Often, DNAs 
corresponding to the same clone (i.e. carrying the same insert) were extracted from 2 
different cultures (i.e. 2 separate colonies) and sequenced in parallel. These two 
sequences were aligned (Gap) to identify possible misreadings. When PCR or sequencing 
primers were to be design, only the regions of complete identity were taken into account. 
This alignment function was also used when searching for gene-specific regions in the rat 
muscle creatine kinase gene.
Obtained sequences were compared to non-redundant sequences in the 
GenBank+EMBL+DDBJ+PDB database through BLAST Sequence Similarity 
Searching, based on the BLAST algorithm (Altschul et al., 1990).
2.4 Statistics.
X2 values were calculated as:
X2 = E - m£)2 / mji
where:
k is the number of classes of animals (two parental classes, agu+ xf/agu' x3 and agu' 
x?lagu x3; and two recombinant classes, agu+ xa/agu' x3 and agu xf/agu' x3, as indicated 
in Figure 4-1).
Xj is the number of animals observed in each class.
mi is the number of animals expected in each class, assuming random assortment of agu 
and the SSLP locus x alleles.
The degrees of freedom (df) are calculated as k-1.
65
C h a p t e r  2. M a t e r i a l s  a nd  M e t h o d s ,
The standard deviation (Green, 1981), SD, was calculated as:
SD = \ r(l-r)
N
where r is the recombination frequency and N the number of animals typed.
The 95% lower (Lj) and upper (L2) limits were calculated as:
Li= r - x . SD 
L2= r + x . SD
where:
r= recombination fraction 
SD=standard deviation
x is a coefficient obtained with Gaussian curves. For a 95% confidence interval, both 
the lowest and the highest values for which the probability is 2.5% are rejected. The x 
value corresponding to this probability is x= 1.96. Calculation of the 95% lower limit 
for the interval C - DlMit3 (Chapter 4) resulted in a negative value. Therefore, the 
highest values for which the probability was 5% were rejected (>L2). This correlated to 
an x value= 1.645.
Conversion of the recombination frequencies (r) to genetic distances (d, in cM) was 
carried out by applying the Kosambi’s mapping function (Green, 1981):
d= 1/4 [loge (l+2r) - loge (l-2r)]
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2.5 E. coli strains.
The E.coli strains which were used in this work are shown below.
STRAIN GENOTYPE REFERENCE/SOURCE
DH5a supE44 AlacU 169((|)80/acZAM 15) hsdRll recAl 
endAl gyrA96 thi-1 relAl
Hanahan, 1983.
DH10B F' mcrk. A{mrr-hsdRM$>-mcrEC) (j)80d/acZAM15 
AlacX14 endAl recAl deoR A{ara-leu)1691 
araD 139 gall]K nupG rpsL
Grant et al., 1990.
F3 DH10B [F::TnlOd-Cam] Kimmerly et al., 1994.
INVaF’ F’ endAl recAl hsdR.ll (rk‘, mk+) supE44 thi-1 
gyrA96 relAl <j)80/acZAM15 AQacZYA- 
argY)m69%-
TA cloning® kit. 
(Invitrogen BV, Leek, The 
Netherlands)
NS3529 recAl mcrA A(mrr-hsdRMS-mcrBC) X,immA,LP 1 
Ximm434nin5X 1 -ere
Pierc Qetal., 1992.
TGI supE hsdAS thi A(lac-proAB) F’ [traD?>6 proAE+ 
lacE /acZAM151
Gibson, 1984.
2.6 Plasmid vectors.
The pDT Blue vector was obtained with the pDT Blue cloning system (ams 
Biotechnology). Plasmid pBluescript II KS+ was obtained from Stratagene (La Jolla, 
CA, USA). Plasmid pGEM-3Zf(+) was obtained from Promega.
2.7 Media for propagation of E.coli.
a) L-broth (LB).
10 g tryptone, 5 g yeast extract, 5 g NaCl, 1 g glucose, 20 mg thymine, made up 
to 1 litre in distilled water and adjusted to pH 7.0 with NaOH.
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b) 2x YT-broth.
16 g tryptone, 10 g yeast extract, 5 g NaCl, made up to 1 litre in distilled water 
and adjusted to pH 7.0 with NaOH.
c) T-broth (TB).
12 g tryptone, 24 g yeast extract, 4 ml glycerol, made up to 900 ml in distilled 
water. Autoclaved and let to cool to 60°C or less. Then, 100 ml of a sterile 
solution of 0.17 M KH2P 0 4, 0.72 M K2H P04 added.
d) SOB medium.
20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 10 ml 250mM KC1, made up to 
990ml with distilled water and adjusted to pH 7.0 with NaOH. Autoclaved and 
let to cool down to room temperature. 10 ml of sterile 1 M MgCl2 added before 
use.
e) SOC medium.
1 litre of SOB medium to which 20 ml of sterile 1 M glucose has been added.
f) L-Agar.
As L-Broth without glucose and the addition of 15 g .f1 agar.
2.8 Antibiotics and Indicators.
The antibiotic concentrations used for both liquid and plate selection were as 
follows:
Antibiotic Stock solution Working concentration
Am pic tlli n I  100 mg.ml'1, prepared in dH20. 100 tig.ml'1
€J* lora m phenko}; I  100 mg.ml'1, prepared in ethanol. 10 |ag. ml'1
Kaitamydj* |  100 mg.ml'1, prepared in dH:0. 25 or 50 fag.ml"1
Streptomycin |  100 mg.ml1, prepared in dH:0. 100 tig.ml'1
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The indicators X-gal (5-bromo-4-chloro-3-indolyl-P-galactopyranoside) and 
IPTG (isopropyl P-D-thiogalactopyranoside) were both prepared at a concentration of 
100 mg.ml'1, and used at the final concentrations of 40 and 50 fig.ml'1, respectively. 
IPTG was dissolved in distilled water; X-gal was prepared in N,N-dimethylformamide. 
When being employed to induce the PI copy number in E. coli host cells, a 1 M IPTG 
solution was prepared. This was added to the cultures to a final concentration of 1 mM.
All the antibiotics and the indicators above were stored at -20°C. When preparing 
plates, these solutions were added to the molten agar once this had been cooled to 
approximately 50°C. In general, the plasmids which did not carry an insert gave rise to 
blue colonies whilst those which did resulted in the growth of white colonies.
2.9 Sterilisation.
All growth media were sterilised by autoclaving at 121°C for 15 minutes at a 
pressure of 15 lbs. Thermolabile substances such as antibiotics were sterilised by 
filtration through 0.22-micron filters. Those antibiotic solutions which had been prepared 
in ethanol need not be sterilised. Sucrose and glucose solutions were either filtered 
through 0.22-micron filters or autoclaved at 104°C for 10 minutes at a pressure of 5 lbs.
2.10 E.coli growth conditions.
Liquid cultures of E.coli strains from which pGEM-3Zf(+), pBluescript II KS+ 
and pDT Blue clone DNAs were to be isolated were grown in L-broth with the 
corresponding ampicillin selection. Volumes of 3 ml of broth were normally seeded and 
the cultures incubated at 37°C for 9-17 hours in an orbital shaker at ca. 250 rpm. In the 
case of the subclone 37B, 5 ml cultures were also prepared and grown at 30°C for 
approximately 15-20 hours. PI clones were grown in volumes of 50, 100, 250 and 500 
millilitres; most cultures were prepared in L-broth and a few in 2x YT- or T-broth. When 
large cultures (100 ml or more) were to be prepared, 3-5 ml cultures were first grown 
overnight and aliquots taken to seed the larger volumes. A final concentration of
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5% sucrose was added to all the PI cultures; the antibiotic kanamycin was added to a 
final concentration of 25 fig.ml'1 when using NS3529 host cells and to a concentration of 
50 Mg.ml'1 when working with DH10B cells. Most PI cultures were grown at 30°C. 
Normally 1 mM IPTG was added to the PI cultures once these had reached an AB59o.595=
0.15-0.2; these were then grown for an additional 4-20 hours.
E.coli strains were also propagated on L-agar plates with the appropriate 
selection. Plates contained ca. 25-50 ml of agar. Except the PI clones, all the plates were 
incubated overnight at 37°C. PI colonies were grown in the presence of 5% sucrose at 
30°C for 20-36 hours.
2.11 Preservation of E.coli strains.
A 0.75-1 ml aliquot of each culture was mixed with 1 ml of 40% (v/v) glycerol, 
2% peptone (w/v), and stored at -70°C. The strains were revived by scraping the surface 
of this frozen stock with a toothpick and streaking onto agar. This allowed the isolation 
of single colonies on the plate.
2.12 PI DNA transfer into DH10B by an F1 episome intermediate.
The transfer into DH10B cells was done via y5-transposition and it involved 
several steps.
L. A single colony of NS3529 containing the PI of interest was seeded into 1 ml 
of LB containing 50 Mg-111!’1 kanamycin, and grown at 37°C overnight. At the same time, 
an F3 colony, grown in a plate containing 10 Mg-111!’1 chloramphenicol, was picked to 
inoculate a 5 ml LB culture which was also grown at 37°C overnight.
Z  1.8 ml of LB was added to a sterile glass test tube; 100 pi from each overnight 
culture was also added and the mix (Ml) incubated on a roller (30 rpm) at 37°C for 3 
hours. A 10'5 dilution of mating mix Ml was plated on L-agar containing 50 Mg-111!’1 
kanamycin/ 10 Mg-111!"1 chloramphenicol, and grown at 37°C overnight. A control was 
prepared where 5 pi of the F3 and 5 pi of the NS3529 cultures was separately spotted
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on a plate which also contained 50 pg.ml1 kanamycin and 10 fig.ml'1 chloramphenicol. 
This control plate was incubated at 37°C overnight.
T As expected, no colonies grew on the control plate, since these cells did not 
carry both kanamycin and chloramphenicol resistance genes.
Between 400 and 600 colonies grew on the Ml plate; these must be NS3529 
cells which had received the F::Tnl0d-Cam factor from the F3 donor and therefore 
exhibited resistance to both antibiotics.
A single colony was picked into 1ml of LB containing 50 fig.ml1 kanamycin and 
10 pg.ml1 chloramphenicol, and grown at 37°C overnight. At the same time, a DH10B 
colony was picked from an L-agar/ 100 fig.ml1 streptomycin plate, to inoculate 5 ml of 
LB. This culture was grown at 37°C overnight.
A Again, 100 (il from each overnight culture was added to 1.8 ml of LB in a 
sterile glass test tube and the mix incubated on a roller (30 rpm) at 37°C for 3 hours. 100 
fil of this mating mix (M2) was plated on L-agar containing 50 fig.ml1 kanamycin/ 10 
fig.ml1 chloramphenicol/ 100 pg.ml*1 streptomycin. A control was prepared, as before, 
with 5 j l l I  of Ml and 5 pi of DH10B cultures being separately spotted on a plate 
containing these three antibiotics. Both plates were incubated at 37°C overnight.
5^  No colonies were observed on the control plate. Approximately 400-500 
colonies grew on the M2 plate; these must be the DH10B cells which had received both 
the F factor and the PI clone from the donor parent.
Some modifications were introduced to the original method when transferring 
PI (DIMcol) DNA:
A considerable fraction of the gridded P1 {DIMcol) bacterial mass was removed 
with a toothpick and resuspended in 100 pi of LB. 90 pi was used to inoculate 1 ml of 
L-broth containing 50 pg.ml*1 kanamycin and 5% sucrose. This culture was grown at 
37°C for nearly 2 hours. PCR amplification showed that the DIMcol sequence was still 
present.
The PI culture was added to 1.8 ml of LB, together with 100 pi of an overnight 
F3 culture, and the mix incubated at 37°C for 3 hours. 100 pi of this mix (Ml) was 
plated and grown at 30°C for 36 hours, until very small colonies were visible on the 
plate.
Six Ml colonies were picked and each resuspended in 100 pi of LB. PCR 
confirmed that all of them contained the DIMcol sequence. 90 pi of each suspension
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was employed to seed each of six 600 pi LB cultures (containing 50 pg.ml'1 kanamycin 
and 10 pg.ml'1 chloramphenicol) and these grown at 37°C for 2 1/2 hours. Again, the 
DIMcol PCR product was obtained from each of these cultures. Two of them were 
pooled, pelleted, resuspended in 100 pi of LB, and mated to an overnight DH10B 
culture. 1 ml from this mix (M2) was centrifuged and the pellet resuspended in 200 pi of 
LB. 100 pi was plated on LB medium containing 50 pg.ml'1 kanamycin/ 10 pg.ml'1 
chloramphenicol/ 100 pg.ml'1 streptomycin, and grown at 30°C until a few colonies were 
visible.
2.13 Introduction of plasmid DNA into E. coli.
2.13.1 Preparation o f competent cells.
The cells were kept at 4°C throughout all the manipulations when preparing 
competent cells. INVaF’ cells, available with the TA cloning® kit (Invitrogen BV., 
Leek, The Netherlands), were also used.
2.13.1.1 Electrocompetent cells.
These cells yielded the highest transformation efficiencies (108-1010 transformants 
per pg of DNA). TGI and DH5a cells were made electrocompetent following the steps 
below.
1._ A volume of 400 ml of L-broth was inoculated with 4 ml of a fresh overnight 
culture. The cells were grown at 37°C with vigorous shaking, to an approximate 
Afioo of 0.5-0.6.
2._ The cells were kept on ice for 15-30 minutes and then pelleted by centrifuging at 
5000 rpm for 15 minutes at 4°C.
3._ The supernatant was discarded and the cells thoroughly resuspended in 400 ml of 
ice cold dH20. The centrifugation step was repeated as before.
4._ The supernatant was removed and the cells resuspended in 250 ml of ice cold 
dH20. Another centrifugation step followed.
5._ The pellet was resuspended in 20 ml of ice cold 10% glycerol and centrifuged as 
before.
72
C h a p t e r  2.  M a t e r i a l s  a n d  M e t h o d s .
6._ The cell pellet was finally resuspended in approximately 0.7 ml of ice cold 10%
glycerol. Aliquots of 40 pi were prepared and left on dry ice for 15 minutes. 
These aliquots were stored at -70°C for up to ~6 months.
2.13.1.2 CaCU method.
Competent INVaF’ and TGI cells were prepared following the protocol 
described below. A transformation efficiency of ~106 was normally obtained. The cells 
were kept at 4°C for a maximum of 2-4 days.
1._ A volume of 100 ml of L-broth was inoculated with 1 ml of a fresh 3 ml 
overnight culture, and the cells grown at 37°C until an A595 of about 0.6 was 
reached.
2._ The cells were centrifuged at 3000 rpm at 4°C for 5 minutes and the supernatant 
discarded.
3._ The cells were resuspended in 25 ml of ice cold 50 mM CaCl2 and left on ice for 
20 minutes. The centrifugation step was repeated.
4._ The cells were finally resuspended in 5 ml of ice cold 50 mM CaCl2 and kept at 
4°C.
2.13.2 Transformation procedures.
When transforming INVaF’ cells which had been obtained with the TA cloning® 
kit, the manufacturer’s instructions were followed.
2.13.2.1 Electro-transformation.
Electroporation was carried out on a Gene Pulser apparatus (Bio-Rad 
Laboratories), set at 25 pF, 200 Q, and 2.50 kV. 0.2 cm cuvettes were used.
The DNA used in these transformations must be in a low ionic strength buffer. In 
the cases where a ligation product was being used in the transformation, this DNA was 
first precipitated with 2-2.5 volumes of 100% ethanol, in the presence of 0.3 M sodium 
acetate (pH 5.2), and then resuspended in 7-8 pi of dH20.
1._ A 40 pi aliquot of electrocompetent cells was gently thawed. The suspension was
mixed with 1-4 pi of DNA (depending on the DNA concentration).
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2._ The mixture was transferred to the bottom of a cold electroporation cuvette and 
left on ice for 0.5-1 minute. The cuvette was then placed in a chilled safety 
chamber slide. This was pushed into the chamber until it was seated between the 
contacts in its base.
3._ Electroporation was carried out at the settings mentioned above.
4._ After the pulse the cuvette was rapidly removed from the chamber and 1 ml of 
SOC medium added to resuspend the cells.
5._ The cells were left on ice for 1 minute and then transferred to a sterile universal. 
The suspension was left on an orbital incubator at 37°C for 1 hour, prior to 
plating.
2.13.2.2 Transformation o f CaCL-competent cells.
In this case, ligation products were directly used in the transformation, without
the need for a precipitation step to remove salts. Aliquots of 5 pi of ligation reaction
were used in these occasions.
1._ The DNA was mixed with a 100 pi aliquot of the cell suspension and left on ice 
for 30 minutes.
2._ The sample was heated at 42°C for 90 seconds and incubated on ice for an 
additional 2 minutes.
3._ 300 pi of 2x YT-broth was added to the cell suspension. The sample was left on 
an orbital incubator at 37°C for 1 hour, prior to plating.
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CHAPTER 3
Establishment of a rat genetic genome scan.
C h a p t e r  3.  E s t a b l i s h m e n t  of  a r a t  g e n e t i c  g e n o m e  s c a n .
3.1 Introduction.
As described in Chapter 1 (section 1.1), the agu mutation did not correlate with 
any detectable alteration in the karyotype of the AS/AGU sub-strain. The function of the 
product of the agu gene at the molecular level could not be predicted and selection of 
candidate genes was therefore not a viable approach to gene identification at this stage. 
In order to determine the position of the agu locus, linkage of the gene to at least one 
genetic marker was sought. Detection of linkage was to involve the analysis of the 
cosegregation pattern of the agu gene with each of a large series of informative SSLPs in 
the offspring obtained from crosses of standard rat lines to the AS/AGU sub-strain. 
Since agu is a recessive mutation, the FI population is phenotypically normal. Therefore, 
backcrosses of the FI offspring to the affected parent were carried out, with the 
concomitant segregation of the mutant and the normal agu alleles in the resulting 
progeny.
Central to these linkage studies was the availability of a wide selection of 
microsatellites for which the PCR conditions had been optimised. Unambiguous 
identification of each particular SSLP allele in each animal required obtaining primarily 
the expected PCR product in the reactions. Very extensive work was thus directed 
towards this aim.
3.1.1 Development of the rat genetic map.
A wide selection of microsatellites was needed to diminish the possibility of 
regions of the genome not being covered by any marker. This latter situation could 
hinder the identification of the agu locus, should this gene map to any of these regions.
Robinson (1972) estimated the length of the rat genome to be approximately 
2400 cM, based on counts of chiasmata in meiosis. According to Jacob et al. (1991) 
about 200 markers would be required to ensure a 99% chance of each marker being 
linked to a map of this size, assuming a random distribution of the markers. At the time 
the project commenced, in 1993, this aim presented itself as a difficult task. The reason 
was the absence of an available detailed genetic map of the rat, with micro satellite 
markers having just started to be used in this species.
Although the start of rat genetics (Lindsey, 1979) was parallel to that of the 
mouse, the rat soon became the model of choice for physiologists and other biomedical
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researchers whereas the mouse became the preferred model for geneticists. This was 
translated into very different rates at which the two genetic maps developed. By 1990, 
over 1300 loci had been identified in the mouse, with more than 960 of these having been 
mapped on specific chromosomes. In contrast, about 330 genetic loci had been described 
in the rat and approximately 200 had been mapped (Hedrich, 1990b). With the discovery 
of microsatellites in some eukaryotic species (Litt and Luty, 1989; Weber and May, 
1989) and the observation that these were also present in the mouse, the genetic map of 
this rodent rapidly progressed (Love et a l , 1990; Cornall et al., 1991). Three-hundred 
and seventeen SSLPs had been typed in the mouse by 1992. These markers were 
detectably linked to approximately 99% of the mouse genome, at an average spacing of
4.3 cM (Dietrich et al., 1992). In comparison, important contributions towards the 
development of the rat genetic map had just started to be made.
Some of the first large collections of data arrived from Levan et al. (1990) and 
Hedrich (1990b). Thirteen linkage groups were defined, with only six of them being 
assigned to specific chromosomes. Markers such as minisatellites were not developed in 
the rat yet. Levan and coworkers carried on with the assignment of 214 loci to 20 of the 
22 rat chromosomes in 1991. This number was raised to 370 loci in the following year 
(Levan et a l , 1992). Nevertheless, very limited linkage information was available, with 
gene orders and distances not being established yet.
It was the groups of Hilbert and coworkers (1991) and Jacob et a l (1991) who 
first demonstrated that rat microsatellites showed similar properties to those found in 
man and mouse and then proceeded to generate a large collection of these genetic 
markers. Jacob and colleagues (1991) developed 290 SSLPs. Of these, 112 were studied 
in F2 populations. Linkage analyses defined 23 linkage groups, each containing 2 or 
more markers, and 10 unlinked microsatellites. More than half of the markers were 
unambiguously assigned to specific chromosomes by means of somatic cell hybrid 
analyses. Nonetheless, the bulk of these data was not published till later on (Jacob et a l , 
1995). Meanwhile, some of the markers became commercially available through 
Research Genetics (Huntsville, Alabama, US).
A major contribution to the rat map was that made by Serikawa and coworkers in 
1992. Searches through published rat sequences and screening of a rat genomic library 
led this group to the identification of 134 SSLPs, corresponding to 118 loci. Sixty-three 
of these were newly assigned to chromosomes. Linkage analyses with most
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of the SSLPs and 29 other markers were carried out. One-hundred and ten markers were 
mapped into 24 linkage groups. Twelve others did not show linkage. A final stage was 
reached where all the chromosomes except 15 and Y had been assigned one or more 
loci. All these markers taken together seemed to offer a 50-70% coverage of the rat 
genome. The same group of researchers extended the number of rat SSLPs to 141, in 
1993 (Kuramoto et a l, 1993). Some of these were assigned to discrete chromosomal 
subregions by fluorescent in situ hybridisation techniques.
The work carried out by Remmers and colleagues was also very important, with 
frequent additions to the maps of the different chromosomes (Remmers et al, 1992; 
Goldmuntz et al, 1993; Zha et al, 1993; Remmers et al, 1993a; Remmers et al, 
1993b). Some of these SSLPs were added to the set of markers being offered by 
Research Genetics.
The work described above constituted the first serious attempts to develop a 
detailed linkage map of the rat genome, correlating with the increasing importance of this 
rodent as a genetic model. All the mapping data published up to the middle of 1993 was 
collected by Yamada et al. (1994) [Appendix A; Figure A-l]. Five-hundred and thirty- 
nine rat loci, of which 167 were typed by microsatellite markers, were assigned to 
specific chromosomes. Another 8 still remained in the linkage groups originally defined 
by Hedrich in 1990. Two-hundred and seventy-six of these loci were located on linkage 
maps. Only those loci for which microsatellite markers were available were practically of 
use in this project.
Parallel to the progress in the generation of genetic markers and mapping of loci 
in the rat, cytological and linkage studies were being carried out to compare the 
emerging rat genetic map to those of mouse and man (Yoshida, 1978; Levan et al, 
1991; Serikawa et a l, 1992; Yamada et al, 1994). Extensive chromosome homology 
was established between the mouse and the rat. This observation was of great 
importance since Stallings and coworkers (1991) had shown the conservation of a 
considerable proportion of microsatellite sequences between closely related species. 
Moore and colleagues (1991) had further demonstrated that this conservation could be 
close enough to allow the use of PCR primers designed in one species to analyse 
microsatellite allelic differences in another. These initial experiments were followed by 
other groups (Jacob et al., 1991; Kondo et al, 1993; Fredholm and Winter?, 1995). In 
contrast to the high success rate (56%) achieved by Moore and colleagues when
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amplifying ovine DNA with bovine primers, and that obtained by Fredholm and Winterfl 
(1995) on the Canidae family, only 12-16% of the mouse/rat PCR primers used by 
Kondo and coworkers (1993) efficiently amplified the corresponding heterologous 
DNAs. Nevertheless, these results were of special interest since it offered the possibility 
of using mouse primers to screen for SSLPs in regions of the rat genome where this type 
of markers were still scarce.
A major breakthrough was the publication in 1995 of a rat genetic linkage map 
which for the first time appeared to cover the vast majority of the genome (Jacob et a l ,
1995). Jacob and colleagues developed 1170 SSLPs and mapped 432 of them in a single 
F2 population. With the exception of two markers on chromosome 9, all the others 
mapped into any of 21 large linkage groups, at an average spacing of 3.7 cM. Linkage 
groups were assigned to 21 of the rat chromosomes [Appendix A; Figure A-2], The 
sequences of the PCR primers were deposited with Research Genetics, becoming 
commercially available. Parallel to this work were the studies by Maihara and coworkers 
(1995). This group obtained 125 PCR primers from the aforementioned company, 
proceeding to their analysis on different inbred strains. Fifty-six of these markers were 
mapped onto the existing linkage map published by Yamada et al (1994). This provided 
a means of integrating the data collected up to the middle of 1993 with the new markers 
developed by Jacob and colleagues (1995).
Quite a few loci putatively involved in disease phenotypes have been identified 
using the rat as a genetic model (Brown et a l, 1996; Gauguier et al., 1996). Yet the rat 
map remains incomplete in comparison with those of man (Murray et al., 1994) and the 
mouse (Dietrich et al., 1994). Further work is being carried out to expand and increase 
detailed coverage of this map. Some groups of researchers are characterising markers 
throughout the whole genome (Yokoi et a l, 1996; Pravenec et a l, 1996). Others are 
leading the development of linkage maps which correspond to specific chromosomes 
(Goldmuntz et a l, 1995; Du et a l, 1995; Du et a l, 1996; Ding et a l, 1996). This is 
often the case when more detailed maps of a specific region(s) already shown to carry 
disease-associated loci are required (Gu et al, 1996; Galli et al., 1996). More complete 
maps are being constructed containing loci detected by a variety of procedures. A good 
example is found in the linkage map reported by Pravenec et al. (1996) where a variety 
of 500 morphological, biochemical, immunogenetic and molecular genetic markers have 
been integrated. Szpirer and colleagues have recently collected the information on all the 
genes and anonymous sequences mapped to date in the rat (Szpirer et a l, 1996).
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Approximately 600 genes have been mapped to specific chromosomes. A linkage map 
containing more than 650 markers has been generated.
3.1.2 Considerations in the establishment o f informative crosses to the AS/AGU sub­
strain.
A large linkage panel was required to ensure identification of the agu region. It 
was therefore crucial to maximise the number of SSLPs that are informative in the 
backcrosses. Selection of reference parents from strains placed at the highest 
phylogenetic distances from AS/AGU should satisfy this requirement. However, two 
immediate disadvantages were encountered in the rat when compared to the situation in 
the mouse. Firstly, the phylogenetics of inbred mouse strains were well documented. In 
contrast, very little information was available about the relations between laboratory 
inbred strains of rats. The trees of genetic relatedness of rat strains that were available at 
the time (Arenas et a l , 1981; Festing and Bender, 1984) reflected a small subset of loci 
involved in specific functions. These functions could restrict the degree to which those 
loci diverged between different rat strains. Therefore these were not a good 
representation of the overall changes in the whole genome and could be misleading, as 
later claimed by Canzian and coworkers in 1995. Secondly, whereas interspecific crosses 
could be exploited in the mouse, this approach was not feasible in rats. This difference 
was critical in the establishment of dense genetic maps. It had been demonstrated that the 
wild mouse subspecies Mus spretus differed from any of the laboratory mouse M  
musculus strains at 72-92% of the SSLPs analysed whilst these inbred strains only 
differed at about 50% or less of the markers when compared to each other (Love et a l , 
1990; Comall et a l, 1991). In contrast, the Norway rat, Rattus norvegicus, and the black 
rat, Rattus rattus (Hayashi et a l, 1979; Baverstock et a l, 1983), can not be intercrossed 
and interspecific mapping is therefore not available in rat.
Over 140 inbred strains of rats were available by 1990 (Greenhouse et a l, 1990). 
Three of these were selected to be analysed, together with the AS/AGU sub-strain, with 
each of a series of 75 microsatellites. These were the Brown Norway (BN), the F344 and 
the PVG strains. Phylogenetic studies had presented the former as the most distant to 
! any of the other inbred strains (Festing and Bender, 1984). These observations had been
i
! further supported by results obtained by Serikawa and colleagues
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when typing several rat strains with microsatellite primers (Serikawa et al., 1992; 
Kuramoto et al., 1993).
The greatest divergence from AS/AGU was demonstrated by the BN and the 
F344 strains (Shiels et al., 1995). Therefore, these two strains were used to establish 
backcrosses to the former.
3.2 Results.
3.2.1 Initial set o f SSLPs: Optimisation o f the PCR conditions.
This part of the project commenced towards the end of 1993 and continued for 
most of the following year. An initial set of 75 microsatellites were studied in duplicate 
by both Dr. P. Shiels and myself. Some sequences were obtained from some of the data 
published by Serikawa et al. (1992) and Kuramoto et al. (1993) and synthesized in 
house. Other primers were bought from Research Genetics (Huntsville, Alabama, US); 
no sequence or linkage data were at the time available for these latter SSLPs, merely 
the chromosomal locations. The PCR conditions were optimised so that a single 
product resulted from each reaction; this was accomplished by adjusting the 
concentration of MgCl2 and changing the annealing temperature and the number of PCR 
cycles. The annealing temperature was usually identical or 1°-5°C lower than the 
melting temperature (Tm) of each primer pair, this being estimated for practical 
purposes as Tm= {(G+C) x 4°C} + {(A+T) x 2°C) (Suggs et al., 1981). Those cases 
where the Tm of each of the oligonucleotides in the primer set differed by 5° to 10°C or 
more proved to be more difficult to optimise. In general, the annealing temperatures 
ranged between 50°-65°C. Most primer sets worked optimally in the presence of ImM 
MgCl2, with higher concentrations resulting in accompanying background. Many 
yielded clear products after 25 PCR cycles; a few others required running 30-35 cycles. 
Our PCR conditions differed, on many occasions, from those previously published The 
conditions for each of the 75 SSLPs are presented in Appendix B, as part of the 
publication by Shiels et al. (1995). The table shows primer set MIT-R1380 as mapping 
to chromosome 19, as this was the information given by Research Genetics. However, 
this primer has been subsequently mapped to rat chromosome 6 (Maihara et al., 1995; 
Jacob etal., 1995).
81
C h a p t e r  3. E s t a b l i s h m e n t  o f  a r a t  g e n e t i c  g e n o m e  s c a n .
3.2.2 Selection of parental strains.
DNAs from PVG, BN, F344 and AS/AGU rats were either obtained from Harlan 
Olac (Oxon, UK) or prepared from the rat spleens. Two different methods were 
followed in the extraction of DNA (Chapter 2; section 2.3.2.1), the first involving 
homogenisation of rat tissue with liquid nitrogen. This was soon replaced by the use of a 
DNA isolation kit (Flowgen Instruments Ltd., UK). Aliquots of each DNA sample were 
used as template in PCR reactions which were run according to the conditions previously 
determined as optimal. The products were run on 4% MetaPhor agarose gels which are 
of higher resolution than the standard agarose gels [Figure 3-1]. The results of this work 
are presented in Appendix B (Shiels et al., 1995). BN and F344 were shown to diverge 
from AS/AGU to a greater extent (at 62% and 47% of the loci, respectively) than the 
PVG strain (at 43% of the SSLPs).
Two separate backcrosses were set up with the BN and the F344 strains as 
reference parents. The reason behind setting up the F344 backcross in addition to the BN 
backcross was to maximise the number of microsatellites that were informative, as some 
of these had only shown allelic differences between the F344 and the AS/AGU strains 
and were thus not useful in the cross to the BN strain.
3.2.3 Optimisation of further SSLPs.
During the time needed to produce the first batches of backcross animals, a 
further set of primers were bought from Reseach Genetics, optimised, and tested on the 
four rat strains. Two new members of the group, Mr. M.Canham and Mr. A. McCallion, 
and myself carried out this part of the work. The main problem was the coverage of the 
larger chromosomes 1-5, especially 1, 3 and 5. The size of these chromosomes was 
estimated to be in the range of 134 cM (chromosome 5) to 221 cM (chromosome 1). A 
single informative marker had been identified in each of the chromosomes 11, 15, 16, 17 
and Y. These were medium-sized chromosomes, with lengths of 70-85 cM. More 
problematic were chromosomes 9 and 20, for which markers which were informative for 
any of the backcrosses had not been identified yet. No informative markers had been 
found on the X chromosome either. However, coverage of the autosomes was the most 
immediate concern since inheritance of the agu mutation did not seem to demonstrate 
any linkage to sex.
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(A) (B)
M MIT-R762 MIT-GCR MIT-R525 M M MIT-R834 R87 M
298 bp
220 bp 
201 bp 
154 bp 
134 bp
75 bp
M MIT-R1704 M
(C)
M l  2 3 4  5 M 6  7 8  9 10 M
ILG6
MIT-NPY1
FIGURE 3-1. Resolution of PCR products on 4% MetaPhor agarose gels.
A lkb DNA ladder (M) was loaded as the size marker on all the gels.
(A) From left to right: products resulting from the amplification of PVG, BN, AS/AGU and 
BN:AS/AGU (mixed in equal volumes) DNA templates with each of the primers MIT-R762, 
MIT-GCR, and MIT-R525, respectively.
(B) Top half of the gel, from left to right: products resulting from the amplification of PVG, 
BN, F344, AS/AGU and BN:AS/AGU (mixed in equal volumes) DNA templates with th 
primers MIT-R834 and R87, respectively. Bottom half: amplification products obtained with th 
primer set MIT-R1704; the order of the samples is as indicated above.
(C) Resolution of multiplexed PCR products obtained in separate reactions with the primer 
MIT-R549 and MIT-R207 on PVG, BN, F344, AS/AGU and BN:AS/AGU (mixed in equa 
volumes) DNA templates (lanes 1-5), and of the products obtained in separate reactions with th 
primers ILG6 and MIT-NPY1 on PVG, BN, BN:AS/AGU (mixed in equal volumes), AS/AGU 
and F344 DNA templates (lanes 6-10).
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(D) From left to right: Amplification products obtained with the primer sets MIT-R609 and TAT 
on PVG, BN, F344, AS/AGU and BN:AS/AGU (mixed in equal volumes) DNA templates.
(E) From left to right: Amplification products obtained with the primer sets MIT-R248 and 
MIT-R217 on PVG, BN, F344, AS/AGU and BN:AS/AGU (mixed in equal volumes) DNA 
templates.
(F) From left to right: Amplification products obtained with the primer sets ACPH and MIT- 
R761 on PVG, BN, F344, AS/AGU and BN:AS/AGU (mixed in equal volumes) DNA 
templates.
(G) From left to right: Amplification products obtained with the primer sets R99 and MIT-R190 
on PVG, BN, AS/AGU, BN:AS/AGU (mixed in equal volumes), and F344 DNA templates.
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The results obtained with some of the new SSLPs are presented in Table 3-1. As 
estimated from the data, the total number of loci shown to differ between AS/AGU and 
each of the other rat strains after the new additions closely followed the values already 
obtained with the initial set of 75 microsatellites. The PVG and F344 strains were now 
exhibiting a very similar degree of divergence from the mutant strain (approximately 
45% and 42% of the loci, respectively). BN and AS/AGU differed at 63% of the 
analysed SSLPs.
The backcross animals started to arrive and extensive typing work was quickly 
commenced by Dr. P. Shiels and myself. As described in Chapter 4, a locus was found in 
these initial screenings which appeared to be linked to the agu gene. Thenceforth, work 
was directed towards the optimisation and testing of SSLPs which mapped to the 
particular chromosome, any further analysis of other primer sets coming to an end. 
Consequently, analyses with heterologous mouse primers were not needed at this point.
3.2.4 Clarification of an ambiguous result
The release in 1995 of the primer sequences which had already for some time 
been commercially available from Research Genetics made possible the comparison of 
the sequences of the primer sets previously bought from this company with others which 
had to that date been analysed in the project. It was then observed that the forward and 
the reverse sequences of the primer sets R101 (Serikawa et al., 1992) and CASAG1 
(Hilbert et al., 1991) were identical and thus amplified the same micro satellite in the oc- 
casein {Csnl) locus. Since our data recorded some differences in the results obtained 
with these two primers (Shiels et a l, 1995), these must be artifactual. Therefore the 
analyses had to be repeated to eliminate the discrepancies. These discrepancies are listed 
below.
a) The annealing temperature determined as optimal for ‘RlOl’ had been 52°C, 
whereas that for ‘CASAG1’ had been 53°C, both PCRs running 25 cycles, in the 
presence of 1 mM MgCl2. Single bands had indeed been obtained with ‘R101’ at 52°C; 
identical results were observed when this primer was used in PCRs run at an annealing 
temperature of 53°C.
b) A small difference had been recorded between the sizes of the products 
obtained with ‘R101’ (120-140 bp) and those yielded by ‘CASAG1’ (115-130 bp). 
Nonetheless, these results could be easily reconciled as, in general, the sizes of the
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Chromosome Primer name Annealing PCR Product size A l l e l e  d i f f e r e n c e s
Temoerature (0C) (bp)
1 IGF2 53 135 -160 AGU=F344=P V G>BN
1 LEUKOS1 b 70 130 AGU=BN=F344=P VG
1 D1N64a 66 300 AGU=BN=F344=P VG
2 MIT-PKLG 55 110-120 P VG>F344> AGU=BN
3 MIT-R593 a 57 170 - 190 BN> AGU=P V G>F3 44
3 MIT-R139a 56 170-200 AGU=F344=P VG>BN
4 M3T-R514 57 270 - 290 P V G>BN> AGU=F3 44
4 SPRD a 57 120 AGU=BN=F344=P VG
5 MIT-R1698 53 135 AGU=BN=F344=P VG
5 MIT-R252 53 195 -220 F344>BN=P V G> AGU
5 M3T-R589a 53 220 AGU=F344=P V G>BN
5 MIT-R1138 a 53 100-140 AGU=F344>BN>P VG
5 MIT-R735 b 55 125 - 135 P VG> AGU=F344>BN
5 MIT-R980b 53 220 AGU=F344>BN=P VG
7 MIT-R513 53 275 AGU=BN=F344=P VG
7 MIT-R1071 53 230-250 P VG>BN> AGU=F3 44
7 MIT-R605 a 53 90-100 F344=P V G> AGU=BN
10 MIT-MHCG 55 170-190 AGU>F344=P V G>BN
12 MIT-R534 54 135 AGU=BN=F344=P VG
12 M3T-R354 53 270 - 300 AGU=F344>P V G>BN
13 MIT-R120b 51 250 AGU=BN=F344=P V G
13 MIT-R982 53 125 - 160 BN> AGU=F344=P VG
14 MIT-R1692a 54 135 - 150 BN> AGU=F344=P VG
14 MIT-R1041b 64 165 - 190 BN=P V G>F344> AGU
14 MIT-ALBZA 53 230-250 AGU=F344=P V G>BN
14 MIT-AFPGA 53 170-190 AGU>BN>P V G*
16 MIT-R220 57 170-190 AGU=F344>P V G>BN
16 MIT-R1254 53 150-160 AGU=P V G>BN=F3 44
18 MIT-ALBA 53 230-290 P VG> AGU=F344>BN
TABLE 3-1. Strain differences observed at each of a series of 29 SSLP loci.
All the primer sets worked optimally in the presence of ImM MgC^; 25 PCR cycles were 
run in all the reactions.
a andb Primer sets for which the PCR conditions were optimised by Mr. A. McCallion and 
Mr. M. Canham, respectively.
* As previously reported for the primer R99 (Shiels et al., 1995), two alleles were obtained 
when typing F344 DNA with the primer MIT-AFPGA. Only single products were produced 
when amplifying any of the other DNAs.
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PCR products were not completely accurate but estimates calculated in reference to a 1 
kb DNA ladder marker. The set of PCR products obtained with each of the primers 
were run side by side; no differences in the size range were observed.
c) The rat strains BN and PVG differed at the Csrtl locus when analysed with 
‘CASAG1’, the BN allele being larger than that present in the PVG strain. However, 
this variation was not found when using the primer ‘R101\
To that date, the analysis of all the PCR products had always been carried out on 
4% MetaPhor agarose gels, prepared with lxTBE; these gels displayed a considerable 
capability for high resolution. However, in the case of ‘RIOT / ‘CASAG1’, the 
ambiguous results obtained with the BN and the PVG strains indicated the need for a 
higher resolution of these PCR products. The difference observed on Metaphor with the 
‘CASAG1’ primer pair had been barely detectable and therefore confirmation was 
needed. The corresponding forward primer was radioactively labelled and used in PCR 
reactions; the products were run on an 8% polyacrylamide gel [Figure 3-2]. Clear 
resolution of each of the products was achieved in this gel system, confirming that a 
difference existed between the BN and the PVG strains, the former carrying a larger 
Csnl allele than the latter. The ‘R101’ results could not be confirmed on 
polyacrylamide gels as the stocks which were being used run out.
The fact that no difference was observed between the BN and the PVG 
amplification products obtained with ‘RIOT when these were run on MetaPhor agarose 
gels was probably due to some variations in the casting and/or the running of the gels, 
or to differences between the two primer stocks since these were obtained from 
different sources. Another explanation would be that the ‘R101’ stocks did not 
correspond to such primer set. This seems unlikely, given the identical annealing 
temperatures and the approximate sizes of the PCR products. The ‘CASAGl’ primer set 
had been bought from Research Genetics; linkage of the amplified locus to other 
markers on chromosome 14 (work carried out by Mr. M. Canham) supported that these 
stocks corresponded to the expected primer sequences.
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M l  2 3 4 5 6 M
200bp
154bp
134bp
FIGURE 3-2. Resolution of ‘CASAGl’-PCR products on an 8% polyacrylamide gel.
Amplification products from: F344 (1), AS/AGU (2), (AS/AGU x BN) FI (3), BN (4), 
BN and PVG DNAs mixed in equal volumes (5), and PVG (6) DNA templates. A 
radioactively labelled 1 kb DNA ladder marker was used as the size standard (M).
The observed laddering pattern is a common feature of dinucleotide repeats and it is 
considered to result from slipped mispairing in the repeat during PCR amplification 
(Luty et ci!., 1990; Hughes, 1993).
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3.3 Discussion.
3.3.1 Factors affecting the reliable interpretation of typing data.
A linkage analysis approach to the localisation of the agu gene in the genome 
was based on the assumption that each parental strain was homozygous at every single 
locus and that no mutations occurred at the marker loci when transmitted from 
generation to generation. Consistent co-amplification of two DNA fragments under 
already optimised PCR conditions may result from either the presence of two different 
alleles at the particular locus (i.e. heterozygosity) or from amplification of two different 
loci of very similar sequences (e.g. gene families, pseudogenes). In two instances, 
amplification of F344 DNA extracted from two different animals yielded divergent 
results where either 1 or 2 bands were consistently amplified, one being always of the 
same size as the AS/AGU PCR product. This was observed with the primer sets R99 
(Serikawa et al., 1992) and MIT-PLANH (Research Genetics). Therefore, these two loci 
must have been homozygous in one animal and heterozygous in the other. Residual 
heterozygosity (Hedrich, 1990c) of the parental strains can, in these cases, lead to 
erroneous interpretation of the genotyping results and may result in failure to detect 
existing linkage. Another primer, MIT-AFPGA (Research Genetics) also resulted in the 
co-amplification of two discrete bands from the F344 DNA template. This primer was 
only tested on one animal; however, a single allele was reported by Jacob and colleagues 
(1995) and it is likely that this locus was heterozygous in the F344 animal studied.
Mutation rates at the genetic markers are considered to be very low (Weber and 
May, 1989; Serikawa et al., 1992). Most of the microsatellite loci analysed in this project 
consist of dinucleotide repeats and the mutation rate at these loci has been observed to 
be even lower than at some tri- and tetranucleotide repeat sites (Weber and Wong, 1993; 
Ellegren, 1995). Moreover, only those mutations which affect the allelic length and yet 
do not disrupt codominant inheritance patterns can cause problems in the linkage 
analyses. Otherwise, changes in allele size are readily detectable.
3.3.2 Establishment of an efficient large scale typing system.
Typing of the progeny was a very labour-intensive effort. A genome-wide search 
approach required the analysis of a very large number of informative loci. A number of
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800 animals was planned to be initially handled until the specific chromosomal region 
carrying the agu gene was clearly established. Once markers were identified in proximity 
to this locus, finer genetic map distances would be obtained through the analysis of a 
larger number of offspring. It was therefore of prime importance to develop a typing 
procedure where a maximal output was obtained, by reducing the time, cost and effort 
inputs. This was achieved through improvements on the processing of the DNA samples 
and other parameters affecting the typing of those DNAs.
The first DNAs were prepared according to a long protocol involving the 
homogenisation of the rat tissue with liquid nitrogen. This method was soon replaced by 
a DNA isolation kit. As demonstrated once the first series of backcross animals started 
to arrive, more than 50 DNAs could be extracted per person per day with this kit. 
Practically all the DNAs were shown to be of a high quality. High DNA yields were 
consistently obtained from small amounts of spleen, presenting this tissue as a very large 
source of DNA. Consistent yields made spectrophotometer recordings for each of the 
samples unnecessary. A standard dilution factor was applied when preparing the working 
stocks. This was a remarkable improvement since taking the OD readings constituted 
one of the most time-consuming steps in the preparation of DNA samples.
A great number of PCR reactions were to be carried out. The possibility of 
multiplexing different amplification reactions, of current application in typing work, was 
considered. However, the vast majority of the studies where this approach is followed 
use fluorescently-labelled primers which allow the unambiguous identification of the 
products amplified by each of the individual primers. Labelled primers were not being 
used in this project. Therefore, a first requisite for the multiplexing of several PCR 
reactions to be feasible was a clear difference in the sizes of the products amplified by 
each primer pair. Similar product sizes could give rise to problems when trying to 
identify the different amplification fragments on the gel. This factor greatly restricted the 
number of reactions which could be multiplexed in future typings of the backcross 
animals. Further restrictions were imposed by the fact that the primers must be 
informative in the same backcross (i.e. the primers typed the same set of animals). 
Moreover, multiplexing of different amplifications in the same PCR reaction involved the 
use of primers which worked under the same conditions. Should the primers require 
different PCR conditions, multiplexing could only be feasible when loading the samples 
on the gel [Figure 3-1(C)] but not in the PCR reaction itself. Multiplexing of some PCR 
reactions was initially tested on the four strains of rat under study. However, a higher
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failure rate was obtained in comparison to single locus amplifications. These 
observations are in agreement with the data reported by Lord and coworkers (1995). 
Therefore, the great majority of the typings were carried out in independent reactions.
Differently from minisatellites, the repeat units found in microsatellites can be as 
small as 1-2 bp. Unambiguous detection of an allelic difference at a single repeat unit 
requires running polyacrylamide gels. This is expensive and time-consuming. Instead, 4% 
MetaPhor agarose gels were solely employed in the establishment of this initial genetic 
scan of the rat genome. This gel system offers high resolution of the products in running 
times of 1-3 hours. According to the manufacturer, 4% MetaPhor agarose gels prepared 
and run in TBE buffer give comparable resolution to 8% polyacrylamide gels when 
analysing fragments in the 70-300 bp range. Concentrations of 5% may be required to 
get very fine resolution of fragments less than 100 bp. These gels are however more 
difficult to prepare and need longer running times. Experience with the 
‘R1017‘CASAG1’ primer showed the resolution of 4% MetaPhor gels is in fact not so 
high. These particular PCR products were in the range 115-130 bp, very close to the 
threshold size which can be resolved on these gels. In general, polyacrylamide gels seem 
to be the most reliable system to study strain differences in these instances, although new 
alternative methods are now available, such as the use of 6% NuSieve agarose gels 
(Plaha et al., 1995). Advantages of this latter system is the high resolution achieved and 
the possibility to run each gel at least five times without repouring. This feature is in 
contrast to 4% MetaPhor gels, since our attempts to reuse the same gel, with or without 
repouring, failed.
3.3.3 Strain distribution pattern of alleles at 103 microsatellite loci.
In agreement with the results obtained by other groups (Serikawa et al., 1992; 
Maihara et al., 1995), the BN strain displayed the greatest number of divergent loci 
when compared to the AS/AGU, the F344 and the PVG strains, differing at 63%, 68% 
and 65% of the tested SSLPs, respectively. These observations are all consistent with the 
phylogenetic tree for inbred strains recently constructed by Canzian and colleagues
(1995), where BN is presented as the most distant of 13 inbred rat strains.
Given the frequency of informative SSLP loci, BN was chosen to be the 
reference parental strain in a first backcross to AS/AGU. F344 and PVG diverged at 
42% and 45% of the loci, respectively, when compared to the mutant strain. Both F344
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and PVG exhibited a proportion of approximately 9% of the loci which differed 
between either of them and AS/AGU but did not show allelic differences between this 
latter and the BN strain. F344 differed at a greater proportion of SSLP loci from BN and 
was selected to be the reference strain in a second backcross.
The selection of BN and F344 to act as the reference parental strains translated 
into 75% of the studied microsatellites (i.e. 77 SSLPs) being informative in the 
backcrosses. According to the calculations by Jacob et al. (1991), the proportion of the 
rat genome expected to lie within d  cM of a marker, assuming random distribution of 
the genetic markers being employed, is approximately l-er2Nd/D, where N  is the number 
of markers and D is the size of the rat genome. Given an estimated genetic length of the 
rat genome D=2,400 cM* (Robinson, 1972), and a number N= 77 markers, and in 
general assuming a random distribution of such markers, 96% of the genome should lie 
within 50 cM of a marker and 85% within 30 cM of a marker. Complete coverage of 
the genome had thus not been achieved. Moreover, assumption of an even distribution 
of the particular markers throughout the genome was already proven wrong. No 
informative markers had been found on the chromosomes 9, 20 or X. Medium-sized 
chromosomes such as 11 (ca. 81 cM), 15 (ca. 81 cM) and 17 (ca. 73 cM) had been 
assigned single markers, whereas others such as chromosomes 10 (ca. 94 cM) and 14 
(ca. 85 cM) had been assigned 9 and 8 informative microsatellite loci, respectively. 
Despite this lack of coverage of the rat genome, linkage of the agu gene to one of the 
characterised SSLPs was detected during the initial typings of backcross offspring. The 
study of rat or mouse microsatellites which mapped outside the identified chromosome 
was not pursued. Further analyses focused instead on SSLPs which mapped to this 
chromosome.
* The length of the genetic map, D, varies according to different estimates (Robinson, 
1972; Jacob et al., 1995; Toyota et a l, 1996). Consequently, calculation of the degree 
of coverage obtained with the available markers depends on the value given to D. More 
recently released rat genetic maps (Toyota et a l, 1996; Bihoreau et a l, 1997) estimate 
the length of the rat genome as approximately 2000 cM. Calculation of the degree of 
coverage provided by the 77 informative markers which were available at the time this 
part of the project was carried out, based on D= 2000 cM, would suggest that 98% of 
the genome should lie within 50 cM of a marker and 90% within 30 cM of a marker.
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CHAPTER 4
Localisation of the agu locus to a single chromosomal region.
C h a p te r  4. L o c a l i s a t io n  of  the agu locus to a s in g le  c h r o m o s o m a l  r e g io n .
4.1 Introduction.
A series of 103 SSLPs were studied in the AS/AGU, the BN, and the F344 
strains of rat. Allelic differences between these latter and AS/AGU were identified at 
63% and 42% of the loci, respectively. These two strains were selected as reference 
parents in backcrosses to AS/AGU. The initial goal was to obtain eight-hundred 
offspring, 400 from each cross. Towards the end of 1994, typings with the optimised 
primer sets started on the batches of litters, as they arrived.
Linkage of any given micro satellite marker to the agu locus was assessed by 
correlating the amplification pattern with the phenotype exhibited by each animal [Figure 
4-1]. One of two possible PCR results was obtained from each DNA sample: a single 
band, of the same size as that corresponding to the AS/AGU homozygote, or two bands, 
of the same size as the products obtained from the AS/AGU and the reference strain, 
respectively.
A microsatellite marker was found which demonstrated a highly significant 
deviation from random reassortment with the agu locus, allowing the chromosomal 
localisation of this gene. Other SSLPs which mapped to the same chromosome were 
studied. Those which were informative between AS/AGU and one of the reference 
strains were used for further linkage analyses, resulting in a more precise location of agu. 
Other markers were available which were not tested, as they could not be typed by PCR 
(Hilbert et al., 1991; Goldmuntz et al., 1993; Pravenec et al., 1996).
4.2 Results.
Each backcross animal was individually identified and its phenotype studied 
(work done by Dr. R. Sutcliffe and Mr. N. Bennett) at weekly intervals from 5 weeks 
after birth onwards, by applying a series of tests already mentioned in Chapter 1 (section
1.1). Once the presence or the absence of the mutant phenotype was unambiguously 
demonstrated, the animals were killed and their spleens extracted and stored at -70°C 
(Mr. N. Bennet, Dr. R. Sutcliffe, Dr. P. Shiels, Mr. M. Canham, Mr. A. McCallion, Dr. 
D. Donald and Mrs. M. Gardiner). DNA was prepared from each tissue sample, as 
described in Chapter 2 (section 2. S. 2.1).
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4.2.1 Identification o f the chromosome which carries the agu gene.
Typings with each primer set were carried out by amplifying ca.100 ng of each 
DNA sample in PCR reactions for which the optimal conditions had already been 
determined. The products were then run on 4% MetaPhor agarose gels. In some 
instances, variations in the DNA concentration resulted in the presence of background 
bands.
On average, 20-50 backcross progeny were initially typed with each of 26 SSLPs 
(work done by Dr. P. Shiels and myself) [Figure 4-2]. The significance of any deviation 
from a 1:1 segregation from the agu locus was statistically assessed by means of x2 
analyses. These data are presented in Table 4-1. One of the primer sets, R33 (Serikawa 
et al., 1992), demonstrated clear linkage to the agu locus (x2 (df=3)= 33.38, p<0.001). 
This microsatellite mapped to the kallikrein (renal) gene {Kal). Typing of 118 
[AS/AGU x (AS/AGU x BN) FI] animals (by Dr. P. Shiels) yielded a recombination 
frequency with respect to the agu locus of 24.6% ± 4.0%. This finding pointed to 
chromosome 1 as the chromosome to which the agu gene mapped.
4.2.2 Narrowing the chromosomal region to which the agu gene maps.
The next step following the identification of the chromosome which putatively 
carried the agu gene was to confirm this result as well as to define a more precise 
location of the gene. To do this a selection of SSLPs known to map to chromosome 1 
were obtained and tested for being informative in our backcrosses. The PCR conditions 
and strain distribution pattern (SDP) of this new set of SSLPs are shown in Table 4-2. 
Linkage estimates of the informative loci on chromosome 1 to agu are shown in Table
4-3. Clear linkage of agu to the loci DlM itl, DlMgh7, DlMit9, DlMco2 and DlCep4 
confirmed that agu mapped to rat chromosome 1 [Figure 4-3].
Two maps were established, one for each backcross. These are shown in Tables
4-4 and 4-5. The locus DlCep4 (initially referred to as 2B1 by Serikawa and colleagues 
(1992) and Goldmuntz et al. (1993)) was identified as the closest to agu (4.3 ±1.3 cM). 
A precise mapping function for the rat genome has not been established yet. In general, 
either the Haldane or the Kosambi’s functions are employed to transform recombination 
frequencies into genetic distances (Green, 1981; Jacob et a l, 1995; Gu et al., 1996). 
When the Kosambi’s function was applied to our data (Chapter 2; section 2.4), 
estimated distances and obtained recombination frequencies were identical when these
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FIGURE 4-2. Typing of TAS/AGU x (AS/AGU x BN) F ll progeny with SSLP markers.
Resolution of the PCR products obtained following amplification of DNA template 
from BN (B), AS/AGU (A), (AS/AGU x BN) FI (FI), and [AS/AGU x (AS/AGU x 
BN) FI] animals, with each of the primer sets R30 (gel (I)), MIT-R762 (gel (II)), R256 
(gel (III)), and MIT-R844 (gels (IV) and (V)). A 1 kb DNA ladder was used as the size 
marker (M).
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SSLP locus (Primer) Chromosome No. of animals typed X2 value (df=3)
DlMgh22 (IGF2)a 1 50 2.32 (0.9>p>0.5)
Lj h (R161) 1 34 4.29 0.5>p>0.1)
Kal (R33)a 1 118 33.38 (p<0.001)
Pkl (R34)a 2 35 0.6 (0.9>p>0.5)
Cpb (CARB08b)a 2 18 2.4 (0.5>p>0.1)
D2MU9 (R479)a 2 17 0.64 (0.9>p>0.5)
D2MU14 (R360)a 2 17 4.5 (0.5>p>0.1)
D2MU17 (R248)a 2 20 2.6 (0.5>p>0.1)
D3MU13 (R244)a 3 20 2.6 (0.5>p>0.1)
A2m (R76)a 4 36 1.5 (0.9>p>0.5)
D4MU19 (R1209)a 4 44 2.72 (0.5>p>0.1)
D6Mit4 (R1126)a 6 14 1.42 (0.9>p>0.5)
D6MU10 (R1380) 6 25 2.36 (0.9>p>0.5)
Myh3 (R6)a 10 20 8 (0.05>p>0.025)
D13MU3 (R578) 13 32 2.5 (0.5>p>0.1)
Ren (R256) 13 50 3.92 (0.5>p>0.1)
Csna (CASAG1) 14 36 6.9 (0.1>p>0.05)
Igfbp3 (RU3) 14 47 0.74 (0.9>p>0.5)
D15kyol (KR62) 15 21 4.71 (0.5>p>0.1)
D16MU2 (R762) 16 32 2.5 (0.5>p>0.1)
D16MU3 (R1254) 16 37 2.03 (0.9>p>0.5)
D16MU5 (R220) 16 34 5.8 (0.5>p>0.1)
D17MU2 (R834) 17 25 0.76 (0.9>p>0.5)
D18MU8 (R844) 18 20 2.0 (0.9>p>0.5)
Adrb2 (R30) 18 36 2.9 (0.5>p>0.1)
Tat (TAT) 19 20 2.8 (0.5>p>0.1)
TABLE 4-1. Segregation of am  and SSLP alleles in backcross progeny. 
a typings carried out by Dr. P. Shiels.
X2 values were calculated as described (Chapter 2; section 2.4).
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FIGURE 4-3. Typing of backcross animals with SSLP markers which are linked to the 
asu gene.
Gels (I) to (IV): Resolution of the PCR products obtained following amplification of 
DNA template from F344 (F), AS/AGU (A), and [AS/AGU x (AS/AGU x F344) FI] 
animals with the primer sets DlMco2 (gels (I) and (II)), and R191 (gels (III) and (IV)). 
Gels (V) and (VI): Resolution of D lM itl  amplification products obtained with DNA 
template from BN (B), AS/AGU (A), (AS/AGU x BN) FI (FI) and [AS/AGU x 
(AS/AGU x BN) FI] animals.
A 1 kb DNA ladder was used as the size marker (M).
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[AS/AGU x (AS/AGU x BN) FI]
LOCUS NAME DISTANCE BETWEEN LOCI (cM) 95% LOWER AND UPPER LIMITS (cM)
DlMghl 7
DlMitl
46.9 36.9 - 56.9
agu
5.5 3.4 - 7.6
C
41.5 32.9-50.1
DlMit3
4.3 0-11.2
DlMgh22
31.2 8.5 - 53.9
TABLE 4-4. Order of loci on rat chromosome 1, based on the tvnine of f AS/AGU x
(AS/AGU x BN) Fll offspring.
[AS/AGU x (AS/AGU x F344) FI]
LOCUS NAME DISTANCE BETWEEN LOCI (cM) 95% LOWER AND UPPER LIMITS (cM)
D1MU9
20.8 4.5-37.1
DlMco2
3.5 1.4-5.6
DlCep4
4.3 1.8-6.8
agu
44.1 27.4 - 60.8
Lsn (R161)
TABLE 4-5. Order of loci on rat chromosome 1, based on the typing of \AS/AGU x
(AS/AGU x F344) F ll offspring.
The order of the loci was established by multiple 3 point cross analyses, and conveys the 
smallest possible number of double crossovers in each region.
The loci Kal and DlMgh7 have been omitted in Table 4-4, as typing of [AS/AGU x 
(AS/AGU x BN) FI] progeny yielded two different orders for these SSLP markers.
Recombination frequencies have been used as direct estimates of the distance between 
adjacent loci (section 4.2.2). Calculation of the 95% lower and upper limits was carried 
out as described (Chapter 2; section 2.4).
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latter were lower than 6%. When applied to recombination frequencies in the range 20- 
32%, the distances obtained were not much different from the recombination values. All 
recombination frequencies above 40% resulted in distances of over 50 cM. Because it is 
not clear how adequate the Kosambi’s function is when applied to very large intervals 
(Donis-Keller et al., 1987; Jacob et al., 1995), and given the good approximation of the 
recombinantion frequencies per se in the smaller intervals, the recombination rate was 
initially used as a direct estimate of the distances between loci.
DlMgh7 and Kal could not be mapped in relation to the flanking loci, agu and 
C, since two different orders were obtained, agu - (20.3 ±3.7 cM) - DlMgh.7 - (21.2 ±
3.8 cM) - Kal was the order observed when studying these three markers on 118 
[AS/AGU x (AS/AGU x BN) FI] progeny. When the same 118 animals were typed at 
Kal, DlMgh.7 and C, the order obtained was Kal - (21.2 ± 3.8cM) - DlMgh7 - (22.9 ±
3.9 cM) - C. These two orders were mutually exclusive since the coat colour locus C 
had been found to map near the DIMitS locus and at 41.5 ± 4.4 cM from the agu gene.
DlM itl and DlMgh7/Kal were taken as the flanking markers of the region of 
interest. New SSLPs which mapped within this area were identified and analysed on the 
different strains, following optimisation of the PCR conditions [Table 4-6]. These loci 
were Cype, Cear, DlMgh5, DlMgh6, DlMghl8, DIMcol, CalmS and Atpla3. The 
primer sets DIKyol (locus Ckmm; mouse M105) and R93 (locus Cebpa), although not 
assigned to any linkage group on rat chromosome 1, were also tested, as these loci had 
already been mapped to this chromosome as well as to the chromosomal region of 
synteny in mouse. Other microsatellites mapping to cytochromes P450 and members of 
the CEA (carcinoembryonic antigen) gene family were also tested (this work being done 
by Dr. P. Shiels and Mr. M. Canham, respectively). None of these markers, with the 
exception of DlMghl8 , showed allelic differences between any of the rat strains under 
study, even when analysed on 6-8% polyacrylamide gels.
DlMghl8 showed strain differences between AS/AGU and the F344 strain. 
However, an unexpected result was obtained with this SSLP since typing of [AS/AGU x 
(AS/AGU x F344) FI] animals indicated that it was not linked to the gene of interest 
nor to other two markers in the region which were informative for the same cross, 
DlCep4 and DlMco2. This is discussed in Chapter 7.
At this point it became necessary to develop new microsatellite markers from the 
region of interest. This work is discussed in Chapter 5. In addition, it was later
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observed that, contrary to the earlier maps (Serikawa et a l , 1992; Kuramoto et al'., 
1993; Yamada et al., 1994), which placed the loci Pkc (protein kinase C, type I) and 
Cgm4 (Cear) at a considerable distance from the DlCep4 locus (at 12 and 23 cM, 
respectively) and distal to Cype, the maps released by Gu et al., Yokoi et al., and Ding 
et a l, all in 1996, indicated that these genes mapped between the two latter loci. The 
protein kinase C, type I gene was mapped by Gu et al. (1996) at 2.5 cM from the 
DlCep4 locus, following typing of over 150 animals. Therefore, given its location, this 
locus was analysed again in the AS/AGU and the reference strains (by Dr. P. Shiels). 
This time the PCR products were run on a 6% polyacrylamide gel, following 
radioactive labelling of the R158 forward primer (Serikawa et a l, 1992). A difference 
was observed in the size of the products obtained with F344 and BN DNA templates 
and that obtained with AS/AGU DNA. Although this primer was informative for both 
backcrosses, it was initially used to type [AS/AGU x (AS/AGU x F344) FI] offspring 
(work done by Dr. P. Shiels). No recombinants were observed following typing of 264 
animals, rendering Pkc the closest locus to the agu gene.
4.3 Discussion.
Linkage of the kallikrein locus to the agu gene (24.6 ±4.0 cM) was observed 
following typing of backcross offspring with a series of 26 SSLPs, indicating that agu is 
located on rat chromosome 1. Chromosome 1 is the largest in rat, considered to be 
about 10% of the female haploid genome {Committee for a Standardized Karyotype o f  
Rattus norvegicus (1973)). A single linkage group of 130 cM and consisting of 18 
microsatellite loci was described for chromosome 1 by Yamada and colleagues in 1994 
[Appendix A; Figure A-l]. The map constructed by Jacob and coworkers in 1995 
contained 40 SSLPs and covered 155.2 cM [Appendix A; Figure A-2]. Further 
microsatellite markers were subsequently developed by other groups (Gauguier et al., 
1996; Yokoi et a l, 1996). Important contributions were made by Gu et a l  (1996), with 
the establishment of a linkage map of chromosome 1 which extended through 193 cM 
[Appendix A; Figure A-3], Also, Ding et a l (1996) identified 2 linkage groups on this 
chromosome, altogether covering about 191 cM [Appendix A; Figure A-4]. By this time
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the length of the female haploid genome was estimated as 3000 Mb or 2250 cM, which 
indicated a length of 226 cM (301 Mb) for chromosome 1.
Following the observations with the kallikrein locus, a further set of 16 
microsatellite markers were tested to refine the location of agu on chromosome 1. Of 
these, 5 were not informative for either of the backcrosses, 3 were informative in the BN 
backcross and 6 in the F344 backcross. The other 2 were informative in both 
backcrosses, although they were only used to type BN backcross progeny, given the 
small size difference between the F344 and the AS/AGU amplification products.
The informative SSLPs and a coat colour marker were used to type backcross 
progeny. Clear linkage of six of these markers to the agu locus confirmed its location on 
rat chromosome 1 and established two linkage maps of this chromosome, one for each 
backcross [Figure 4-4]. Other microsatellites were also analysed which resulted not to 
be informative for any backcross. In addition, analysis on polyacrylamide gels showed a 
difference in the size of the AS/AGU and the BN and the F344 products at the Pkc 
locus. Typing of [AS/AGU x (AS/AGU x F344) FI] offspring placed this marker in 
close proximity to the agu gene. Unambiguous location of the loci Kal and DlMgh.7 
could not be determined since two discordant orders were established. These typings 
were carried out once; therefore confirmation of each individual genotype should be the 
first step towards identifying the correct order. This was not judged to be a high priority 
in this project, since these loci are distant from agu. The order agu - Kal - DlMgh7 - C 
[Figure 4-5] is in agreement with the map published by Gu et al. (1996), where the order 
DlCep4 - Pkc - Kal - DlMgh7 is presented. However, whereas this group shows a 
distance of 7.8 cM between Kal and DlMgh7, the recombination rate obtained in this 
work is greater than 21%. A close similarity in the order and distances between the loci 
has been otherwise observed between the work published by Gu et al. (1996) and the 
results obtained in this project. This strongly suggests that the order agu - Kal - 
DlMgh.7 - C is correct and that the contradictory data and the large distance established 
between Kal and DlMgh.7 are the result of typing errors.
The order of all the other mapped loci is in agreement with previous linkage 
maps (Jacob et al., 1995; Gu et al., 1996; Ding et al., 1996). Contrary to the map 
released by Yamada et al (1994), Pkc maps at the other side of the DlCep4 locus, near 
the Cype gene. This is the order found in the maps of Gu et al (1996) and Ding et al
(1996). The distances between the loci are very similar to most of the published data.
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DlMghl 7
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44.1
4.3
C
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31.2
DlMgh22 (Igf2)
FIGURE 4-4. Linkage maps for rat chromosome 1.
The left panel was obtained following the typing of [AS/AGU x (AS/AGU x BN) 
FI] offspring. Data from typing [AS/AGU x (AS/AGU x F344) FI] animals led to 
the establishment of the map on the right.
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agu
Kal
'DlMgh.7
C
FIGURE 4-5. Probable order for DlMsh7 and Kal on rat chromosome 1.
Order obtained following the typing of 118 [AS/AGU x (AS/AGU x BN) FI] animals at 
the loci Kal, DlMgh7 and C. A different order was obtained when the same set of 
animals were typed at the loci agu, Kal and DlMgb.7 (section 4.2.2). Evidence that the 
order shown is correct comes from the data published by Gu et al. (1996) and from the 
genetic map recently released by Bihoreau et al. (1997).
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5.1 Introduction.
A high-resolution genetic map is essential for positional cloning experiments. 
Genetic markers provide the means to identify the chromosomal position of the locus in 
question and to subsequently narrow down the location to a distance of 1 cM or less. A 
physical map can then be obtained for further analysis (Rommens et al., 1989; Harshman 
eta l., 1995; Wang etal., 1996).
In the case of this project, by the time a chromosomal fragment of approximately 
25-30 cM in length (ca. 35-45 Mb) was established as containing the agu gene, no other 
informative SSLPs were available which mapped to this region. The linkage to Pkc had 
not yet been identified. It thus became necessary to search for new microsatellites within 
that chromosomal area. Two main approaches were followed. One approach was based 
on the observations by Stallings and colleagues (1991) and Moore and coworkers (1991) 
that some PCR primers defined in one species can be used to amplify conserved 
repetitive sequences in related species. This possibility has been exploited by other 
groups (Jacob et al., 1991; Kondo et al., 1993; Fredholm and Winteri, 1995). As 
previously done by Kondo and colleagues (1993), mouse primers were used in this work 
to amplify rat genomic DNA. The other method was based on the screening of a rat 
genomic PI library to identify clones carrying sequences which mapped or putatively 
mapped to the region under study. New SSLPs were then identified within the insert by 
probing the PI clones with labelled oligonucleotide repeats and sequencing the 
hybridising DNA fragments.
5.1.1 Development o f new SSLP markers.
Comparative mapping between different species can sometimes be a reliable 
means towards a preliminary characterisation of chromosomal regions which are not 
covered in one of the species. The robustness of this approach is closely dependent on 
the number of genetic markers which are present in the linkage map of each of the 
species being compared; these sequences are the basis to the accurate identification of 
conserved regions between the genomes.
The mouse and human regions of synteny with the rat chromosomal fragment of 
interest were sought. Not surprisingly, a closer homology was observed between the 
rodent maps than between these and the human map. Levan and colleagues (1991) and
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Yamada et al. (1994) reported, respectively, that 15 out of 16 and 18 out of 22 genes 
mapped to rat chromosome 1 were located on mouse chromosome 7. The human 
homologues of these rat genes were mainly distributed on chromosomes 11 and 19. The 
same correlation to the human chromosomes was observed with mouse genes on 
chromosome 7 (Copeland et al., 1993). Comparison of our results with the work done 
by Saunders and Seldin in 1990 indicated that the orgw-containing region was likely to 
correlate to the proximal region of mouse chromosome 7 and to human chromosome 
19q.
5.1.1.1 Amplification o f rat genomic DNA with heterologous mouse SSLP primers.
A set of 10 mouse SSLP primer sets were selected (by Dr. P. Shiels) that mapped 
to the region in mouse chromosome 7 which appeared to be syntenic to the area of 
interest in rat chromosome 1. These were used (by Dr. P. Shiels and myself) to amplify 
rat genomic DNA, aiming to identify homologous rat markers. Some of the primer pairs 
yielded a very high background of amplified bands that impeded the identification of a 
single main product, even when 5% formamide was added to the PCR reaction. Others 
did not yield any product. Four amplifications resulted in a defined band; however, when 
the AS/AGU product was compared to those from the BN and the F344 genomic DNAs, 
no strain difference was observed. Therefore, no further work was done on these SSLPs. 
Other mouse primer sets were used to amplify DNAs from a panel of mouse x rat 
somatic cell hybrid clones (work done by Miss N. Craig) to confirm that the rat PCR 
product mapped to the rat chromosome of interest. However, the attempts to 
differentiate the mouse PCR product from the rat product failed, rendering this assay not 
useful in practice.
5.1.1.2 Isolation o f rat PI genomic clones for SSLP analysis.
Development of new rat microsatellite markers was achieved following the 
completion of a whole series of experiments on a rat genomic PI library. This library is 
described in Chapter 2 (section 2.3.5). PI clones can carry large inserts (70-95 kb on 
average) (Sternberg, 1990b; Smoller et al., 1991; Sternberg, 1992), and this system has 
been reported to be much more stable than, for example, YACs (Albertsen et al., 1994; 
Nehls et al., 1995). It was therefore considered that any given PI clone containing a 
selected marker was likely to carry other sequences which are adjacent to this marker in
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the chromosome. These inserts were therefore ideal substrates for the development of 
new microsatellite markers in the region.
Comparison of the rat and mouse genetic maps allowed the selection of a set of 
genes which, being placed in both the rat region of interest and the mouse chromosomal 
fragment of synteny, were considered to be putatively close to the agu gene. These loci 
were used to identify chromosomal regions containing SSLP markers which could be 
useful in refining the existing genetic map.
Most of the chosen loci contained already established SSLPs which had not 
shown any strain difference when the AS/AGU, the BN and the F344 strains of rat had 
been tested (Chapter 4). The primer pairs which amplified these micro satellite regions 
were now selected for future screening of the PI library. ATPase, Na+K+ transporting, 
alpha 3 polypeptide (Atpla3; primer set ATP1A3), calmodulin El (Calm3; primer pair 
CALM3) and DIMcol (primer DIMcol) were some of these loci; some members of the 
cytochrome P450 and of the CEA families were also selected by Dr. P. Shiels and Mr. 
M. Canham, respectively, to identify PI clones of interest. The primer set R158 was also 
used to screen the PI library, following identification of Pkc as the closest marker to 
agu. The estimated position of these loci is shown in Appendix A.
Analysis of the genes present in the mouse region of synteny led to the selection 
of an additional number of rat homologues, even though these were not mapped in the 
rat yet. These were the creatine kinase, muscle form (Ckmm; locus DIKyol), the 
ATPase-like vacuolar proton channel (Atpl), the ionotropic glutamate receptor, kainate 
5 (Grik5), the sodium channel beta-1 subunit (Scnnlb) and the prostaglandin I receptor 
(Ptgir) genes. No micro satellite had been identified in any of the latter four genes nor in 
some of the CEA genes. In these instances, a primer set was designed to the 3' 
untranslated region (3' UTR) of the gene. These primer pairs were initially used in SSCP 
analyses (by Dr. P. Shiels, Mr. M. Canham and Miss N. Craig); no differences were 
detected between the AS/AGU rat and any of the reference strains. These primers were 
then employed to screen the PI library.
My work focused mainly on the Scnnlb gene (Miss N. Craig designed a 
corresponding PCR primer set, DlGul02, and optimised the amplification conditions), 
and on the DIMcol rat SSLP.
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5.2 Results.
The amplification products obtained with the primer sets DlGul02, DIMcol, 
CALM3, and a CAr/ww-specific primer pair which was designed following comparison 
of both the muscle and the brain creatine kinase (Benfield et al., 1984; Bendfield et al., 
1985) [Figure 5-1], were sequenced. These sequences were each confirmed with the 
published sequence prior to the utilisation of the primers to screen the PI library. All 
the amplification products were, as expected, specific to the corresponding loci [Figure
5-2]. The primer sets CALM3 and CKM were stored for a possible future use. 
Thenceforth my work was centered on the Scnnlb and the DIMcol loci.
5.2.1 Identification o f PI clones containing DNA sequences from the region o f 
interest
The optimised primer sets for selected rat loci were used to screen the PI 
library. Identification of single PI clones carrying the respective PCR sequence was 
achieved in 3 stages. These are described in section 2.3.5.2.
Around 12 primer sets were initially tested by the group. Most of the genes were 
found following screening of the first fifty primary PI pools; a few of them required 
testing further sets of pools. In a small number of cases the PCR signals were not 
reproducibly obtained in consecutive amplifications. Confirmation of the presence of 
the PCR sequence was then achieved by purifying the DNA in the lysate with QIAEX 
II-resin (section 2.3.13) and using this DNA as template in the PCR reactions.
5.2.2 Sequence confirmation o f the PCR product obtainedfrom a single PI clone.
An aliquot (1 pi) from each of the PI cell cultures was used as template in PCR 
reactions; the amplification products were purified and sequenced. PI clones selected 
for the rat loci Scnnlb and DIMcol, respectively, yielded PCR products corresponding 
to the published sequences of these two loci. These PI clones were called V\{Scnnlb) 
and P\(DlMcol)) [Figures 5-3 (A) and 5-3 (B)].
5.2.3 PI DNA isolation from a positive single clone.
Cultures were prepared with each of the two PI clones under study. Bacteria 
were always grown in the presence of 25 pg.ml'1 kanamycin and 5% sucrose, since the
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FIGURE 5-1. Design of a Cknim-specific PCR primer set
The sequences of the rat skeletal muscle creatine kinase {Cknim) composite mRNA 
(top sequence; Benfield et al., 1984; Accession M10140) and the rat brain creatine 
kinase (Ckb) mRNA (bottom sequence; Benfield et al., 1985; Accession M14400) 
were aligned and compared, in search for regions specific to the Ckmm gene. Gene- 
specific regions, shown above, were found at the 3* end of the sequences compared. A 
Cfow/w-specific PCR primer was designed (underlined). Amplification with this primer 
set was carried out at an annealing temperature of 63 °C for 25 cycles, in the presence 
of 1 mM MgCh.
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(a) Rat skeletal muscle creatine kinase composite mRNA, complete cds.
(Length =1410; Accession Ml0140)
Q u e r y : 22 GACTACAT6ATCCCTGCGCAGAAGTAGGCGCCGCACAGAGCGCACCAGTCAGCGGCTTGC 81
III l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t : 1189  GACGACATGATCCCTGCGCAGAAGTAGGCGCCGCACAGAGCGCACCAGTCAGCGGCTTGC 1248
Q u e r y : 82 AGCTGGAGCCCCGCCCCCTGGAANNCCAACCAACCGACTTTGCCCTCTGGGTTCTGGCCA 141
l l l l l l l l l l l l l l l l l l l l l l l  I I I III I I I I I I I Ml I I I I I I I I I I II II II I II 
S b j c t :  1249  AGCTGGAGCCCCGCCCCCTGGAAGTCCAACCAACCGACTTTGCCCTCTGGGTTCTGGCCA 1308
Q u ery : 142 ATGANAAC 149
INI III
S b j c t :  1309  ATGAGAAC 1316
(b) R.norvegicus CaMlII gene for calmodulin EQ
(Length = 7727; Accession X14265)
Q u ery : 162 ACTGC CTGTGGGGGC GC GIUTGATGGGC CAC AGGC GTTCC AGTTTTTCTGTTGTTGC CTG
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
ACTGC CTGTGGGGGC GCGTCTGATGGGCC ACAGGC GTTC C AGTTTTTCTGTTGTTGC CTG
103
S b j c t : 50 1 1 50 7 0
Q u ery : 102 GCAC C AGGAATC AGTTCNTAGAGCAC AGGACTTGGTTTTGTTGATTGCTGC CATATCTTC
II II 1 1 1 1 1 II 1 1 1111 1 1 1 II 1 II 1111 1 II 1 II II II 1 1 II 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 
GCAC C AGGAATC AGTTC CTAGAGCACAGGACTTGGTnTGTTGATTGCTGC CATATCTTC
43
S b j c t : 5071 5 1 3 0
Q u ery : 42 AATGCNTGGTGCATA 28  
i i i i i  i i  i I i i i i i
S b j c t : 5131
M i l l  1 1 1 1 1 II 1 1 
AATGCCTGGTGCATA 51 4 5
Q u ery : 250  TCACTTGCTTCCTTCTACC AGAGNTC AGATACCCTGACCCCAACTCAAGCTGGCAG 195
I I I II I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
S b j c t :  491 1  TCACTTGCTTCCTTCTACCAGAGCTCAGCTACCCTGACCCCAACTCAAGCTGGCAG 49 66
FIGURE 5-2. BLAST searches with the sequences obtained from amplification with
(a) the CKM forward primer (CKM-F) and (b) the CALM3 reverse 
primer (CALM3-R).
As indicated, the two PCR products were confirmed as Ckmm (Benfield et al., 1984) 
and Calm3 (Nojima, 1989) fragments, respectively. A tract of nine (TCCC) is found in 
the Calm3 gene, expanding from nucleotide 4972 to nucleotide 5008.
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Rattus norvegicus chromosome 1 microsatellite sequence DIMcol.
(Length = 342; Accession U19349)
Query: 59 TITCAACACCTTrCAAGTAAACAAATGTGTTAATGAAATAGAAGAGGAGTTTTTGTnT 1
I I I I ( I I I I I i i I I I I I i I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I M  H i l l  
S b j c t : 120 TTTCAACACCTTTCAAGTAAACAAATGTGTTAATGAAATAGAAGAGAAGnTTI'G 1TJLT 178
Query: 115 CTTATCTGCGAGTGGATACCATA 93
l i l l l l  t i l l  l l l i l l l l l l l
S b j c t :  62 CTTATCAGCGAATGGATACCATA 84
[
It
F
|
II
1
II
FIGURE 5-3 (A). Confirmation of the DIMcol sequence obtained from a P\( DIMcol) 
culture.
BLAST search with the sequence obtained following amplification of DNA from a 
P\(DlMcol) culture with the reverse DIMcol primer. The sequence of the forward 
DIMcol primer is underlined. A (TG)n stretch expands from nucleotide 85 to 
nucleotide 118.
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FIGURE 5-3 (B) .  Sequence alignment of the DlGul()2-PCR product obtained
from the P 1 (Sennib) clone and the rat Scnnlh gene.
Comparison of a fragment of the rat Scnnlb gene (top; Isom et. a l 1992; Accession 
M91808) with the sequence obtained from amplifying DNA from a PI (Scnnlb) culture 
with the primer set DlGul()2 (bottom). Both the sequence of the forward primer and 
the sequence complementary to the reverse primer are underlined. Amplification was 
carried out at 55°C for 30 cycles, in the presence of 1 mM MgCh.
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vector used in the construction of the library was ^AdlQsacBW. IPTG was added to the 
cultures when the cells were in early log phase, resulting in the inactivation of the laclq 
repressor and the concomitant increase in the copy number of the plasmid (section
2.3.5.1).
Prior to isolation of the PI DNA, PCR reactions were carried out to confirm the 
presence of the Scnnlb and the DIMcol sequences in their respective cultures. Presence 
of the Scnnlb sequence was always confirmed; however, none of the corresponding 
cultures showed amplification of the DIMcol locus. Confirmation of the presence of 
this sequence was only achieved when the cells were grown on solid media (section
5.2.5.1).
Various methods, described in section 2.3.2.3, were employed to isolate PI 
DNA. The PI clone carrying the Scnnlb fragment was isolated following the Birnboim 
and Doly procedure, and also the Qiagen ‘Midi’ method and the modified Qiagen ‘Midi’ 
protocol I [Figure 5-4]. Isolation of PI DNA containing the DIMcol sequence was done 
by applying either of the two modified Qiagen ‘Midi’ protocols (I and n).
The Birnboim and Doly procedure was the most rapid method of isolation, the 
PI DNAs being in general very clean; however, this method yielded the lowest amounts 
of DNA (ca. 2-5 pg), since it employed small volumes of bacterial culture. Repeated 
isolations were therefore required to ensure continued availability of the particular DNA.
Isolation of PI using Qiagen-tip 100 was unsatisfactory. The considerable yield 
of PI DNA (ca. 10-50 pg) was contaminated with a considerable amount of bacterial 
chromosomal DNA. The modified Qiagen ‘Midi’ protocol I was adopted as a 
compromise between these two methods. High yields of considerably clean PI DNA (ca. 
20-50 pg) were isolated.
In a few instances, the single phenol/chloroform extraction step was not efficient 
enough to purify the PI DNA. This problem was more commonly encountered when 500 
ml cultures were being used, and resulted in either complete absence of digestion or 
incomplete digestion when the DNAs were treated with restriction endonucleases; 
different enzymes exhibited different activity efficiencies in each case [Figure 5-5]. This 
problem was overcome by repeating the phenol/chloroform extraction 1 or 2 more times 
or, preferably, by introducing a proteinase K treatment step followed by a second 
phenol/chloroform extraction (section 2.3.2.3).
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(I) (II) (III)
Ml Ml Ml  M2
FIGURE 5-4. Comparison of the PI DNA obtained following: various methods 
of isolation.
The three gels show ?\(Scnnlb)  DNA following digestion with BglU.
(I) Lane 1: 24 pi of a total of 28 pi of DNA isolated from a 25 ml culture with 
the Bimboim and Doly method.
(II) Lane 1: 50 pi of a total of 500 pi of DNA isolated from a 500 ml culture, 
following the Qiagen ‘Midi’ procedure.
(III) Lane 1: 8 pi out of 400 pi of DNA isolated from a 500 ml culture following 
the modified Qiagen ‘Midi’ protocol I.
The size markers are X DNA digested with Hindlll (M l) and a 1 kb DNA ladder 
(M2). The asterisk (*) indicates a very old sample of a X / Hindlll marker.
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FIGURE 5-5. P K D lM col) DNA that has lost the DIM col  marker sequence.
Resolution on a 1% agarose gel of the restriction fragments obtained following 
digestion of the DNA extracted from a Pl(D lM col)  culture that has lost the reference 
DIM col  sequence, with Bglll (lane 2), EcoBdJ Hindlll (lane 3), Kpnl/Hincll (lane 4), 
BamYll (lane 5). Restriction with the enzymes Bglll, Kpnl and H indi  failed. Successful 
digestion with Bglll was observed after the DNA was treated with proteinase K and 
phenol/chloroform-extracted.
The size standards are a X/Hindlll marker (lanes 1 and 8) and a 1 kb DNA ladder (lane
7).
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The modified Qiagen ‘Midi’ protocol n, although the most cumbersome and 
time-demanding procedure, proved to be the most efficient method for PI DNA 
isolation, in terms of both quality and quantity (ca. 50-150 pg). It therefore became the 
method of choice when large amounts of clean PI DNA were to be prepared.
5.2.4 Transfer o f PI clones to DH10B.
The quantity and the quality o f PI DNA isolated from single clones was of 
central importance for the subcloning of SSLP-containing DNA fragments as well as for 
the direct sequencing of the ends of the PI insert. Previous communications had 
reported the isolation of greater amounts of PI DNA from ere' host strains than from 
cre* bacteria such as NS3529; this DNA also appeared to be of better quality (Kimmerly 
et aL, 1994). All the isolated PI clones were therefore transferred to DH10B cells, 
which did not express the Cre recombinase enzyme. The transfer into DH10B cells was 
carried out via yS-transposition. The steps followed are described in Chapter 2 (section 
2. 12).
Restriction digests of PI {Scnnlb) DNA isolated from NS3529 and from DH10B 
demonstrated an at least 5- to 10-fold increase in the amounts of DNA obtained from 
the latter host strain. This was also the case when working with the PI (DIMcol) clone. 
The difference was accentuated when IPTG was added to the DH10B cultures. [Figure
5-6].
5.2.5 Observed instability o f the Pl(DlMcol) clone.
5.2.5.1 Loss o f the DIMcol sequence. Growth on solid media.
As mentioned earlier, problems arose when trying to grow the PI {DIMcol) 
clone in liquid media. PCR reactions set up on different cultures demonstrated that the 
DIMcol sequence had been lost in all of them. This result was consistently encountered 
with cultures of various volumes which had been grown at either 37°C or 30°C and with 
or without IPTG; only a few 3 ml cultures which had been grown at 30°C and which 
were not yet dense showed presence of the marker sequence, and further growth of 
these cultures resulted once again in loss of the PCR signal. To confirm that the absence 
of PCR product was due to the loss of the particular sequence in the PI DNA and not to 
inhibition of the PCR reaction by contaminants such as excess cell debris, the DNA was
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FIGURE 5-6. Effects of IPTG and the host strain on PI DNA yields.
(I) Notl/BamYR digests of PI {Scnnlb) DNA extracted from 500 ml NS3529 (lane 1) and 
DH10B (lane 2) cultures. In each case, 7jLtl of a total of 400pl of isolated DNA was 
digested.
(II) EcoBl digests of P \(D lM co l) DNA isolated from 250 ml DH10B cultures which 
were (+) or were not (-) induced with IPTG prior to extraction of the DNA. Each DNA 
was resuspended in a final volume of 200 pi; digestion was carried out with 6 pi of 
DNA from the uninduced culture (-), and on 3 pi of DNA from the induced culture (+).
The size standards used were a X/HindlU marker (M l) and a 1 kb DNA ladder (M2).
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purified from a small volume of culture (30 pi) with QIAEX II-resin, and the PCR 
repeated; no product was obtained.
The PI DNA was isolated and analysed in restriction reactions with EcoRI, 
BamHI, BgUl and Kpnl, showing an insert of at least 40-60 kb [Figure 5-5]. Thus, the 
insert had not been completely lost, although some rearrangement had occurred in the PI 
DNA which must have been advantageous for the growth of this clone.
Maintenance of the DIMcol sequence was attained by growing the clone on 
solid medium Great part of the bacterial mass corresponding to the gridded 
V\(DlM col) clone was removed with a toothpick and resuspended in 180 pi of L-broth; 
30 pi aliquots were plated on each of 6 LB plates containing 25 pg.ml1 kanamycin and 
5% sucrose, and grown at 30°C for 22 hours, until a confluent lawn of cells was 
observed on each plate. The colonies were eluted with L-broth and pooled into a 
Nalgene tube, in an approximate final volume of 25 ml. An aliquot (1 pi) of this culture 
was used as template for amplification with the DIMcol primer set; this time, a strong 
signal was obtained. This DNA was isolated following the modified Qiagen ‘Midi’ 
protocol II.
When the restriction patterns of both the DNA which had lost the PCR sequence 
(PI DNA(PCR")) and the newly isolated DNA (PI DNA(PCR+)) were compared 
following BamYQ. and BglU digestions, no clear differences were observed. Therefore, 
the rearrangement(s) which had taken place during growth in liquid media did not seem 
to involve drastic alterations of the ¥\(DlMcol) DNA.
5.2.5.2 Transfer o f PI (DIMcol) to DH10B cells.
This process involved several cycles of growth which had by now proved to be 
unfavourable for the maintenance of the DIMcol sequence in the PI DNA. This problem 
was conclusively demonstrated when transfer of the PI clone to DH10B following the 
appropriate mating steps (section 2.12) resulted in DH10B colonies which had lost the 
DIMcol fragment. On the other hand, it had been observed that small cultures 
maintained this sequence while still exhibiting a weak growth. Therefore, transfer to 
DH10B cells was again attempted, this time with the introduction of a few modifications 
to the original protocol, these concerning growth times and culture volumes. The 
procedure is described in Chapter 2 (section 2.12).
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Several DH10B colonies were picked following transfer of the PI molecule, and 
PCR reactions were carried out on the corresponding lysates. All the clones contained 
the DIMcol sequence. Small (3 ml, 50 ml) and large (500 ml) cultures were prepared 
and grown at 37°C; this time, no loss of the PCR signal was observed.
5.2.5.3 Stability o f the PI (DIMcol) clone in the DH10B host strain.
Absence of the DIMcol PCR product could be the result of either deletions 
involving one or both DIMcol primers, or of some rearrangement where both 
oligonucleotide sequences were maintained but at a different position than in the original 
fragment, in such a manner that amplification of the intervening sequence was not 
feasible (since no PCR product was obtained at all). Both the PI DNA which had failed 
to give the DIMcol PCR product and the DNA which showed amplification of this 
fragment were isolated from 50 ml DH10B cultures following the Birnboim and Doly 
procedure. Two sets of cultures were prepared in each case. One (culture (a)) was 
directly seeded with a single colony from the M2 plate, and the other (culture (b)) 
inoculated with 0.5 ml from a 3 ml culture which had been seeded with another M2 
single colony and grown at 37°C overnight. Both 50 ml cultures were grown at 37°C for 
approximately 14 hours. Digestion of the isolated DNA with Kpnl followed and the 
fragments were run on 1% agarose gels and blotted onto nylon membranes.
Both the forward and the reverse DIMcol primers were radioactively labelled 
and used in separate experiments to probe the filters prepared. No signal was observed 
when probing PI DNA(PCR) with either primer. This indicated deletion of both 
sequences from the original PI DNA during growth. Probing of PI DNA(PCR+) 
prepared from each of the two 50 ml cultures ((a) and (b)) resulted in hybridisation 
signals with both labelled primers; both the forward and the reverse probe fit up the same 
Kpnl fragment. However, this hybridising fragment was shown to be different in each 
digest, corresponding to a ca. 7 kb band in DNA (a) and to a >20kb band in DNA (b); 
this was associated to a difference in the respective digestion patterns [Figure 5-7].
To test the possibility that the PI DNA(PCR+) was not stable and may be still 
prone to change into the PI DNA(PCR') form as the number of growth cycles increased, 
a set of four 50 ml cultures were prepared where the second culture was inoculated with 
0.5 ml from the first culture (this having been seeded with a single
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FIGURE 5-7 Instability of the P K D lM col)  clone. Loss of the DIMcol sequence.
(A) Kpnl digests of DNA extracted from 50 ml PI {DIMcol) cultures.
Lanes 1 and 5: PI DNA (PCR+) from culture (a) [PI DNA (PCR')-(a)].
Lanes 2 and 6: PI DNA (PCR+) from culture (b) [PI DNA (PCRf)-(b)].
Lanes 3 and 7: PI DNA (PCR") from culture (a) [PI DNA (PCR')-(a)].
Lanes 4 and 8: PI DNA(PCR') from culture (b) [PI DNA (PCR)-(b)].
Details are given in the text. The size standard is a X/HindlU marker (M).
(B) The two identical halves of the gel were blotted and probed separately with the 
forward and the reverse DIMcol primers, respectively. Identical results were obtained 
with both probes.
125
Chapter 5. Development of  new genetic markers.
colony from the M2 plate) after an overnight growth at 37°C, and so forth. PCRs on 
these cultures showed that all of them retained the DIMcol sequence. Surprisingly, 
when Kpnl digests of these DNAs were prepared, a fourth digestion pattern (identical 
for all of them) was observed which was different from the two DNA(PCR+) digests and 
from the unique pattern obtained with DNA(PCR) [Figure 5-8]. The DIMcol primers 
hybridised to the larger >20 kb fragment.
To ascertain that the differences in the digestion and hybridisation patterns were 
not due to contaminants in the DNA, impeding complete digestion with the restriction 
enzyme, two controls were added: a) some of the samples underwent treatment with 
proteinase K, followed by a phenol/chloroform extraction, and were subsequently 
digested and compared to the original patterns, and b) Kpnl digests of PI DNA(PCR+) 
which had been purified through a CsCl gradient were compared to the previous results. 
The DNAs which had undergone proteinase K treatment exhibited the same digestion 
and hybridisation patterns as the originals. DNA purified through the CsCl gradient 
gave the same results as those obtained with DNA(PCR+)-(a) [Figure 5-9]. Growth in 
the absence or presence of IPTG did not have any effect on either the digestion pattern 
or the size of the hybridising fragment.
5.2.6 Identification of repeat sequences in PI inserts.
The isolated DNAs were digested with various restriction endonucleases and the 
restriction patterns analysed on 0.8%-l% agarose gels. Both PI (Scnnlb) and 
¥\(DlM col) were found to carry inserts of considerable size (at least 50-60 kb).
Southern blots of the digests were prepared and probed with radioactively 
labelled oligonucleotide repeats [(AC)i0, (CT)i0 and (GC)10]. Analysis of both PI clones 
demonstrated that probing with (AC)i0 resulted in several hybridisation signals of 
considerable strength [Figures 5-10 (A) and 5-10 (B)]. No clear signals were obtained 
with (CT)]0 or (GC)i0 probes. Thus (AC)-containing microsatellites were initially 
sought. Two approaches were used to subclone (AC)-containing fragments from the PI 
insert: I) subcloning of specific gel-purified fragments; II) shotgun cloning of whole PI 
digests.
The first approach was only followed with the V\(Scnnlb) clone, since several 
of the hybridisation signals corresponded to restriction fragments in the approximate
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FIGURE 5-8. Apparent stability of the V \(D lM col) clone in the DH1QB host through 
consecutive subcultures.
Kpn\ digests of DNA extracted from V \(D lM col) cultures. Details are given in the text. 
Lane 1: PI DNA (PCR+)-(b).
Lanes 2 to 5: set of four successive subcultures from an M2 (D lM co l+) colony.
Lane 6: PI DNA (PCR>(a).
Lane 7: PI DNA (PCR>(b).
A 1 kb DNA ladder (M) was used as the size standard.
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FIGURE 5-9. Further confirmation of instability in the ?\(DJM col)  clone.
(A) Kpnl digests of DNA extracted from PI (DIMcol) cultures. Lane 1: PI DNA 
purified through a CsCl gradient. Lane 4: PI DNA (PCR+)-(b). Lane 5: PI DNA (PCR~)-
(b). Details are given in the text. The size standards used are a X/Hindlll marker (lane 3) 
and a 1 kb DNA ladder (lane 6).
(B) The gel was blotted and probed with the reverse DIM col primer.
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FIGURE 5-10 (A). ?\(Scnnlb)  DNA. Screen for repeat sequences.
(I) BglU (lane 1) and Spe I (lane 2) digests of PI {Scnnlb) DNA, run on a 1% agarose 
gel. The size standards are a X/HindUl marker (M l) and a 1 kb DNA ladder (M2).
(II) The digested DNA was blotted onto a nylon membrane and probed with a 
radioactively labelled (AC),0 oligonucleotide.
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FIGURE 5-10 (B). P \(I)lM col)  DNA. Screen for repeat sequences.
(I) #g/II (lane 1) and BamHI (lane 2) digests of ?\(D1 Mcol) DNA, run on a 1% agarose 
gel. The size standards are a X/HindUl marker (M 1) and a 1 kb DNA ladder (M2).
(II) The digested DNA was blotted onto nylon membranes and probed with a 
radioactively labelled (AC),0 oligonucleotide.
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size range of 1.7-4.8 Kb which were clearly visible on the gel. This method was not 
applied to the PI (DIMcol) clone as the fragments which hybridised to the (AC)10-probe 
were either too faint on the gel and therefore the DNA prone to be lost during the 
purification process, or too large to ensure cloning. At the same time, shotgun cloning of 
the entire PI digest represented a quicker approach where several microsatellite- 
containing clones could be identified in a single experiment. This second approach was 
applied to both PI DNAs.
5.2.6.1 Subclonim o f sel-vurified fragments.
Four strong signals were observed when BglU digests of the PI {Scnnlb) DNA 
were probed with an (AC)10 probe. Three of these signals corresponded to sets of bands 
in the approximate size ranges of 4.5-5 kb, 3.5-4 kb and 1.7-1.9 kb [Figure 5-10 (A)].
Each set of bands was extracted from the gel and purified with QIAEX E-resin 
(2.3.13). Ligation of each DNA fragment to a itamFE-digested vector (either pGEM- 
3Zf(+) or pBluescript E KS+) was carried out, as described in Chapter 2. BamHl was 
chosen as the site for cloning because no BglU. sites were present in the multiple cloning 
site (MCS) of any of these vectors and both these enzymes generate ends which are 
compatible with each other. Cells were transformed and plated on medium containing 
ampicillin and the indicators X-Gal and IPTG. Both pGEM-3Zf(+) and pBluescript E 
KS+ carry a portion of the lacZ gene which provides a-complementation for blue/white 
selection of the recombinant clones; when grown in the presence of X-Gal and IPTG 
those recombinants carrying an insert are generally white whereas those lacking inserts 
are mostly blue.
White colonies resulting from each of the transformations were picked to 
inoculate 3 ml cultures which were grown at 37°C overnight. Plasmid DNAs were 
isolated from these cultures and analysed on 1% agarose gels. The presence of (AC)- 
repeats on those clones which carried an insert was confirmed by preparing Southern 
blots and probing them with the radioactively labelled (AC)i0 oligomer.
DNA extracted from pGEM-3Zf(+) clones which carried either of the two 
subcloned smaller PI fragments resulted in the identification of a clone carrying an 
(AC)-containing 2 kb insert (clone 56A) [Figure 5-11]. The DNA from two of these 
colonies was prepared for sequencing.
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FIGURE 5-11. Subclones of the ?](Scnnl b) clone. Screen for repeat sequences.
(I) Two different clones were obtained following subcloning of the PI {Scnnlb) DNA 
Bgbll fragments in the size range of 1.7-2 kb. Lane 1: pGEM3Zf(+) plamid DNA; lanes 
3 to 7: recombinant DNA obtained from five different white colonies. All the DNAs 
were digested with both BcoRl and HindUl. The size standards are a X/HindlU marker 
(M l) and a 1 kb DNA ladder (M2).
(II) The digested DNA was blotted onto nylon membranes and hybridised to a 
radioactively labelled (AC),0 oligonucleotide. A DNA fragment of approximately 1.6 kb 
lit up (clone 56A).
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Three different insert sizes were observed in subclones of the set of PI 
fragments in the 3.5-4 kb range. One of them, corresponding to an insert of 
approximately 3.6 kb in size was found to hybridise to the (AC)i0 probe [Figures 5-12
(I) and (II)]. Further subcloning of this DNA was carried out after a smaller Kpnl-HincU 
fragment was identified as containing the repeat [Figures 5-12 (III) and (IV)]. The 
corresponding band, of approximately 2.1 kb in size, was gel-purified and ligated to 
pGEM-3Zf(+), which had already undergone gel-purification following digestion with 
both enzymes Kpnl and Hindi. Electrocompetent DH5a cells were transformed. A 
number of white colonies were picked from the plates, 3 ml cultures set up and grown, 
and the plasmid DNAs isolated. Several of these colonies were found to carry the Kpnl- 
HincU fragment (clone 56B); the presence of the (AC)-repeat was re-confirmed by 
probing a Southern blot of these DNAs. The DNAs from two of these positive colonies 
were prepared for sequencing.
Subcloning of the two DNA fragments in the 4.5-5 kb region gave rise to clones 
exhibiting two different digestion patterns and therefore carrying both fragments. The 
larger insert (ca. 4.6 kb) was found to carry the (AC)-repeat [Figure 5-13]. Digestion 
with different restriction endonucleases showed that this insert did not contain any 
EcoRl, Notl, Kpnl or HindUl sites, since double digestion of the plasmid DNA with the 
first two enzymes only resulted in the extraction of the insert from the pBluescript II 
KS+ vector and single digestions with Kpnl and HindUl led to linearization of the 
plasmid DNA. Digestion of this DNA with Hindi gave rise to five fragments, including 
a band corresponding in size to the linearised vector on its own. Probing of a Southern 
blot resulted in a weak signal on a 2.5 kb fragment, which could indicate the presence of 
a very short (AC)-repeat, and two strong hybridisation signals, one corresponding to a
1.1 kb DNA band and the other to the vector fragment. There being only one HincU site 
in the pBluescript II KS+ vector, the larger hybridising signal must be the vector DNA 
together with a short stretch of insert DNA at its 3'-end, this fragment containing an 
(AC)-repeat. The proximity of the repeat to the 3'end of the vector DNA ensured its 
direct sequencing with the -21 M l3 forward primer so that it was unnecessary to 
subclone this fragment. Therefore, this plasmid DNA was prepared for sequencing 
(clone 56C). Further subcloning of the other two possible hybridising fragments could 
have been carried out and at least another SSLP could have been found this way.
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FIGURE 5.12. Subclones of the P X(Scnnlb) clone. Screen for repeat sequences.
(I) Lane 1: Linearised pGEM-3Zf(+) plasmid. Lanes 2 to 4: EcoRl, Hin&\\\, and 
/fcoRI////>zdIII digests of the DNA extracted from a single white colony (Q3-1) 
following transformation with a pGEM-3Zf(+) vector which carried either of the 3.5- 
4kb PI ()Scnnlb) DNA fragments. Lanes 5 to 7: restriction fragments of DNA extracted 
from another white colony (Q3-2); the same digestions as those above were carried out. 
The size standards are a X/HindU\ marker (M l) and a 1 kb DNA ladder (M2).
(II) The digested DNA was blotted onto nylon membranes and probed with a 
radioactively labelled (AC),0 oligonucleotide. Clone Q3-2 was shown to carry an (AC) 
repeat.
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(III) Lane 1: pGEM-3Zf(+) plasmid DNA digested with EcoRl. Lanes 3 and 4: 
Aval/HindUl and KpnVHincll digests of clone Q3-2. Lanes 6 to 9: EcoRl, 
EcoRl/Hindlll, Aval/HindUl, and KpnVHincll digests of a third clone, Q3-3. The size 
standards are a X/Hindlll marker (M l) and a 1 kb DNA ladder (M2).
(IV) The digested DNA was blotted onto a nylon membrane and hybridised to a 
radioactively labelled (AC)10 oligonucleotide. Clone Q3-2 was shown to carry an (AC) 
repeat in a ca. 2.1 kb KpnVHincll fragment. This fragment was subcloned into a 
pGEM3Zf(+) vector (clone 56B).
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FIGURE 5.13. Subclones of the PI (Scnnlb) clone. Screen for repeat sequences.
(I) Lanes 1 to 4 and lanes 6 to 9, respectively: EcoRl/Notl, Kpnl, Hincll and Hindlll 
fragments corresponding to two different pBlueScript subclones of the PI {Scnnlb) 
clone. Lane 5: pBlueScript II KS+ digested with EcoRl. The size standards are a 
X/Hindlll marker (M l) and a 1 kb DNA ladder (M2).
(B) The digested DNA was blotted onto a nylon menbrane and probed with a 
radioactively labelled (AC)I0 oligonucleotide. The results indicated that one of the 
clones carried at least two (AC) repeats (clone 56C).
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However, the fact that three microsatellites had already been identified and shotgun 
cloning was going to be carried through led to the termination of any further work with 
these clones.
5.2.6.2 Shotgun cloning of Sau3Al-Pl dizests.
Approximately 0.5-1 pg of both PI {Scnnlb) and V\(DlMcol) DNAs, prepared 
by the modified Qiagen ‘Midi’ protocols I and H, respectively, was digested with 
Sau3Al. The DNA was then ligated to 50-60 ng of pBluescript II KS+ vector DNA 
which had been digested with BarriHL, SAP-treated and gel-purified with QIAEX II- 
resin, as previously described (Chapter 2). BarnHI was chosen as the cloning site in the 
vector since it cuts the vector DNA only once and it generates staggered ends which are 
compatible with those obtained from digestion with Sau3Al. TGI cells made competent 
by the CaCl2-method were transformed, plated, and grown at 37°C overnight. Two- to 
three-hundred white colonies were picked from each transformation, gridded on petri 
dishes, and grown at 37° for an additional 10 hours; duplicates of each plate were 
prepared. One set of duplicates were kept as master plates; the other set were used to 
prepare duplicate filters for colony hybridisation experiments, as explained in section 
2.3.17. The filters were probed with a radioactively labelled (AC)10-oligomer. Four 
colonies from the V\(DlMcol) clone and five from VI(Scnnlb) gave hybridisation 
signals in both duplicate filters; the signals observed on the set of filters firstly prepared 
were in most cases considerably stronger than those coming from the replicate filters 
prepared later. This was probably due to most of the bacterial mass having been taken 
up by the first set of filters. The signals on the filters were correlated to their respective 
colonies on the master plates and these were used to set up 3 ml LB cultures which were 
grown at 37°C overnight. Also, a white colony which did not give any hybridisation 
signal was randomly selected and a culture prepared. The plasmid DNAs were isolated 
from these 10 cultures and digested with both EcoVl and Notl, located at either side of 
the BamHl site used for cloning. These inserts were shown to be approximately 1.3, 2.5,
1.3 and 0.8 kb in the four Pl(D/Afco/)-subclones (37A, 37B, 37C and 37D), and 2.9, 
3.1, 0.6, 2.9 and 0.35 kb in the P !(£<:«« 7 6)-subclones (56D, 56E, 56F, 56G and 56H), 
respectively. The DNAs were run on a 1% agarose gel and blotted to be probed again 
with the (AC)-oligomer [Figure 5-14]. All the DNAs except the one prepared from the 
non-hybridising colony (thus being used as a negative
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FIGURE 5.14. Subclones of Sau3Al DNA fragments from the Pl(Scnnlb) and the 
? \(D lM co l) clones.
(I) Lanes 1 to 4: PI (D/ATco/)-subclones 37A, 37B, 37C, and 37D, respectively. Lane 5: 
pBlueScript II KS+ plasmid DNA digested with ifcoRI. Lanes 6 to 10: PI (Scnnlb )- 
subclones 56D, 56E, 56F, 56G, and 56H. The inserts were extracted from the 
pBlueScript vector DNA by digesting with EcoRHHindUl. A X/Hind\ll marker (M l) 
and a 1 kb DNA ladder (M2) were used as the size standards.
(II) The digested DNAs were blotted onto a nylon membrane and hybridised to a 
radioactively labelled (AC)i0 oligonucleotide. All the clones except that on lane 5 were 
shown to carry (AC) repeats.
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control) showed hybridisation signals, confirming the results obtained with the colony 
hybridisation experiment. These DNAs were prepared for sequencing.
5.2.7 Establishment of new SSLPs.
Subcloning of V\(Scnnlb) and V\(DlMcol) DNAs resulted in the identification 
of 8 and 4 (AC)-containing clones, respectively. A total of 14 DNAs were prepared (two 
of them, corresponding to clones 56A and 56B, were prepared in duplicate), and 
sequenced from each end with the -21 M l3 Forward and Reverse primers.
Initially, (AC)-repeats were found within two of the three DNA inserts obtained 
from subcloning specific gel-purified fragments from V\(Scnnlb) (clones 56A and 56C) 
and also within the inserts present in the shotgun clones 56F and 56H. The sequences 
obtained from these latter two clones demonstrated to be the same; furthermore, this 
sequence was also found in the 56C clone. An (AC) repeat was identified within the ca. 
0.8 kb insert carried by the V\(DlMcol) subclone 37D. No repeats were established 
within any of the other DNAs (in the size range of 1.3 to 3.1 kb) following this first 
round of sequencing. The V\(DlMcol) subclones 37A and 37C proved to be the same 
clone.
Internal primers were designed from the ends of the sequences obtained with 
both the forward and the reverse M l3 primers to carry out further sequencing of the 
inserts. A (CA)-repeat was found in the 56B clone. No repeats were reached within any 
of the remaining VI(Scnnlb) shotgun subclones (2.9 and 3.1 kb in size). Since three 
microsatellites had already been identified within this PI clone, no further work was 
carried out with these DNAs. An (AC)25 repeat was identified in clone 37A. Certain 
anomalies were observed when studying the DNA from clone 37B; this case is 
discussed below (section 5.2.7.1).
PCR primers were designed from the regions flanking each repeat. Two of the 
repeats were found near the 3' end of the sequences obtained; in these cases, primers 
could not be designed from the downstream flanking regions since multiple misreadings 
were already observed in these sequences. A primer was designed upstream of the 
repeat to be used for further sequencing of the insert. It corresponded to a sequence 
close to the repeat so that, once a second primer was designed from the other side of the 
(AC) region, both could be employed to amplify 150-300 bp fragments in PCR 
reactions. This was the case with clones 56B and 37D. Primers DlGul5-F and 
DlGul8-R were designed, respectively, from the sequences preceding each repeat and
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used in a new set of sequencing reactions. DlGul5-R and DlGul8-F were designed 
from each of the new sequences, repectively. As well as yielding good sequences of the 
regions downstream the repeats, a (TACA)9 motif was found towards the end of the new 
sequence obtained with the DlGul5-F primer. The primer DlGul9-F was designed 
from the upstream region but, again, the sequence downstream this new repeat was not 
good enough to design a reverse PCR primer. However, the 2.1 kb insert had also been 
sequenced from the other end with an internal primer, providing a sequence which 
overlapped to a certain degree with that containing the (TACA)-motif. This sequence 
was used to design the DlGul9-R primer.
5.2.7.1 Observed instability in one o f the PI (DIMcol) subclones.
Digestion of the DNA isolated from the P1 (Z)7Mco7)-subclone 37B with the 
enzymes EcoKl and Notl yielded 3 insert fragments, of approximately 0.5, 0.65, and
1.3 kb, respectively. However, the intensity of these bands was of a much lesser 
intensity than that of the vector DNA. Analysis of undigested plasmid DNA 
demonstrated the presence of at least two different plasmids in the sample. To test the 
possibility that these plasmids had been introduced in the same bacterial cell during 
transformation, an aliquot of this DNA was used to transform competent cells. A set of 
22 white colonies were picked into and equal number of 3 ml L-broth cultures and these 
grown at 37°C overnight. Plasmid DNA was subsequently isolated from each culture 
and analysed on a low concentration agarose gel. Three different patterns were obtained 
this time, following digestion with both EcoKl and Notl: a) 3 fragments as before; b) 2 
fragments, of 0.5 and 1.3 kb; c) a single 0.5 kb insert. The 0.5 kb fragment appeared as a 
strong band in all the digests, in contrast to the 1.3 kb and the 0.65 kb bands which 
were, when present, much weaker. Analysis of the undigested samples showed that only 
in the latter case (c) was a single plasmid present. At least two plasmids were present in 
the other cases. These observations indicated that the original plasmid DNA carried an 
insert of approximately 2.4 kb and this was undergoing deletions during growth, 
consequently leading to the observed mixture of different plasmid molecules in single 
bacterial cultures.
Sequencing of any of these DNA samples was not appropriate since it was the 
0.65 kb fragment which had been shown to hybridise to the (AC)10 probe. Nevertheless, 
sequencing of one of the samples where this fragment was present was attempted. As
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expected, the low amounts of intact plasmid, together with the abundance of plasmid 
molecules which only carried a 0.5 kb insert, resulted in sequence only being obtained 
from the 0.5 kb fragment.
An aliquot of the original DNA was again used to transform electrocompetent 
TGI cells. This time, the plates were incubated at 30°C. Cultures were seeded with each 
of 12 white colonies and the plasmid DNA isolated. The 3 patterns previously observed 
were obtained again. One of the samples was selected which still carried some intact 
plasmid; the DNA was digested with: i) EcoRl, ii) Notl, and iii) EcoRllNotl. Analysis of 
the products obtained from each single digestion indicated that the 1.3, the 0.65 and the 
0.5 kb bands corresponded to NotHEcoRl, EcoRR EcoRl, and Notl]Notl fragments, 
respectively. Therefore, the EcoRl and the Notl restriction sites in the insert must be 
distributed as follows:
Notl 
(BamHI) ,
<3 M13 Forward Primer Noll fg sg i )L -------
R
Ampicillin
EcoRl
(BamHI) \  ^  Reverse Primer 
EcoRl
The whole of the remaining DNA was then digested with Notl, in an attempt to 
separate plasmid DNA which carried the (AC)-containing fragment from deleted forms. 
The rationale behind this step was: a) The 0.65 kb EcoRl-EcoRl fragment (0.65 E-E) 
would remain attached to the vector DNA following digestion with Notl; and b) the 3 
possible plasmid DNAs would give rise to different restriction patterns ((A), (B) and
(C)). These are shown below, next to a X/Hindlll marker.
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23 kb --------
9.4 kb --------
6.6 kb --------
4.4 kb --------  --------  --------
2.3 kb _____
2.0 kb --------
0.56 kb --------  --------  --------  --------
(A) (B) (C)
Pattern (A) results from the digestion of plasmid DNA carrying only a 0.5 kb 
insert; pattern (B) is obtained from those molecules carrying both the 1.3 and the 0.5 kb 
fragments; pattern (C) is only obtained following digestion of the intact recombinant 
molecule.
It was possible therefore to recognise the Notl restriction fragment which 
contained the 0.65 E-E insert sequence as a band of approximately 4.9 kb. This band 
was subsequently extracted from the gel and purified with QIAEX El-resin. An aliquot 
(2pi) of this DNA was digested with EcoRl. The presence of the 0.65 E-E fragment was 
thus confirmed. However, the yield of DNA was not high enough to ensure availability 
of the DNA were more than one sequencing run required to characterise the repeat. 
Consequently, the DNA was self-ligated and an aliquot of this DNA used to transform 
electrocompetent TGI cells. A set of ten 3 ml L-broth cultures were prepared and the 
plasmid DNA isolated. The same single plasmid molecule was obtained from all of 
them; digestion of three of these DNAs with EcoRUNotl yielded the expected 1.3 and 
0.65 kb bands. This plasmid was thus stable. Two of the DNAs were prepared for 
sequencing.
Given the position of the cloned 0.65 E-E insert fragment (shown above), 
sequencing was carried out with the M l3 Reverse primer. Two imperfect repeats were 
obtained. A PCR primer set, DlGul3, was designed and the amplification conditions 
optimised.
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5.2.8 Evidence of chimaerism in the PI (DIMcol) clone.
Mapping studies with the newly developed SSLPs revealed that the 
microsatellite markers DlGul3  and D lG ul8, established within the V\(DlMcol) clone, 
mapped to rat chromosome 8 and not to chromosome 1. The location of DlGul4  could 
not be confirmed in any of two mouse x rat somatic cell hybrid panels. However, 
DIMcol was shown to map to chromosome 1, as reported by Gu et al. (1996). This 
work is described in Chapter 6.
Two possible explanations could account for these unexpected results:
a) The PI clone originally gridded and identified as carrying the DIMcol 
fragment was in fact a combination of two PI clones, carrying inserts derived from 
chromosomes 1 and 8, respectively. These two DNAs had thus been simultaneously 
isolated (following growth on solid medium) and used in the shotgun cloning 
experiment.
b) The PI DNA isolated was indeed extracted from a single clone and this clone 
was chimaeric, carrying a fragment of chromosome 1 and a fragment of chromosome 8.
Strong evidence in favour of this second possibility was obtained following 
amplification of PI DNA with the four sets of primers (DIMcol, {Dl}Gul3, 
{Dl}Gul4 and (Dl}Gul8), following transfer of the PI clone(s) to DH10B cells. Four 
different digestion patterns had been observed following Ap«I-digestion of PI DNAs 
extracted from DH10B cells (section 5.2.5.3). Three of these corresponded to clones 
which contained the DIMcol fragment, in contrast to a fourth clone, which did not 
carry this fragment. PCR on each of these DNAs demonstrated that one of the clones 
carried all the four microsatellite loci; a second clone carried only the DIMcol 
sequence; amplification of a third DNA template yielded a strong signal corresponding 
to DIMcol and a very faint band from the (.Dl)Gul4 locus. The DNA which did not 
carry the DIMcol sequence carried both the (Dl)Gul4 and the (Dl)Gul8 fragments, 
but not the (Dl)Gul3 microsatellite [Figure 5-15].
5.2.9 Seauencine of the PI insert ends.
Sequencing of the V{(Scnnlb) DNA insert was not carried out since typing with 
the DlGul6 primer pair had shown this region of the chromosome to be quite distant 
from the agu locus. Prior to the characterisation of V\(DlMcol) as a highly probable
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*
FIGURE 5-15. Evidence of chimaerism in the P\(D1 M c o l )  clone.
Screening of DNAs isolated from various DH10B cultures.
Top half of the uel.
Lanes 1 to 6: PCR products obtained with the DIMcol primer. Lane 1: no DNA 
control; lane 2: PI DNA (PCR )-(a); lane 3: PI DNA (PCR+)-(b); lane 4: PI DNA from 
the second subculture of an M2 (D lM coT) colony; lane 5: PI DNA (PCR')-(a); lane 6: 
rat genomic DNA.
Lanes 7 to 12: PCR products obtained with the (D1 )Gul 8 primer. The order of the DNA 
templates is as before.
Bottom half o f the gel.
Amplification products obtained with the primer sets (D l)G ul3 (lanes 1 to 6) and 
(D1 )Gul4 (lanes 7 to 12). The order o f the templates is as before. Although not clear in 
the figure, a faint PCR signal was observed with (Dl)Gul4 on lane 10 (*). Details are 
given in the text.
The marker used is a 1 kb DNA ladder (M).
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chimaeric clone, both the PI {DIMcol) DNA isolated from NS3529 cells and that 
obtained from the DH10B strain were used as templates in sequencing reactions. Two 
different methods were employed to prepare each of these DNAs:
a) The DNA was isolated from 250 ml cultures following the modified Qiagen ‘Midi’ 
protocol II and subsequently dialysed.
b) The PI DNA was isolated and prepared following the protocol described in 2.3.18.1.
Both PI (DIMcol) DNA samples, each isolated from a different host (i.e. 
NS3529 and DH10B) were prepared following both methods above; each DNA was 
sequenced with the T7 and the SP6 primers.
Sequencing of the DNAs prepared according to the second protocol (b) failed. 
Sequencing of the ¥\{DlMcol) DNA isolated from the NS3529 strain and purified 
through a CsCl gradient resulted in a very poor sequence when using the SP6 primer 
and failed when using the T7 primer. However, good sequences were obtained for each 
of the insert ends with the DNA isolated from the DH10B host which had been prepared 
according to the first protocol (a). It was also observed that the most successful 
sequencing of this PI DNA was achieved when the sample had been freshly prepared; 
older samples failed to give sequences of comparable quality.
The sequences obtained for each end of the PI insert were checked against the 
available database to be confirmed as unique sequences in the genome (i.e. non- 
repetitive) and, if applicable, correlate them to known sequences in rat and/or other 
organisms. The T7-end sequence was then shown to correspond to rat LINE sequences, 
which are highly repetitive. In contrast, the sequence obtained with the SP6 primer 
showed some homology to non-repetitive sequences in the database.
5.3 Discussion.
5.3.1 Comparative mapping.
Comparative mapping of the rat, the mouse, and the human genomes indicates 
that the rat chromosomal region of interest is syntenic to the proximal fragment of 
mouse chromosome 7 and to human chromosome 19q. Increasing numbers of mapped 
loci in each of the corresponding linkage maps (Gu et al., 1996; Ding et al., 1996; 
Brilliant et al., 1996; Ashworth et al., 1995) allow more detailed comparisons of these
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regions (Stubbs et al., 1996). Gene order and distances can then be more accurately 
correlated. Establishment of close homology at high resolution levels can play an 
important role in the identification of disease genes, as it permits the selection of 
‘candidate’ sequences in the area (Eppig and Nadeau, 1995).
5.3.2 Amplification of rat genomic DNA with heterologous mouse primers.
Approximately 30% (7 out of 23) of the mouse PCR primers that were used to 
amplify rat genomic DNA in this project yielded single products. This is in contrast to 
the 12% success rate reported by Kondo et al. (1993). However, a very small number of 
mouse primer sets were used in this work, in comparison to the 166 primer pairs tested 
by Kondo and colleagues. It must also be kept in mind that, given that none of the 
amplified rat products showed differences between any of the parental strains in the 
backcrosses, these were not further analysed. Therefore, these fragments were not 
sequenced; it could be the case that some of these are not the expected rat homologues 
of the mouse SSLPs.
5.3.3 Rat bacteriophage PI library.
The vector pAdlQsacW. was used to construct the library. This vector offers a 
positive selection system for clones carrying an insert. This feature represents a major 
improvement in comparison to its precursor vector, pAdXO (Sternberg, 1990a; 
Sternberg, 1992). First, most of the clones which do not contain an insert are eliminated 
when grown in the presence of sucrose; thus, overgrowth of these clones in detriment of 
those which carry an insert does not normally occur. This permits pooling considerable 
numbers of individual clones when organising the library, without compromising the 
identification of single clones in the pool (Pierce et al., 1992; Sternberg, 1992). Second, 
recombinant pAdlOsacBTL molecules are directly selected following growth in the 
presence of kanamycin and sucrose. In contrast, screening for colonies which are both 
kanamycin-resistant and tetracycline-sensitive has to be carried out in order to identify 
pAdXO recombinant molecules (as the cloning site in the PI vectors maps within the 
tetracyclineR-gene).
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5.3.3.1 Screening o f the PI library.
The library consists of 209 primary pools (550 clones/pool, on average). Most 
primer sets identified at least one positive pool following screening of 50-80 of these. 
The high rate of positive hits agrees with the claim that the library represents greater 
than 2.5 genome equivalents (Southard Smith and MacDonald, 1993).
During screening of these primary pools it was observed that some of the signals 
obtained with some primers were not reproducible. Two main factors were accountable 
for this: a) cell debris interfering with the PCR reaction, as demonstrated by the fact that 
purification of the DNA in the lysates with QIAEX E-resin resulted in consistent, clear 
signals; and b) residual nuclease activity in the sample. This latter was observed in a 
couple of instances when, correlating with a failure in the system to maintain the lysates 
frozen while stored, the particular samples did not give the expected PCR signals, even 
after purification of the DNA. When fresh lysates were prepared and immediately 
treated with QIAEX E, the expected PCR sequences were reproducibly obtained, 
confirming the original signals as true positives. When compared, the only noticeable 
difference between our protocol to prepare the lysates and that presented by Southard 
Smith and MacDonald (1993) was the 10 and 20 minutes employed, respectively, to 
boil the lysates. New lysates were prepared where minimal aliquots of each primary 
pool were removed and resuspended in 100 pi of dHzO, and boiled for 20 minutes; 
thenceforth, clean, reproducible signals were obtained. Subsequent work (carried out by 
Dr. D. Donald and Ms. N. Craig) was based on the screening of large pools of clones 
picked following growth of each primary pool on plates, aiming to ensure the 
representation of each individual clone in the sample. Reproducible strong signals were 
obtained in these studies.
5.3.4 Comparison of PI DNA extracted from two different host strains.
Progress in the manipulation of PI clones was sometimes hindered, either 
because too small amounts of DNA had been isolated or because the quality of the 
sample was not as good as was desirable. A method had been described by Kimmerly 
and colleagues (1994) where PI clones had been transferred to DH10B cells following a 
2-step mating protocol which exploited the F factor transduction and yS-transposition 
events. This group reported that the PI DNA isolated from this new host was of a 
clearly higher quality. The same procedure was thus followed with our PI clones, with
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the same results. PI DNA was isolated from both the NS3529 and the DH10B strains 
and used as template in sequencing reactions with the T7 and the SP6 primers; only the 
DNA extracted from the latter host yielded good quality sequences. Different methods 
were employed to prepare the DNA; although PI (DIMcol) DNA only gave good 
sequences when purified through a CsCl gradient, other PI DNAs have been 
successfully sequenced in the lab following a simple phenol/chloroform extraction or 
PEGgooo precipitation in the presence of MgCl2. Also, a drastic decline in the success of 
the sequencing process was observed as the samples became older, with the freshly 
prepared DNAs always producing the best results. An increase in the amount of PI 
DNA isolated from DH10B cells when compared to that obtained from the NS3529 
strain was also clear, even in those instances where the NS3529 cultures had been 
induced and the DH10B cells had not.
Kimmerly and coworkers have proposed two arguments which could explain the 
superiority of the DNA extracted from DH10B: a) this strain lacks the Cre recombinase 
enzyme, impeding the formation of PI multimers by lox-mediated recombination which 
might not be released as well as PI monomers following cell lysis; and b) DH10B 
carries a mutation in the endA gene which, in its wild-type, encodes an endonuclease.
5.5.5 Identification o f new rat SSLPs.
Radioactively labelled dinucleotide repeats were mainly used to screen for the 
presence of repetitive sequences in the inserts of the isolated PI clones. This type of 
probe was preferentially used, since (AC)n and (AG)„ are the most abundant repeats in 
the rat genome (Beckmann and Weber, 1992). Mononucleotide repeats were not sought 
since, contrary to the reported informativeness of these DNA stretches in mouse (Love 
et al., 1990), analyses on the rat (Serikawa et al., 1992) did not indicate that these 
motifs could be a rich source of informative markers in this species. Moreover, 
detection of strain differences at mononucleotide repeat loci may require resolution at 
the single base pair level. Tri- and tetranucleotide repeat probes were not widely used as 
these markers are less abundant than some dinucleotide repeats.
In agreement with numerous reports (Beckmann and Weber, 1992; Serikawa et 
al., 1992), (AC)n was the most frequently identified motif. Screening of the PI (Scnnlb) 
and the V\(DlMcol) clones with an (AC)i0 probe resulted in the establishment of seven 
new SSLPs [Table 5-1]. The Scnnlb gene maps at approximately 8 cM from Pkc in the
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mouse map. Selection of this and a few other genes (e.g. Grik.5) as reference sequences 
for the isolation of PI clones occurred at the initial stages of this part of the project, at a 
time in which the location of Pkc relative to the agu gene had not yet been established. 
Subsequent positioning of Pkc in our linkage map allowed a further refinement of the 
flgw-containing region, and thus of the selection of “reference” loci to carry on the PI 
library screening with. Therefore, a second set of marker sequences (Pkc, Atpl, Ptgir, 
DIMcol) were used to screen the PI library, in parallel to the on-going analyses of PI 
clones carrying genes from the CEA family.
5.3.6 The PI (DIMcol) clone.
5.3.6.1 Instability o f the PI (DIMcol) clone.
All the attempts to grow the Pl(DlMcol) clone in liquid media resulted in the 
loss of the DIMcol-PCR product. This did not occur when the clone was grown in solid 
medium. Therefore, it seemed that P\(DlMcol) was an unstable clone. Loss of some 
sequence(s) in the genomic insert must confer some advantage to the growth of the 
clone, with the new PI variant overgrowing the original clone.
The subsequent observation that 2 of the SSLPs isolated from the Pl(DlMcol) 
clone mapped to rat chromosome 8 raised the possibility that the bacterial colony 
originally identified as containing this PI consisted of 2 different clones, carrying 
chromosome 1 and chromosome 8 fragments, respectively. Were this the case, loss of 
the DIMcol product in liquid cultures could result from the bacteria containing the PI 
which carried a chromosome 8 fragment overgrowing the culture. Growth on solid 
medium would in turn lead to the simultaneous isolation of both PI clones. However, 
this possibility was rejected, as probing of Ap«I-digests of PI DNA isolated from 
various (DlMcol+)-DHlOB cultures demonstrated differences in the restriction 
fragment which carried the SSLP under study. This could only result from instability in 
the P\{DlMcol) clone.
No loss of the PCR product was observed when DH10B cells carrying the 
DIMcol sequence were grown in liquid media. It thus seemed that the PI was stable in 
this ere' strain. However, when DNA was isolated from several DH10B colonies and 
digested with Kpnl, three different patterns were obtained. On the other hand, 
consecutive culturing of one of the colonies did not result in any change in the digestion 
pattern. Therefore, it could be hypothesized that the PI {DIMcol) clone is indeed stable
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once inside DH10B hosts, and that the differences observed correspond to different 
mating events of individual DHlOBs to single NS3529 cells carrying each a PI 
molecule which may or may have not undergone changes during the mating steps. The 
observation that PI DNA which had lost the DIMcol marker prior to mating yielded a 
unique digestion pattern (with each of EcoRl and Kpnl) when extracted from several 
DH10B colonies could indicate that complete stability of the PI clone is achieved 
following the changes undergone by these particular PI molecules, independently from 
the host strain.
5.3.6.2 Characterisation o f PI (DIMcol) as a chimaeric clone.
At least 2 of the 3 SSLPs isolated from PI DNA which carried the DIMcol 
sequence were shown to map to rat chromosome 8 ({Dl}Gul3 and {Dl}Gul8). These 
results could be explained by either the simultaneous isolation of DNA from 2 co­
existing clones, or by the occurrence of chimaerism in the ¥\(DlM col) clone. Although 
the first possibility can explain the loss of the DIMcol-PCR product in liquid cultures 
(5.3.6.1), several observations have been made which strongly argue against this 
hypothesis, in favour of the second explanation.
(a) A small number of restriction fragments were observed on low agarose gels 
following single Kpnl, BglU and BamHI digestions of PI DNA which carried the 
DIMcol sequence. Moreover, summing of the estimated fragment lengths did not seem 
to indicate the presence of more than one PI clone.
(b) Assuming that the (DlMcol )-DNA correlates to the PI carrying a fragment 
of chromosome 8, and that the (DlMcol+)-DNA was extracted from a mixed population 
of this latter and the real PI {DIMcol) clone, presence of the PI clone that carries a 
chromosome 8 fragment does not result in any clear difference between the BamHI or 
the BglU. digestion patterns of these two DNAs.
(c) DIMcol-containing DNA was transferred into DH10B bacteria through the 
formation of an intermediate F* episome. Small modifications affecting culture 
volumes and growth times were added to the original protocol described by Kimmerly 
and colleagues (1994). Individual DH10B colonies were picked following transfer of the 
PI DNA and tested for the presence of the DIMcol sequence. All of them were 
positive. Accepting the co-existence of two PI clones in the original NS3529 bacterial 
colony, the results indicate that only ¥\(DlM col) clones or heterologous colonies
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consisting, again, of both PI clones, were obtained following transfer of the PI DNA. In 
contrast, colonies formed by PI clones which only carried the chromosome 8 fragment 
were not observed. This seems unlikely, given the hypothesized faster growth of this 
latter clone in comparison to ¥\(DlMcol).
(d) Analyses of the different PI DNAs with all the DIMcol, (Dl)Gul4, 
(Dl)Gul3 and (Dl)Gul8 primer sets showed that the (DlMcol )-DNA also lacked the 
(Dl)Gul3 sequence, whereas the other three types of (DlMcol+)-DNA represented a 
spectrum which ranged from the presence of all four SSLPs to the presence of DIMcol, 
exclusively. The presence of SSLPs derived from different chromosomes in the DNA 
isolated from DH10B cells is the strongest evidence against the presence of two 
different PI clones in the original bacterial colony, as it is extremely unlikely that these 
two clones would still co-exist in DH10B colonies following transfer of PI DNA 
through two separate mating steps.
The observations made on the V\{DlMcol) clone are unexpected, since most 
studies present PI vectors as a very stable cloning system (Albertsen et al., 1994; Nehls 
et al., 1995; Harsman et al., 1995), even when carrying repetitive sequences (Smoller et 
al., 1991); also, reports on chimaeric PI molecules are rarely encountered. Nehls and 
colleagues (1995) observed that YAC instability often relates to the nature of the DNA 
fragment being cloned. This could be the case with the Vl(DlMcol) clone. Chimaerism 
and instability could result from these regions in chromosomes 1 and 8 being highly 
unstable. The maintenance of different combinations of SSLPs in the PI DNA as well 
as the difficulties to maintain the (D7)Gw73-containing fragment in standard pBluescript 
IIKS+ subclones agree with this explanation.
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6.1 Introduction.
Allelic differences between the parental rat strains in the backcrosses were sought 
at each of the newly established SSLP loci. Informative markers were subsequently 
mapped by typing backcross progeny, and added to the previous genetic map. Typing of 
F344 backcross animals at the DIGulS locus did not show linkage of this marker to the 
agu gene. Screening of somatic cell hybrid clones demonstrated that at least two of the 
microsatellites established within the ¥\(DlMcol) clone, including DlGul3, mapped 
instead to rat chromosome 8.
In parallel to this work, all the backcross progeny were typed with the closer 
flanking markers available at the time. Subsequent mapping of internal markers was 
carried out by only typing those animals that carried a crossover between any of the 
flanking loci and agu. This considerably reduced the number of animals to be typed, and 
allowed the screening of much larger numbers of backcross offspring. This approach 
ultimately led to the mapping of the R158 microsatellite locus. This marker was found 
to map at less than 0.5 cM from agu.
6.2 Results.
6.2.1 Search for strain differences at the newly identified SSLP loci.
F344, AS/AGU and BN genomic DNAs were used as templates in PCR reactions 
with each of the new SSLP primers [Table 6-1]. When run on 4% MetaPhor agarose 
gels it was observed that PCR on F344 DNA with the DlGul6 primer set resulted in 
two products (of approximately 205 and 220 bp), the smallest being the same size as 
that obtained when amplifying AS/AGU and BN DNAs. A third band, of approximately 
370 bp in length, was also obtained from the AS/AGU template. [Figure 6-1]. Although 
weaker than the ca. 205 bp band, it was clear and, as confirmed later, it always 
accompanied the smaller AS/AGU product. Therefore, both this larger AS/AGU 
fragment and the ca. 220 bp F344 product were considered to result from the 
amplification of specific sequences present in the corresponding genomic DNAs, and 
not as PCR artifacts.
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SSLP locus Approximate PCR 
product size
Annealing 
temperature ((Q b
Allele differences
D IG ul7 203 bp 56 AS/AGU=BN=F344
DlGul5 215 bp 54 AS/AGU=BN=F344(I)<F344(fi)c
DlGul9 239 bp — —
D lG ul6 208 bp 66 AS/AGU=BN=F344(I)<F344(II)C
D0Gul4a 
CDlGul4)
176 bp 60 AS/AGU=BN=F344.
D8Gula 
(.DlGul3)
171 bp 60 AS/AGU=BN<F344
D8GuT
(DIG11I 8)
230 bp 54 AS/AGU=BN=F344
TABLE 6-1. Allelic differences at newly developed SSLP loci.
a The microsatellites DlGul3  and D lG ul8 were subsequently shown to map to rat 
chromosome 8 and were renamed D8Gul and D8Gu2, respectively. Chromosomal 
localization of the marker DlGul4 could not be established and is currently called 
D0Gul4.
b All the PCR reactions were carried out for 25 cycles, in the presence of 1 mM 
MgCl2 . The primer set DlGul9 was not tested.
c Two PCR products [(I) and (II)] were obtained from the amplification of F344 DNA 
template with each of the primer pairs DlGul5 and DlGul6.
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M 1 2 3 4 M
400 bp 
300 bp
200 bp
100 bp
FIGURE 6-1. Resolution of the amplification products obtained with the primer set 
" D lG ul6 .
Resolution o f the PCR products obtained from amplifying F344 (lane 1), AS/AGU (lane 
2), BN (lane 3), and (AS/AGU x BN) FI (lane 4) DNA templates with the primer set 
D lG ul6 . A 100 bp DNA ladder was used as the size standard (M).
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Linkage of the larger F344 product to the agu gene was assessed by typing a set of 
animals from the [AS/AGU x (AS/AGU x F344) FI] cross [Figure 6-2] and then 
searching for a correlation between the presence of this band and the display of a normal 
phenotype and vice versa. A  %2 test showed this correlation to be in fact highly 
significant (%2 (df=3)= 106.4; p<0.001), pointing at D lG ul6 as a new polymorphic 
marker between the F344 and the AS/AGU strains.
When the SSLP loci DlGul3 , DlGul4, DIGulS, DlGul7  and D lG ul8 were 
analysed on 4% MetaPhor agarose gels none of them was found to be detectably 
polymorphic for any of the three rat strains under study. When resolved on 6% 
polyacrylamide gels, however, DlGul3 and DlGul5  were shown to be polymorphic 
between the F344 and the AS/AGU strains. The DlGul9  locus was not analysed.
6.2.2 Mapping o f the new informative SSLPs.
One hundred and sixty-two [AS/AGU x (AS/AGU x F344) FI] animals were typed 
with the DlGul6 primer, the results indicating an approximate distance of 9.3 ± 2.3 cM 
to the agu locus, distal to DlCep4. Twenty-nine [AS/AGU x (AS/AGU x F344) FI] 
animals were typed with the DlGul5 primer set [Figure 6-3]. Clear linkage to the agu 
locus was observed (x2 (df=3)= 27.41; p<0.001). A recombination frequency of 7% ± 
4.7% was obtained. Another 9 litters where a crossover had been detected between agu 
and D lG ul6 were also typed with this primer, yielding identical results to those 
observed with the DlGul6 primer pair. These observations support the expected 
mapping of DlGul5  very close to DlGul6.
Thirty-six [AS/AGU x (AS/AGU x F344) FI] animals were typed with the primer 
set DlGul3. Contrary to the expected result, the corresponding locus did not show 
linkage to the agu gene (x2 (df=3)= 1.5; 0.5<p<0.9). The location of DlGul3  was 
subsequently studied by screening a panel of mouse x rat somatic cell hybrids (Szpirer 
et al., 1984). DlGul3 was then demonstrated to map to rat chromosome 8 [Figure 6-4], 
therefore explaining the lack of linkage to agu. The DlGul3 marker had been isolated 
from a PI clone which carried the DIMcol microsatellite (Chapter 5). This latter had 
been mapped by Gu and colleagues (1996) to the region of interest in rat chromosome 1. 
Consequently, the location of DIMcol was assessed with the somatic cell hybrid panel. 
The results obtained agreed with those reported by Gu et al. (1996), confirming that 
DIMcol maps to chromosome 1 in the rat. The same hybrid clones were also used
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MFA M
FIGURE 6-2. Typing of [AS/AGU x (AS/AGU x F344) FU offspring with the primer 
set D lG ul6.
Resolution on a 4% agarose gel of the PCR products obtained from the amplification of 
F344 (F), AS/AGU (A), and [AS/AGU x (AS/AGU x F344) FI] DNA templates with 
D lG ul6 . A 1 kb DNA ladder was used as the molecular weight standard (M).
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298 bp
220 bp
201 bp
FIGURE 6-3. Resolution of D lG ul5  PCR products on a 6% polyacrylamide gel.
The products obtained from amplification of F344 (F), AS/AGU (A), and [AS/AGU x 
(AS/AGU x F344) FI] (lanes 1-25) DNA templates with the primer set DlGul5 were 
run on 6% polyacrylamide gels. The DIGu 15-forward primer was radioactively labelled 
prior to PCR amplification.
A radioactively labelled 1 kb DNA ladder was used as the size standard (M).
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M 1 2 3 4 5 6 7 8 9 1011 12 13 14 151 617  M
FIGURE 6-4. Screening of a panel of mouse x rat somatic cell hybrids with the primer 
set (D l)G ul3.
(D l)G ul3  was assigned to rat chromosome 8 following screening of a panel of mouse x 
rat somatic cell hybrid clones. The order of the DNA templates was as follows:
Lane 1: no DNA control.
Lane 2: empty lane.
Lane 3: BWTG3 mouse DNA.
Lane 4: Sprague-Dawley rat DNA.
Lane 5: Empty lane.
Lane 6: Clone LB251.
Lane 7: Clone LB600.
Lane 8: Clone BS140hl.
Lane 9: Clone BS511.
Lane 10: Clone LB510.6.
Lane 11: Clone LB330.
Lane 12: Clone LB860.
Lane 13: Clone LB780.
Lane 14: Clone LB 1040.
Lane 15: Clone LB1040.TG3.
Lane 16: Clone LB780.6.
Lane 17: Clone LB330.TG3.
A 1 kb DNA ladder was used as the size marker (M).
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to map the other two microsatellites which had been isolated from the same PI clone, 
DlGul4  and D lG ul8. D lG ul8 was shown to map to rat chromosome 8, whereas 
DlGul4  could not be mapped, as the rat PCR product could not be distinguished from 
that of the mouse. These data are presented in Table 6-2.
A third informative marker, DIGulO, was identified in the agu region. This SSLP 
was isolated by Ms. N. Craig from a PI clone carrying the Grik5 gene. Typing of 203 
[AS/AGU x (AS/AGU x F344) FI] animals by Ms. N. Craig showed that this locus 
mapped at 7 ± 1.8 cM from the agu locus, distal to DlCep4.
6.2.3 Mapping o f the R158 microsatellite locus.
The position of the rat R158 microsatellite marker in relation to agu could not be 
defined following the typing of 264 backcross progeny, as no recombinants were 
identified. Therefore, unambiguous mapping of both genes demanded the typing of a 
larger set of animals. Moreover, analyses with this primer set required the running of 
radiolabelled PCR products on polyacrylamide gels. This method is more costly and 
time-consuming than the agarose gel system being used during most of this work. In 
order to increase the efficiency of the screening process at the R158 locus as well as at 
any other new microsatellite marker close to agu, a panel was formed with the 
backcross animals where a recombination event had taken place between agu and any of 
the four closest flanking markers, DlMitl and DlMgh7, mapped on the [AS/AGU x 
(AS/AGU x BN) FI] cross, and DlCep4 and DIGulO, mapped on the [AS/AGU x 
(AS/AGU x F344) FI] cross. Analysis with these markers was carried out on standard 
4% agarose gels. Furthermore, a difference in the sizes of the DlCep4 and the DIGulO 
PCR products allowed the multiplexing of both reactions, greatly improving the 
efficiency of these tests [Figure 6-5]. In addition to the typings already described above 
and in Chapter 4, a larger set of DNAs were prepared (by Mrs. M. Gardiner and myself) 
and I carried on with the screening for recombinants at either of the aforementioned 
loci. Altogether, a total of 400 BN backcross animals and over 500 F344 backcross 
progeny were typed. In parallel to this work, a third backcross was set up, [(AS/AGU x 
F344) FI x AS/AGU). Nearly 400 offspring were typed at both DlCep4 and DIGulO, 
in search for possible differences in the recombination frequencies in the (AS/AGU x 
F344) FI males and the (AS/AGU x F344) FI females. In contrast to a recombination 
frequency of 4.9% ± 0.96% in the interval DlCep4 - agu in FI females, the
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TABLE 6-2. Assignment of (Dl)GulS and (Dl)Gul8 to rat chromosome 8. 
Confirmation of the location of DIMcol on rat chromosome 1.
Nine, twelve, and thirteen rat x mouse somatic cell hybrid clones were screened with the 
primer sets DIMcol, (Dl)Gul3, and (Dl)Gul8, respectively. The results indicated that the 
two latter loci mapped to rat chromosome 8. DIMcol was shown to map to rat 
chromosome 1, in agreement with the data published by Gu and colleagues (1996).
a Independent hybrid clones are those derived from distinct fusion events. Non-independent 
clones are indicated by asterisks.
b A + or a - indicates the presence or absence of the PCR product, respectively. 
c A + indicates that the rat chromosome is present in more than 55% of the metaphases. A 
(+) indicates that the chromosome is present in 25-55% of the metaphases; (-) indicates that 
the chromosome is present in less than 25% of the metaphases (d in these two latter cases, 
the hybrid in question was not taken into account to establish the number of discordancies 
for that particular chromosome). A - indicates absence of the rat chromosome.
NT: The clone was not tested with that particular primer set.
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FA M
DlGulO
R191
FIGURE 6-5. Resolution of amplification products obtained from multiplexed 
R191/DlGulO-PCR reactions.
PCR reactions were carried out at 55°C for 27 cycles, in the presence of ImM MgCb 
and in a final volume of 15 pi. Both primer sets were added in each reaction. The 
amplification products were resolved on standard 4% agarose gels.
A: Product from the amplification of AS/AGU DNA template.
F: Product from the amplification of F344 DNA template.
M: 1 kb DNA ladder marker.
Remaining lanes: PCR products obtained from the amplification of DNA extracted from 
[AS/AGU x (AS/AGU x F344) FI] offspring.
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recombination rate observed in this interval in FI males was 2.5% ± 0.8%. 
Recombination frequencies in the interval agu -DIGulO were similar in both sexes (i.e. 
6.9% ± 1.1% in the FI female, and 7.2% ± 1.3% in the FI male).
Typing of recombinant animals with the R158 primer (by Ms. N. Craig) showed 
that this microsatellite locus maps at less than 0.5 cM from agu and distal to DIMitl.
6.3 Discussion.
6.3.1 Mapping o f new rat SSLPs.
The SSLP loci DlGul5  and D lG ul6 showed differences between the AS/AGU 
and the F344 strains of rat. Amplification with the primer pair DlGul6 yielded 2 
specific bands with both the F344 and the AS/AGU DNAs. One of the products was of 
the same size in both strains, whereas the size of the larger fragments differed. Mapping 
of these strain-specific larger bands could not be carried out through the screening of 
somatic cell hybrid clones, as the parental rat strain used in their construction (Sprague- 
Dawley) only presented the lower band, common to all three strains, AS/AGU, BN, and 
F344. Two amplification products were also obtained with the DlGul5 primer on F344 
DNA. The lower band was of the same size as the product amplified from the AS/AGU 
and the BN DNAs. The larger fragment was specific to the F344 strain.
These observations could indicate the presence of residual heterozygosity at the 
DlGul5  and the D lG ul6 loci, as previously observed in a few other cases (Chapter 3). 
On the other hand, the primer sets could be amplifying other loci in the genome which 
bear, specifically in the F344 strain, a very high homology to the sequence amplified in 
common in all the strains. These sequences can be, for example, pseudogenes or genes 
belonging to the same family, which have diverged to a lesser extent in the F344 strain 
than in the others. This explanation could also apply to the larger AS/AGU product 
obtained with the DlGul6 primer set.
A clear correlation of the F344-specific larger band and the display of a normal 
phenotype was observed when typing [AS/AGU x (AS/AGU x F344) FI] litters with 
each of the primer sets DlGul5 and DlGul6 (i.e. 76 of 82 normal animals typed 
carried 2 D lG ul6 alleles, and 18 of the 18 normal litters typed with the DlGul5 primer 
carried 2 alleles at this SSLP locus). This eliminates the possibility that any of these two
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loci is not linked to the agu gene. The same relationship was observed between presence 
of a single allele at each of these SSLP loci and the display of an affected phenotype. 
This strongly argues against the possibility that the different F344 animals used in the 
crosses to AS/AGU carried a different number of SSLP alleles (either 1 or 2) at 
DlGul5  or D lG ul6. Furthermore, comparison of the expected frequency of each 
genotype, assuming residual heterozygosity at either of these loci, with the observed 
data, clearly demonstrated that this was not the case. Residual heterozygosity at either 
DlGul5  or D lG ul6 must result, in the absence of recombination between the SSLP 
and the agu loci, in a ratio of animals exhibiting a normal phenotype and carrying 2 
alleles at the SSLP locus (agu+ DlGul5(16)T/agw DlGul5(16)&), to animals exhibiting 
an affected phenotype and carrying 1 allele at the SSLP locus (agu DlGul5(16)*/agu 
DlGul5(16)% of 1:2. In disagreement with this expectation, the data obtained indicate 
that both genotypes are found at approximately the same frequency. In addition, animals 
which carry a single SSLP allele and exhibit a normal phenotype (agu+ DlGul5*/agu' 
DlGul5a) should be observed at the same frequency than animals which exhibit a 
normal phenotype and carry two SSLP alleles (agu+ DlGul5(16)r/agu DlGul5(16)% 
and this is not the case. These results and the similar distances estimated between 
DlGul5/DlGul6 and the agu loci (~7-9 cM), and the 8 cM distance reported between 
the Scnnlb and the Pkc genes in mouse (Brilliant et al., 1996) strongly support the 
validity of using the DlGul5 and the D lG ul6 F344-specific alleles as informative 
markers in studies of the segregation of loci in the agw-containing region. DlGul5, 
D lG ul6, and a third microsatellite locus, DIGulO, were added to our linkage map of 
rat chromosome 1, all distal to DlCep4. The final map is shown in Chapter 8.
Three SSLPs were isolated from a PI clone carrying the DIMcol sequence. 
However, two of these, DlGul3  and DlG ul8, were shown to map to rat chromosome 
8, following screening of a rat x mouse somatic cell hybrid panel (Szpirer et al., 1984). 
Accordingly, these loci have been renamed D8Gul and D8Gu2, respectively. The third 
one, DlGul4, could not be mapped with this panel, as the rat product could not be 
distinguished from the mouse product. The same problem was encountered when the 
parental rat and mouse strains corresponding to a different panel of somatic cell hybrids 
were tested. Mapping of this marker could be attempted by probing blots of digested 
genomic DNA from the rat and the mouse parental strains and from the panel of
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somatic cell hybrid clones with the (Dl)Gul4 primers. Meantime, this locus is referred 
to as D0Gul4.
6.3.2 Mapping of closer markers.
Mapping of markers such as R158, located very proximal to agu, require the typing 
of very large numbers of animals, as increasingly smaller distances are associated to a 
reduction in the frequency of crossovers. An approach was followed where the 
backcross progeny were screened for the presence of recombination between agu and 
the closer flanking markers available. Given the proximity of these loci to agu, the 
failure to observe recombination in these intervals was considered as a strong indication 
that no crossovers had indeed occurred in the region. The alternative explanation, that 
this apparent lack of crossover events may result from more than one recombination 
event taking place in any of the intervals, was considered highly unlikely.
Two reciprocal F344 backcrosses were designed in order to study the frequency of 
recombination in the FI male and in the FI female, respectively. A considerable 
reduction in the recombination frequency was observed in the interval DlCep4 - agu in 
FI males. This is in agreement with the numerous reports of an overall greater genetic 
length of the homogametic sex in various species (Haldane, 1922; Weissenbach et al., 
1992; Donis-Keller et al., 1987). No marked differences were observed in the agu - 
DIGulO segment. Non-uniformity of the differences in recombination between the 
male and the female genome has been previously described (Donis-Keller et al., 1987). 
This heterogeneity suggests the existence of sex-specific points for recombination in the 
genomes.
Typing of the animals which carried a crossover in any of the intervals allowed a 
more efficient screening for the presence of recombination between agu and yet closer 
markers. In this way, approximately 200 animals, of a total of nearly 1300, were 
selected and typed with the primer set R158. This microsatellite marker was now shown 
to be separable from the agu mutation, and was mapped at less than 0.5 cM from the 
latter. This result allowed the initiation of physical mapping of the agu region, which is 
presently being carried out.
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7.1 Introduction.
A region containing the agu gene was initially defined, flanked by the loci 
DlM itl and DlMgh7/Kal (Chapter 4). Markers mapping within this part of rat 
chromosome 1 were optimised and tested for allelic differences between AS/AGU and 
either of the selected reference strains, BN and F344. One of these markers, DlM ghl8 
yielded then an unexpected result. This locus, mapping within the cystatin S gene (Cox 
and Shaw, 1992), demonstrated a strain difference between F344 and the mutant strain. 
According to the map released by Jacob and coworkers (1995) this SSLP mapped 
between the loci DlM itl and Cype, close to DIMghS. However, when the 
corresponding primer set CYSS was used to type [AS/AGU x (AS/AGU x F344) FI] 
offspring, no linkage of DlMghl8 to the agu gene was detected. No linkage to DlMco2 
or DlCep4 was identified either. These observations resulted in the location of 
DlM ghl8 on the rat genome being called into question. This was firstly investigated by 
screening a panel of mouse x rat hepatocyte hybrids (Szpirer et al., 1980).
Somatic cell hybrids have been extensively used in the establishment of genetic 
maps. This system was initially applied to the mapping of human and mouse loci 
(Minna and Coon, 1974; Kozak et al., 1975). Subsequently this resource was made 
available for the mapping of rat loci. It was Weiss and Ephrussi who, in 1966, observed 
a preferential loss of rat chromosomes in rat x mouse somatic cell hybrids. Possible 
explanations for this phenomenon are differences in the replication times of the 
chromosomes in each species or adquisition of selective advantages by the clones where 
loss of rat chromosomes occurs.
Mouse x rat somatic cell hybrids were isolated by Szpirer and colleagues (1980) 
following fusion of mouse hepatoma cells and adult rat hepatocytes. The hybrid clones 
showed the expected random segregation of the rat chromosomes, thus being an 
excellent material to locate rat loci on their corresponding chromosome. The hybrids 
were subjected to detailed cytogenetic analyses (Szpirer et al., 1984; Szpirer et al., 
1992). Presence or absence of each particular rat chromosome was firstly identified on 
high-quality G-banded metaphase spreads (Szpirer et al., 1984). Unambiguous 
identification of rat chromosomes X, 1, 2, 3, 4, 7, 9, 11, 12, 13, 14 and 15 was readily 
achieved in most cases. Clear identification of a few other chromosomes was more 
difficult due to similarities to each other or to mouse chromosomes (e.g. rat 
chromosome 8, which is very similar to mouse chromosomes 9 and 13). Further
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analyses, which included some small modifications to the fixation procedures, allowed a 
more accurate identification of the chromosomal constitution of the hybrids (Szpirer et 
al., 1992). Two kinds of clones were obtained which contained either a single or a 
double set of mouse chromosomes. Both types segregated rat chromosomes and 
normally retained from 4 to 20 of these. In general, a larger number of mouse 
chromosomes correlated to decreased numbers of rat hepatocyte chromosomes. 
Observations by Weiss and Ephrussis (1966) seemed to indicate that the genomes of the 
two parental species are both active in the hybrid clones. On this basis, Szpirer and 
colleagues employed BWTG3, a mouse hepatoma cell line which is deficient in the 
enzyme hypoxanthine phosphoribosyltransferase (HPRT), to construct the hybrid panel. 
Selection of the clones was carried out in DHAT selective medium (containing 
hypoxanthine, aminopterin and thymidine). Therefore, the rat gene coding for this 
enzyme must be retained for the survival of the cells in such medium. This correlated 
with the presence of the rat X chromosome in practically all the clones, in agreement 
with observations in other mammals, where HPRT seems to map to this chromosome. 
No other selection was applied, and the rat autosomes which were retained varied 
among the different hybrids.
Numerous mapping studies using this and other panels of mouse x rat somatic 
cell hybrids have proved this system to be very suitable for mapping loci in the rat 
(Yoshida, 1978; Szpirer et al., 1984; Szpirer et al., 1992; Szpirer et al., 1984; Levan et 
al., 1991; Serikawa et al., 1992). This was once again demonstrated in this work. 
Correlation of the rat chromosome constitution of each of the clones with the presence 
or absence of the DlM ghl8 PCR product showed that, in fact, this locus did not map to 
rat chromosome 1. This result was consistent with previous observations when attempts 
to detect linkage of this SSLP to the agu gene and other markers in the region had 
failed. Confirmation of this result as well as a more precise location of DlM ghl8 on the 
rat genetic map was achieved through linkage analysis studies.
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7.2 Results.
7.2.1 Strain differences at the D lM ghl8 locus. Typing o f [AS/AGU x  (AS/AGU x  
F344) F I] offspring.
As mentioned in Chapter 4 (section 4.2.2), allelic differences were observed at 
the DlM ghl8 locus between the AS/AGU and the F344 strains of rat. Typing of 
backcross offspring was carried out as previously (i.e. about 100 ng of DNA was used 
as template in PCR reactions run at the conditions determined as optimal; the 
amplification products were then run on 4% MetaPhor gels).
The primer pair CYSS (locus DlMghl8) was used to type 92 [AS/AGU x 
(AS/AGU x F344) FI] animals [Figure 7-1]. No linkage of the DlM ghl8 locus to agu 
was detected, both exhibiting independent segregation in the offspring (x2 (df=3)= 1.13, 
0.9>p>0.75). Lack of linkage to DlCep4 was also demonstrated, following analysis of 
91 litters with the primers CYSS and R191 (locus DlCep4), (x2 (df=3)= 0.82, 
0.975>p>0.9). Similar results were obtained when typing 53 animals at both loci 
D lM ghl8 and DlMco2 (%2 (df=3)= 7, 0.1>p>0.05).
Prior to these results it had been observed that the approximate sizes of the PCR 
products obtained with the F344 and the BN DNA templates were 110 and 135 bp, 
respectively [Figure 7-2]. This was in disagreement with the data presented by Jacob et 
al. (1995), where these products had been assigned sizes of 133 and 111 bp respectively.
7.2.2 Cloning o f  the D lM ghl8 PCR product. Sequence confirmation.
In order to confirm that no mistakes had been made during the synthesis of the 
primer set CYSS and that the discrepancies observed in relation to the original data 
were not the result of a variation in the primer sequences, the PCR product obtained 
from the F344 template was cloned into a pDT Blue vector (Chapter 2; section 2.3.16). 
Part of the ligation product was used to transform electrocompetent TGI cells and these 
plated on medium containing 100 pg.ml'1 ampicillin as well as the indicators X-Gal and 
IPTG; the plates were incubated at 37°C overnight. The yield of PCR product was quite 
low, and only a few colonies grew on the plates; most of these were white. Plasmid 
DNA was isolated from three cultures seeded with single white colonies and the 
presence of the PCR insert confirmed by amplification of 1 pi of each DNA sample
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FIGURE 7-1. Typing of f AS/AGU x (AS/AGU x F344) F ll progeny with the primer 
" pair CYSS.
Two examples of resolution of D lM ghl8  PCR products on 4% MetaPhor gels. The 
DNA templates correspond to F344 (F), AS/AGU (A), and [AS/AGU x (AS/AGU x 
F344) FI] offspring. A 1 kb DNA ladder (M) was used as the size standard.
M P B A F FI M
FIGURE 7-2. Strain distribution pattern of D lM ghl8  alleles.
Resolution on a 4% MetaPhor gel of the PCR products obtained following 
amplification o f PVG (P), BN (B), AS/AGU (A), F344 (F), and (AS/AGU x F344) FI 
(FI) DNA templates with the primer set CYSS. A 1 kb DNA ladder (M) was used as the 
molecular weight standard.
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with the primer set CYSS. This approach was an alternative to the analysis of the 
restriction pattern obtained following double digestion with, for example, the 
endonucleases Hindlll and EcoiRl, located at each side of the cloning site, and therefore 
useful to extract the insert from the pDT vector. The three DNAs isolated yielded 
amplification products of the right size (resolved in 4% MetaPhor agarose gels); no 
product was obtained from either a “no template” reaction or from a PCR reaction with 
pDT Blue DNA as the template.
Two of these three DNA samples were sequenced with the -21 M l3 Forward 
primer and a T7 sequencing primer (Chapter 2; section 2.3.18.2). This allowed the 
confirmation of the PCR primer sequences as those reported to amplify the DlM ghl8 
locus. A (GT)24 motif interrupted twice by single (CT) and (TT) units constituted, 
together with the primer sequences, most part of the insert, with the CYSS-L primer 
already running into the (GT) stretch. The PCR product was found to consist of 115 bp; 
a BLAST search and direct comparison of both sequences [Figure 7-3] demonstrated 
the product to be identical to a fragment of the rat cystatin S (Cys S) gene (Cox and 
Shaw, 1992). These results thus confirmed the previous observations (i.e. lack of 
linkage to the agu gene; allele in the F344 strain of a smaller size than that in BN and 
AS/AGU rats) to indeed correspond to the DlM ghl8 locus.
7.2.3 Mapping o f the DlMghl8 locus.
7.2.3.1 Screening o f  somatic cell hybrid clones.
The next step towards finding a possible interpretation of the data which had 
been obtained was to confirm the location of DlM ghl8 on the rat map. This was done 
by screening a panel of mouse x rat somatic cell hybrids (Szpirer et a l, 1980) for the 
presence of the DlM ghl8 locus, via PCR. Prior to screening, PCRs were carried out on 
both the mouse (BWTG3) and the rat (Sprague-Dawley) DNA templates to check that 
these yielded products of a different size. This was required to ensure that the rat signal 
could be unambiguously identified. No product was obtained with the mouse DNA 
template, presenting the panel of somatic cell hybrids as a valid assay to map the locus 
to its corresponding chromosome.
Fourteen hybrid clones were screened with the primer set CYSS [Figure 7-4]. 
Comparison of the segregation pattern of the different rat chromosomes with the 
presence or absence of the rat-specific PCR product in each clone demonstrated a
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FIGURE 7-3. Sequence confirmation of the D lM zhl8 PCR product with the rat Cvs S 
gene.
The PCR product obtained following amplification of F344 DNA template with the 
primer set CYSS was cloned into a pDT Blue vector and sequenced with the -21 Ml 3 
forward primer and a T7 primer. The alignment of the sequence obtained with the T7 
primer (bottom row) and a fragment of the rat Cys S gene (top row) is shown above. 
The sequences of the CYSS forward and reverse primers are underlined. The vector 
sequence which is complementary to the -21 M l3 forward primer is indicated in bold.
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FIGURE 7-4. Screening of rat x mouse somatic cell hybrid clones with the primer set 
" CYSS.
Amplification products obtained with the primer CYSS on DNA from BWTG3 mouse 
(lane 1), Sprague-Dawley rat (lane 2), and rat x mouse somatic cell hybrid clones. The 
products were run on a 1% agarose gel. A 1 kb DNA ladder (M) was used as the size 
standard.
Hybrid clones: LB251 (lane 3); LB600 (lane 4); LB780.8 (lane 5); LB1040.TG1 (lane
6); LB 210.1 (lane 7); LB330 (lane 8); LB780 (lane 9); LB860 (lane 10); LB780.6 (lane 
11); LB510.6 (lane 12).
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perfect correlation of the presence of the amplification product with the maintenance of 
rat chromosome 3 in the hybrid clones, and vice versa [Table 7-1]. Different numbers of 
discordant clones were found for each of the other rat chromosomes, including 
chromosome 1. Thus, contrary to the published location of DlM ghl8 on the latter, the 
data indicated that this microsatellite mapped to rat chromosome 3 (Duran Alonso et al., 
1997).
7.2.3.2 Linkage analysis.
Further mapping of the (Dl)Mghl8 locus was carried out by investigating 
linkage to other markers on chromosome 3 which were also informative for the 
[AS/AGU x (AS/AGU x F344) FI] cross. Only were 2 of these found among all the 
optimised SSLPs in the panel (Chapter 3): D3Mit4 (primer set R593; Jacob et a l , 1995) 
and R69 (locus Scn2a; Serikawa et al., 1992). Sixty-four offspring were typed in 
common with the 3 primer sets. A clear linkage was observed between (Dl)Mghl8 and 
D3Mit4 (%2 (df=3)=46.9, p<0.001). Linkage of the former to Scn2a was not significant 
(X2 (df=3)= 5.375, 0.5>p>0.1). Three point cross analysis indicated the order of the loci 
to be (Dl)Mghl8 - D3Mit4 - Scn2a (Duran Alonso et al., 1997). An additional number 
of animals had been typed for the individual adjacent pairs of loci. A total of 77 
offspring were analysed at both the (Dl)Mghl8 and the D3Mit4 loci; sixty-five animals 
were typed in common at the D3Mit4 and the Scn2a loci. The distance between the first 
two markers was estimated as 10.4 ± 3.5 cM and that between D3Mit4 and Scn2a as
41.5 + 6.1 cM. These data translate into the following linkage map [Figure 7-5]:
FIGURE 7-5. Order o f the loci (D l)M sh l8 . 
D3Mit4 and Scn2a on rat chromosome 3.
Recombination frequencies are shown to the 
left o f the chromosome. The 95% lower and 
upper confidence limits are indicated in 
parentheses.
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7.3 Discussion.
An informative SSLP locus was found, DlMghl8, which putatively mapped in 
the region containing the agu gene. According to a published map (Jacob et a l, 1995) 
this locus was located between DlMitl and Cype. Therefore, this microsatellite marker 
was expected to map at a distance of less than 7.6 cM (95% upper confidence limit for 
DlMitl).
Allelic differences were demonstrated between the AS/AGU and the F344 rat 
strains at this locus. Contrary to previously released data, the DlMghl8 allele in the 
latter was smaller than that in the BN and the AS/AGU strains. Moreover, typing of 
[AS/AGU x (AS/AGU x F344) FI] progeny with the corresponding primer pair CYSS 
indicated that this locus was not linked to the agu gene nor to two other markers in the 
region of interest, DlCep4 and DlMco2. Correlation of these results with the published 
DlM ghl8 locus was confirmed by cloning and sequencing the PCR product. Mapping 
of this SSLP within the cystatin S (Cys S) gene was equally demonstrated.
PCR screening of a panel of mouse x rat somatic cell hybrid clones showed 
(Dl)Mghl8 to map to rat chromosome 3 and not to chromosome 1. In contrast to the 
perfect correlation observed between the former and the rat-specific PCR product, more 
than 50% of the clones were discordant with the expectation of this marker being on rat 
chromosome 1. This is summarised below, in Table 7-2. This new location of 
(Dl)Mghl8 explains the failure to detect any linkage of this marker to other 
chromosome 1 loci, experienced by this group and also reported by Gu and coworkers 
(1996).
Chromosome 1 Chromosome 3
+ +
+ 1 7 8 0
(Dl)Mghl8
TABLE 7-2. Correlation of the presence or absence of the lDl)M zhl8-PCR product 
with each of the chromosomes 1 and 3 in a panel of 14 mouse x rat 
somatic cell hybrid clones.
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Further evidence of (Dl)Mghl8 indeed mapping to rat chromosome 3 was 
obtained from linkage analysis studies. Another SSLP marker which mapped to this 
chromosome, D3Mit4, was clearly demonstrated to be linked to the locus under study, 
at a distance of about 10 cM. Three point cross analysis between these two markers and 
a third chromosome 3 locus, Scn2a, showed that (Dl)Mghl8 mapped distal to the latter. 
Comparison of the data obtained with the map published by Jacob and coworkers 
(1995) showed a close similarity between the distances estimated between D3Mit4 and 
Scn2a. These were 41.5 cM and around 40 cM, respectively. A more precise location of 
(Dl)Mghl8 could not be defined, as none of the other SSLP loci analysed to that date 
were informative for the [AS/AGU x (AS/AGU x F344) FI] cross. Nonetheless, 
according to the estimated distances, it seems likely that the Cys S gene will map in the 
region flanked by the loci D3Mit2 and D3Mgh3, presented in the map by Jacob et al. 
(1995).
Given its location, (Dl)Mghl8 was renamed D3Gul, according to the rat 
nomenclature committee.
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8.0 Introduction.
The AS/AGU strain of rat constitutes a new genetic model of movement 
disorder. The phenotypic abnormalities exhibited by these animals are believed to result 
from mutation at a single locus, agu. The main objective of this work was the mapping 
of the agu mutation to a genetic interval of 1 cM or less, which allowed the initiation of 
the physical mapping. In the absence of any evidence for the function of the product of 
the agu gene, a positional cloning approach was required. Microsatellite loci were 
selected as genetic markers (Litt and Luty, 1989; Weber and May, 1989), and linkage to 
agu was sought in two sets of backcross progenies. Co-segregation of alleles at agu and 
the kallikrein (Kal) gene, located on rat chromosome 1, indicated that agu mapped to 
this chromosome. Linkage analysis studies with other available SSLP markers allowed 
the establishment of a 25-30 cM interval containing the agu gene. Attempts to develop 
new informative markers through the amplification of rat genomic DNA with mouse 
SSLP primers failed. In contrast, screening of a rat PI library with dinucleotide repeats 
resulted in the isolation of various new microsatellite markers. The agw-containing 
region was consequently narrowed down to ca. 11 cM. This was still too large an 
interval to attempt the physical mapping of the region.
The publication in 1996 of two genetic maps of rat chromosome 1 (Gu et al., 
1996; Ding et al., 1996) revealed that the protein kinase C, type I {Pkc) gene mapped 
within the agw-containg interval. The microsatellite locus R158, identified within Pkc, 
was shown to be informative for both backcrosses in this project. Typing of backcross 
progeny demonstrated that this SSLP locus maps at less than 0.5 cM from agu, thus 
making it possible to start the physical mapping of this region. The final genetic map is 
shown in Figure 8-1.
8.1 Precise genetic mapping of the agu mutation.
8.1.1 Approaches to the chromosomal localisation o f agu.
A genome-wide search was required to identify the location of the agu locus on 
the rat genome. Microsatellites were selected as the genetic markers, on the basis of
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4.9
<0.5
-D1M co2
- D lM it l  
~D 1 Cep4
jagu 
•Pkc
2.5
~D1Gu10 
JD1Gu16/D 1Gu15
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FIGURE 8-1. Composite map of the asu-containing region in rat chromosome 1. 
Distances between loci (in cM) were calculated using the Kosambi’s map function, and 
are indicated to the left of the chromosome. The microsatellite loci DlM itl and 
DlMgh7 were used to type BN backcross offspring. Their position should be regarded 
as approximate since it does not correspond to the number of recombination events 
observed between these and the rest of the loci, mapped on the F344 backcross.
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their widespread distribution on the genome, the high rate of allelic variation, and the 
ease with which these loci can be typed by PCR amplification (Luty et al., 1990; 
Beckmann and Weber, 1992; Serikawa et al., 1992). Nevertheless, high-resolution maps 
of the rat genome are not available yet, in comparison to the mouse (Dietrich et al.,
1994) and man (Murray et al., 1994). At the time this work was started, between 50 and 
70% of the rat genome was covered by genetic markers (Serikawa et al., 1992), only a 
proportion of which were informative in either or both of the backcrosses used. 
Therefore, linkage of the available rat markers to the agu locus might not have been so 
readily detected, if at all. Typing of backcross progeny with a very large number of 
SSLPs might have been required in order to establish linkage of at least one marker to 
agu. Automated genotyping, not used in this work, could have then been a crucial factor 
in increasing the efficiency of the screening process, as combinations of the various 
fluorescent dyes and of amplification reactions which yield products of different size, 
allow a higher throughput (Edwards et al., 1991; Smith, 1995). In addition, separate 
pools could have been prepared with DNAs extracted from normal and from affected 
offspring, respectively (Michelmore et al., 1991; Williams et al., 1993; Sheffield et al.,
1995). Random assortment should be observed between agu alleles and alleles at SSLP 
loci which are not linked to agu. Therefore, amplification with these markers should 
yield two signals of approximately the same intensity in each DNA pool, one 
corresponding to the AS/AGU allele and the other to the allele from the reference strain 
in the backcross (i.e. BN or F344). In contrast, amplification of the pool prepared with 
DNAs from affected progeny with SSLP markers which are linked to agu, should yield a 
single main product, corresponding to the AS/AGU allele. The signal given by the allele 
from the reference strain should weaken as the markers get closer to the agu gene. 
Confirmation of a possible linkage would then require the typing of the individual 
animals at the particular microsatellite locus.
A proportion of 25% of the SSLPs which were initially studied did not show 
allelic differences between the parental strains in the backcrosses. Williams et al. (1997) 
have demonstrated the use of SSCP analyses to reveal polymorphism at micro satellite 
loci which do not differ in the number of repeats. Therefore, in the absence of linkage of 
any of the informative markers to agu, the uninformative loci could have been further 
analysed in SSCP assays. Moreover, analysis of a larger number of rat strains prior to the 
establishment of the backcrosses may have revealed a
183
Chapter 8. General  discussion.
greater divergence between AS/AGU and some strains other than BN and, especially, 
F344, than between these two latter and AS/AGU.
Genome scan analyses could also have employed other types of genetic markers, 
such as random amplified polymorphic DNA (RAPDs). These polymorphisms result 
from the amplification of genomic DNA with single 9-10 nucleotide primers of arbitrary 
sequence (Williams et al., 1990). A series of DNA fragments are obtained with each 
primer which can be easily analysed on agarose gels. Advantages of these markers are 
the simplicity of the technique and, above all, the fact that no sequence information is 
required for the development of amplification primers. This is in contrast to SSLPs, 
where establishment of new markers requires identifying repeat sequences in cloned 
DNA fragments and obtaining the unique sequences flanking both sides of the repeat, as 
already described in Chapter 5. Moreover, the amplification of various DNA fragments 
in a single reaction renders RAPDs a fast and efficient method to detect differences 
between genomes. A further increase in the level of polymorphism has been observed 
following digestion of the templates prior to PCR (Koebner, 1995). This may be due to a 
reduction in the secondary structure, which in turn allows the primers to anneal more 
efficiently to the template. Disadvantages of this approach are problems with 
reproducibility and with the interpretation of some banding patterns. Careful 
standardization of the amplification conditions has been reported to solve many of the 
problems of poor reproducibility (Meunier et al., 1993; Micheli et al., 1994). Resolution 
on polyacrylamide gels eliminates the apparent co-migration of DNA fragments of very 
similar size. However, it is not possible to distinguish between fragments which are 
identical in size but differ in sequence. Another drawback is that heterozygotes can not 
be distinguished from one of the parental homozygotes. This is due to the fact that 
RAPDs are the result of amplification of a given DNA fragment from one of the 
genomes but not from the other. Consequently, for RAPD markers to be useful in the 
mapping of the agu mutation, these should result from the amplification of DNA from 
the reference strain and not from AS/AGU. In this way, presence of the RAPD fragment 
in the backcross progeny would be indicative of heterozygosity at that particular locus. 
An alternative would be the cloning of the informative RAPD fragments and their 
sequencing (Kurata et al., 1994), thus allowing the designing of appropriate primers at 
both ends of each fragment. Primer pairs which are developed through this route define 
what is called sequence-characterised amplified regions
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(SCARs) (Naqvi and Chattoo, 1996). These polymorphisms are highly reproducible and 
allow the differentiation between heterozygotes and both parental homozygotes.
Representational difference analysis (RDA) could well have been an alternative to 
the sequential screening for linkage of agu to other genetic loci. This method has already 
been described in Chapter 1 (Lisitsyn et al., 1993; Lisitsyn, 1995). Another approach 
that could be considered is RFLP subtraction (Rosenberg et al., 1994), which results in 
the purification of restriction fragments from a genome (‘tracer’) that do not have a 
counterpart of the same size in a competing genome (‘driver’). This method differs from 
RDA in that the size fractionation of the DNA fragments is carried out through gel 
purification instead of PCR and that amplification of ‘tracer’-specific DNA (i.e. the 
‘tester’ DNA in RDA) is only carried out after the last subtractive hybridisation step, 
when the sample has been greatly enriched for ‘tracer’ molecules. A greater power and 
specificity has been reported for this latter technique (Rosenberg et al., 1994). Although 
technically demanding, these methods are to be seriously considered in projects such as 
the positional cloning of the agu gene, where dense genetic maps of the organism in 
question are not available. Search for informative markers which map within the agu- 
containing region could be carried out with a pool of affected backcross or F2 animals 
as the source of ‘driver’ DNA and FI animals from the corresponding cross as those 
providing the ‘tester’ DNA. In this case, the ‘driver’ DNA most likely contains alleles 
from both AS/AGU and the reference parent at all the loci except at those mapping to 
the chromosomal region of interest (i.e. the agu gene and proximal loci). In contrast, the 
‘tester’ DNA also carries an allele from the reference parent at these loci. Therefore, 
sequences which only correspond to the reference parent are not subtracted and are 
instead selectively amplified. These products can subsequently be cloned and analysed.
8.1.2 Approaches to the precise mapping of agu.
Prior to the discovery of the close linkage of the Pkc gene to agu, the agu- 
containing region could not be narrowed down to less than 25-30 cM, as more 
informative markers were not available. Despite the failure in establishing new 
informative microsatellite loci based on the amplification of rat genomic DNA with 
mouse SSLP primers, the number of loci tested in this project was small. Given the high 
density maps currently available for the mouse (Dietrich et al., 1994; Brilliant et al.,
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1996), a rapid assay of all the mouse SSLPs mapping within the region of interest in 
mouse chromosome 7 would still remain a sensible approach to the identification of new 
markers in the agw-containing fragment in the rat. Integration of newly identified rat 
products into the rat map would first require their confirmation as new rat 
microsatellites, by sequencing. Linkage analysis studies would be carried out with those 
markers which were informative in the backcrosses. The conservation of synteny at these 
loci between the mouse and the rat would result in the refinement of the agu region. The 
close synteny observed to date between the region of interest on rat chromosome 1 and 
proximal mouse chromosome 7 would also validate the use of rat homologues of mouse 
genes on chromosome 7 to be screened for cleaved amplified polymorphic sequences 
(CAPS) (Konieczny and Ausubel, 1993). Strain differences at these marker loci are 
revealed following amplification of the same gene fragment in each strain and digestion 
of the PCR products with a panel of restriction enzymes. The DNA fragments are then 
analysed on standard agarose gels, in search for differences in the digestion patterns. 
Inclusion of introns in the sequence to be amplified maximizes the possibility of finding 
differences between the strains.
Genetically directed representational difference analysis (GDRDA) (Lisitsyn et 
al., 1994), already described in Chapter 1, and microdissection approaches, could be two 
other alternatives to the screening of the PI library with available reference sequences 
(i.e. uninformative rat SSLP loci; rat homologues to genes mapped in the region of 
interest on mouse chromosome 7). GDRDA could be attempted on ‘driver’ and ‘tester’ 
DNA pools prepared as described above (section 8.1.1), with the difference that only 
affected backcross animals which carried a cross-over between the agu gene and either 
one or both proximal flanking markers (e.g. DlM itl and Kal (or DIMghT), in the case 
of [AS/AGU x (AS/AGU x BN) FI] offspring), would be selected to create the ‘driver’ 
DNA pool. This selection would further refine the chromosomal area within which allelic 
differences were to be identified.
Microdissection is widely used as a means to isolate specific chromosomal 
fragments which can then be further characterised. The dissected DNA can be digested 
with specific restriction endonucleases and the fragments used to construct libraries, 
following ligation to adaptor sequences, PCR amplification, and cloning into appropriate 
vectors (Johnson, 1990). Clones thus derived from the agu region could be directly 
analysed for the presence of repeat sequences. Meltzer and colleagues (1992)
I
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have reported the successful generation of a set of amplification products from specific 
chromosomal regions, by using a universal primer to initiate the amplification of the 
microdissected DNA fragment at various sites throughout its length. These products can 
be labelled and directly used to probe genomic libraries prepared from either whole 
genomes or specific chromosomes (Flejter et al., 1995). Thus, this approach eliminates 
the use of any microchemical techniques on the dissected DNA. DNA fragments 
obtained from the amplification of the agu region following microdissection could be 
employed to screen the rat PI library. Microdissection of the agw-containing region 
would overcome a limitation inherent to the approach followed in this project, i.e. 
dependence on the availability of reference sequences to identify genomic clones which 
derive from the region of interest.
The vast majority of SSLP loci which mapped to the agu region had to be 
analysed on polyacrylamide gels, since the use of 4% MetaPhor gels did not ensure the 
resolution of 2 bp differences. Search for tri- and tetranucleotide tandem repeats when 
developing new micro satellite markers could have overcome this requirement, since 
allelic differences between strains must then correlate to size differences of 3 bp or more.
A large proportion of the microsatellite markers identified to date in the region 
carrying the agu gene are not informative for any of the backcrosses established. Had the 
Pkc marker R158 not been informative either, the lack of heterogeneity observed 
between AS/AGU and the F344 and the BN strains at the agw-containing region would 
have become a major obstacle to the precise genetic mapping of this mutation. In this 
case, search for other rat lines that differ from AS/AGU at SSLP loci in this interval, and 
establishment of new crosses of the most divergent strains to AS/AGU, would have been 
critical, and one or several of the methods described above used to isolate new genetic 
markers close to the agu locus. However, this was not necessary, as mapping of the 
R158 microsatellite at less than 0.5 cM from agu provided a starting point for physical 
mapping.
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8.2 Future work.
8.2.1 Physical mapping of the agu region.
The identification, by Dr.P.Shiels, of a PI clone which carries the R158 
microsatellite locus [PI(R158)\, constitutes the first step in the physical mapping of the 
agu-containing region. Probes derived from the ends of the genomic insert are to be 
used to screen the entire PI library, in search for overlapping clones. These probes can 
either be subclones of the end fragments or PCR products amplified following the 
determination of DNA sequences at the ends of the PI clone (Kimmerly et al., 1994). 
Alternatively, riboprobes can be synthesized from the T7 and the Sp6 promoters present 
at each side of the cloning site on the $Ad\0sacR\\ vector (Southard-Smith et al., 1994).
Various problems can be encountered during chromosome walking. Presence of 
repetitive sequences at the ends of the genomic insert precludes these from being used to 
search for overlapping clones. This may restrict the utility of some of the end sequences, 
given the abundance of long interspersed elements (LINEs) in the rat genome. In the 
case that both ends of the genomic insert were constituted by repetitive sequences, a new 
clone carrying the R158 sequence could be sought for. Alternatively, further sequencing 
of the P\(R158) insert ends could be carried on until a region of unique sequence was 
identified. A third possibility would be to use sequence-tagged-sites (STSs) derived from 
the P I(R158) clone to identify overlapping clones. It could also happen that the genomic 
region which is adjacent in the chromosome to the DNA fragment carried by the 
Vl(R158) clone is absent from the library. This would result in the cessation of the 
walking. In addition, the presence of chimaeric clones in the library could seriously 
endanger the identification of genomic regions which are adjacent to the jR/5#-region in 
the chromosome. The quality of the genomic library is thus of prime importance.
Successful walking approaches are often based on the use of a combination of 
different genomic libraries (Rommens et a l, 1989; Albertsen et al., 1994; Wang et al., 
1996). A brief description of these libraries is given in Chapter 1 (section 1.3). Rat 
genomic libraries have been recently constructed using the YAC (Cai et al., 1997) and 
the PAC vector systems. Integration of these latter and the PI library should ensure the 
coverage of the agu region, overcoming problems due to the presence of repetitive 
sequences or to the lack of representation of a particular genomic region in a library.
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A thorough characterisation of the identified overlapping clones is critical. 
Confirmation of the overlap between clones can be achieved through the analysis of the 
restriction patterns obtained with each clone, following partial digestion with a panel of 
restriction endonucleases (Wada et al., 1990; Hamvas et al., 1994). However, detection 
of overlap between two clones using this method requires that the region in common is 
considerably large. Another way to detect overlap between clones is to analyze the STSs 
carried in each clone (Albertsen et al., 1994). The clones must also be compared to the 
genomic region, in search for any rearrangements that may have taken place when 
constructing and/or analyzing the library (Feil et al., 1990b). In this context, 
development of microsatellite loci within the clones serves two purposes, the 
establishment of STSs which can be used in the analysis of overlapping clones, as stated 
above, and the identification of possible new informative markers between AS/AGU and 
the reference strains. In this latter case, typing of the backcross progeny should result in 
a further refinement of both the genetic and the physical maps. Moreover, these markers 
would allow the orientation of the walk. Independently from the linkage analyses, 
confirmation of the chromosomal location of each newly developed STS is essential in 
any walking approach. As explained in Chapter 1 (section 1.3), mapping of non- 
polymorphic sequences may be carried out by screening a panel of somatic cell hybrids. 
A radiation hybrid panel of the rat genome is currently under construction (James and 
Lindpaintner, 1997). This type of hybrids represent a considerable refinement to the 
mapping with somatic cell hybrids, as they allow a precise localisation of genetic loci on 
the chromosomes (James et al., 1994).
8.2.2 Identification o f genes in the agu region.
Various strategies can be followed to isolate the genes present in a region of the 
genome for which a physical map has been constructed (Parrish and Nelson, 1993; 
Monaco, 1994). Each method presents different advantages and disadvantages. 
Therefore, a combination of several of these techniques are in general applied in these 
studies. More traditional approaches are based on the identification of sequences within 
the genomic clones which are conserved across different species (Monaco, 1986). 
Disadvantages of this method are the failure to detect genes that have diverged between 
species and the amount of work involved. A second method relies on the identification of 
CpG islands, which are often associated with genes (Bird, 1986; Bird, 1987;
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Rommens et al., 1989). These are small, hypomethylated CpG-rich regions, normally 
containing a cluster of recognition sites for rare-cutter restriction endonucleases. Lack of 
methylation at these sites results in cleavage in both the cloned fragment and the genomic 
DNA, following digestion with the appropriate restriction enzymes. However, not all 
genes are associated with CpG islands, and these will be missed. Moreover, even when 
present, CpG islands may be located at a considerable distance from the transcribed 
region.
Other methods are based on the hybridisation of the genomic clones to cDNA 
libraries. Limiting factors in these studies are the possibility that the gene is expressed in 
a tissue-specific manner and therefore be present in some cDNA libraries but not in 
others, and the quality of the cDNA library itself. This latter feature is concerned with 
the representation of all the mRNAs present in the tissue used to construct the library. 
Pooling various cDNA libraries is often carried out in order to minimise the possibility of 
a given mRNA not being represented in the cDNA sample. Complex probes such as 
cosmid, PI, YAC clones, can be used to screen cDNA libraries (Elvin et al., 1990; 
Albertsen et al., 1994). However, problems arise due to the presence of repetitive 
sequences. Use of YAC inserts as probes has been shown to be particularly troublesome, 
yielding poor signals and a high background, and a considerable number of false 
positives. An alternative approach is known as hybrid selection (or cDNA selection). 
This has been reported to be a very efficient method for the identification of genes 
contained in genomic clones (Hattier et al., 1995; Harshman et al., 1995). The clones are 
immobilised on nylon filters and hybridised, following suppression of repetitive 
sequences, to cDNA inserts amplified from a cDNA library with vector primers (Parimoo 
et al., 1991; Lovett et al., 1991). Unbound cDNAs are eliminated and the hybridisation 
step is repeated 2 or 3 times. The cDNAs which are bound to the array of genomic 
clones following the last hybridisation step are eluted. These are then amplified with the 
same vector primers previously used to amplify the cDNA inserts, and cloned. This 
approach is simpler and less labour intensive than direct screening of cDNA libraries. 
Manipulations of large genomic clones such as YACs are not required. An improvement 
in the efficiency of this method has been obtained by carrying out the hybridisation step 
in solution, following biotinylation of the genomic DNA (Korn et al., 1992). A problem 
with hybrid selection is that pseudogenes that have not deviated extensively from the 
active gene also select cDNAs.
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Other methods for the identification of expressed sequences are exon 
amplification (or exon trapping), and screening for splice sites. Exon trapping consists in 
the cloning of genomic fragments into appropriate vectors carrying either a splice donor 
site (Duyk et al., 1990) or both a donor and an acceptor site (Buckler et al., 1991; 
Hamaguchi et al., 1992). Presence of an exon in the cloned genomic DNA results in the 
splicing of this fragment into mature mRNA following expression in cell lines. Reverse 
transcription-PCR (RT-PCR) is subsequently carried out on the mRNA sample. The 
presence of possible exons is recognised by the sizes of the PCR products. The main 
disadvantages of this approach are the greater complexity of this method, the rate of 
false positives obtained due to the activation of cryptic splice sites, and the failure to 
detect genes that do not contain introns. Furthermore, some splicing events are tissue- 
specific or temporally regulated, and may not occur in the cell lines being used. 
Screening for splice sites (Melmer and Buchwald, 1992) can be carried out by 
hybridisation to degenerate oligonucleotides corresponding to splice site consensus 
sequences. This method is simple and inexpensive and appears to be highly efficient.
An additional procedure towards gene identification is the sequencing of genomic 
DNA. Coding sequences can then be sought for, based on developed computer 
algorithms (Fickett, 1996). Sequence comparison through the available databases may 
reveal sequence homology between species, pointing to the presence of an exon. 
Analysis of a large region involves the generation of huge amounts of sequence data. 
Also, a sequence window (ca. 99 bp) is required for detection. Very small exons may 
thus be missed; however, it is unlikely that all exons of a gene will pass undetected.
Genomic fragments containing putative expressed sequences are normally used to 
probe Northern blots of mRNA, in order to confirm and analyse expression. These 
studies precede and/or complement the screening of cDNA libraries.
8.2.3 Identification of the agu mutation.
Searches for the agu mutation will be conducted on the genes identified in the 
physical map, by comparing the sequences in the AS and in the AS/AGU strains. Priority 
will be given to those genes which identify cDNA molecules in cDNA libraries prepared 
from total brain or dissected SN, and also to genes which show homology to
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sequences with a known function which could be putatively related to the agu 
phenotype.
Initial analyses could focus on identified cDNAs. Alternatively, genomic inserts 
could be directly sequenced. Isolation of full-length cDNAs may be difficult. A strategy 
for the production of full-length cDNA clones has been devised by Frohman et a l 
(1988), termed ‘rapid amplification of cDNA ends’ (RACE). This technique is based on 
the amplification of the region between a known short sequence in the particular cDNA 
molecule and its unknown 3' or 5' end
There are various methods to detect differences in the sequence of DNA 
fragments. Some of these are RFLP, SSCP and DGGE analyses, which have already 
been described in Chapter 1 (section 1.3). The sensitivity of the latter two methods 
decreases with increasing fragment length. Most exons in the mammalian genomes are 
less than 300 bp in length, which allows their direct analysis. Longer sequences can be 
analysed by multiplexing several PCR reactions and separating all the resulting 
products on the same gel (Nigro et al., 1995; Ozgelik and Andralis, 1995; Traystman et 
al., 1990). Alternatively, Tawata et al. (1996) have reported the successful 
identification of single base changes in PCR products of up to ca. 16 kb in length, by 
carrying out a long-range PCR and digesting the amplification product prior to SSCP 
analysis.
Two other methods that detect sequence differences between DNA fragments 
are thermal gel gradient electrophoresis (TGGE), similar to DGGE except that the DNA 
is denatured across a temperature gradient (Fischer and Lerman, 1983), and 
heteroduplex analysis (HA), based on the lower mobility on polyacrylamide of 
heteroduplex DNA , formed by the annealing of a normal and a mutant DNA strand, 
compared to that of homoduplex DNA (Delwart et al., 1993).
Presence of mismatches in heteroduplex DNA can also be detected by selective 
cleavage of the mismatched base pairs following reactivity with appropriate chemicals 
(chemical cleavage of mismatch, CCM) or enzymes (enzyme mismatch cleavage, 
EMC). A limited success was initially reported for these approaches. However, new 
variants of these methods are achieving increasingly higher levels of sensitivity. An 
example is the mapping of mutations using T4 endonuclease VII (Youil et al., 1995). In 
the work reported by Youil et al. (1995), this endonuclease recognized 17 out of 18
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single bp mutations. The mismatch A • A/T • T was not detected; in addition, some 
nonspecific nuclease activity of the enzyme was observed.
DNA sequencing is the most direct way to detect mutations. Availability of 
fluorescence-based automated sequencers allows the rapid analysis of long stretches of 
DNA. This is, however, an expensive approach when attempting to sequence large DNA 
regions. Consequently, DNA sequencing is often used in combination with some of the 
methods described above. Notwithstanding, DNA sequencing is always the ultimate step 
to define a mutation once a difference in the DNA sequence has been detected by any 
given method.
Should a single nucleotide change be consistently detected when analysing a 
certain DNA fragment from both AS and AS/AGU animals, various features of this 
variation in the sequence could add supportive evidence of its putative identity as the 
agu mutation. Were this base change found in the coding regions, this must be confirmed 
as a non-silent mutation, that is, the nucleotide change results in a new codon, 
corresponding to a different amino acid from that found in the normal protein, or to a 
translation termination signal. Alternatively, the mutation could occur in either a splice 
site or in a regulatory region.
Final confirmation of the putative identity of a gene as agu would ultimately 
come from targeted gene experiments. Successful gene replacement in the rat has not 
been reported, although further developments in transgenic technology could make this a 
feasible approach (Campbell et al., 1996b; Clouthier et al., 1996). Alternatively, gene 
targeting could be carried out in mouse, and the effects on the phenotype assessed.
8.3 Final remarks.
8.3.1 The agu gene and the molecular basis of movement disorder.
The AS/AGU strain of rat is likely to be a good model for certain movement 
disorders. Neurochemical and histological data, together with the general improvement 
of the condition in these animals following L-dopa administration or fetal midbrain 
transplants, further suggest a particular role of this mutant as a genetic model for
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Parkinson’s disease. This would constitute an important finding, given the scarcity of 
genetic animal models for this pathology.
A genetic etiology in Parkinson’s disease has not been favoured until recently, 
but has now been accepted for a subset of cases. Clear evidence comes from studies of 
multicase families. Genetic factors have already been proposed and even characterised 
(Harris et a l, 1995; Polymeropoulos et a l, 1996, 1997; Wilhelmsen et a l, 1997). 
Characterisation of the agu gene is expected to shed new light on the mechanisms 
involved in dopaminergic deficiency in the basal ganglia. Comparative mapping analysis 
suggests that the human homologue of this gene resides on chromosome 19. Correlation 
of PD cases to this chromosome has not been reported to date.
A series of different factors have been proposed in the pathogenesis of PD, such 
as deficient antioxidative mechanisms. These abnormalities can lead to disruption of the 
cell membrane and intracellular signalling pathways, resulting in cell death. 
Polymeropoulos et al (1997) recently identified a mutation in the a-synuclein gene, in 
affected individuals in a large Italian kindred. This genes codes for a presynaptic nerve 
terminal protein thought to be involved in neuronal plasticity. Interestingly, the reduction 
in dopamine levels recorded in AS/AGU animals, compared to normal AS rats, is much 
smaller in the gross analyses than in microdialysis studies of the extracellular fluid of the 
striatum in these animals. This suggests that the agu mutation is associated with a defect 
in the functional release of dopamine in the striatum.
8.3.2 Future development of the rat genetic map.
Positional cloning of the agu gene will contribute to the development of the rat 
genetic map. New genetic markers have already been isolated. Additionally, the large 
size of the backcrosses being used in this project ensures reliable estimates of the genetic 
distance between loci. These are thus a suitable substrate for the construction of genetic 
maps of the rat genome which integrate markers already available from different sources 
and newly established loci. Similar approaches are already being carried out (Courvoisier 
et a l, 1997; Bihoreau et a l, 1997). Panels of backcross animals carrying a crossover 
between any two adjacent loci could be established, as has been done with the markers 
R191 and DIGulO, flanking the agu locus. Typing of the appropriate panel with any new 
internal marker would allow the mapping of this locus
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with a high level of resolution, eliminating the need to screen very large numbers of 
animals.
The establishment of a high-resolution genetic map of the rat genome is essential 
for the full exploitation of this animal as a genetic model. Although traditionally used in 
anatomical and physiological studies, the rat has become a rich source of models for 
polygenic and common multifactorial traits. A wide array of inbred strains of rat is 
currently available (Greenhouse et al., 1990). Rat models exist for hypertension (Hilbert 
et al., 1991; Jacob et al., 1991; Gu et al., 1996), diabetes (Gauguier et al., 1996; Galli et 
al., 1996), immunological responses (Ben-Nun et al., 1982), various infectious diseases, 
drug and chemical addiction, renal failure (Brown et al., 1996), and cancer (Hsu et al., 
1994). Moreover, in some cases the laboratory rat has shown to be a more appropriate 
model than, for example, the mouse, traditionally favoured by mammalian geneticists. 
Very clear examples are found in the role of rat models in hypertension studies as well as 
in organ transplantation experiments.
Sequencing of short cDNA fragments and their mapping on the genome greatly 
facilitates gene identification. These sequences are known as ‘expressed sequence tags’ 
or ESTs (Nelson, 1995). A considerable effort is being directed towards the 
development of ESTs in the human (Adams et al., 1992) and the mouse genomes 
(Davies et al., 1994b; Stewart et al., 1997). It is logical to assume that the increasing 
interest in the rat as a genetic model will also lead to the establishment of rat ESTs. This 
will, in turn, enhance the potential of the rat genetic map to contribute to the further 
development of the mouse and the human maps, through comparative mapping analyses 
(Eppig and Nadeau, 1995). Development of a large array of ESTs located throughout 
the genome will provide a ready source of candidate genes in regions suspected of 
carrying a disease-gene. Identification and characterisation of genes in the agu- 
containing region will contribute new ESTs to the rat map.
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APPENDIX A.
Rat genetic maps.
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FIGURE A-2. Rat genetic linkage map taken from Jacob et al. (1995).
A total number o f 430 SSLPs have been integrated into 21 linkage groups, each 
corresponding to one o f 21 rat chromosomes. Gene names are shown in parentheses. 
Markers placed on the same horizontal line did not show recombination in any o f the 46 
animals studied. The numbers to the left o f  the chromosomes are estimated distances 
(in cM) between adjacent loci. The orientation o f  the chromosomes is not known except 
for chromosomes 1 and 2, where the short arms are shown at the top.
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FIGURE A-3. Linkage maps for rat chromosome 1 taken from Gu et al. (1996).
The map on the left-hand side was constructed with the data from 151 F2 (LEW x S) 
rats, and that on the centre with data obtained from 159 F2 (WYK x S) rats. The map on 
the right-hand side is the result of combining both sets of data. Distances (in cM) 
between adjacent loci are indicated to the left of the chromosome.
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FIGURE A-4. Linkage maps for rat chromosome 1, taken from Ding et al, (1996).
From left to right: Linkage maps based on the typing of 40 F2 progeny from the rat 
crosses F344/N x LEW/N, BN/SsN x LEW/N, and DA/Bkl x F344/Hsd, respectively. 
T^ Vo linkage groups were established with the first cross, which covered 191 cM. 
Distances between adajacent loci are given in percentage of recombination.
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